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It is feasible that RNA is one of the oldest biomacromolecules still present in living cells today. 
The versatility of RNA is perhaps one of the most important reasons why it still has such a central 
position. Arguably, the most well-known function of RNA is to confer the genomic information 
embedded in the DNA into functional proteins, but RNAs can be utilized for many other different 
purposes. Examples of this include the use of RNA as a structural component (e.g. the tRNAs), 
the use of RNA as a catalytic subunit (i.e. ribozymes) and the use of RNA as a regulatory element 
(e.g. miRNAs). This great variety of functions also implies that the metabolism of these important 
biomolecules must be tightly regulated within a cell. One of the many different factors that 
govern this regulation is a protein complex with associated 3’-5’ exoribonuclease activity called 
the RNA exosome, which has been conserved in archaea and eukarya, while eubacteria contain 
a similar protein complex called the degradosome. This chapter will give an outline of the thesis 
combined with a brief review of our current knowledge on the RNA exosome, addressing its 
structure and function in different species.
Discovery of the exosome
While the discovery of the human RNA exosome complex was facilitated by its association 
with disease (see Chapter 2), the first indication of the presence of such a protein complex 
came from studies in yeast. Around 1990, research focused on the most abundant type of RNA 
species: the ribosomal RNAs (or rRNAs). The rRNAs are believed to constitute as much as 75% 
of the total RNA content of a cell, and since they are essential components of the ribosomes, 
they are directly involved in the production of virtually all proteins operating in a living cell. 
One of the constituents that make up the large subunit (60S) of the yeast ribosome is the 5.8S 
rRNA. It is initially transcribed as a large precursor rRNA (also pre-rRNA), which is modified 
by several endonucleases and exonucleases to produce the mature 5.8S rRNA and the two 
larger RNA components of ribosomes. This process is often referred to as ‘maturation’, and 
much effort was put into finding and characterizing the protein(s) that are involved in this 
process. For this reason, temperature-sensitive yeast mutants were screened for defects in 
pre-rRNA maturation by northern blot hybridization experiments, which revealed aberrant 
5.8S rRNA species that were extended at either their 5’ or 3’ end. 
The 5’-extended pre-5.8S rRNA species were found to be a result of a mutation in the Pop1 
gene, which was later shown to be a part of a large multi-protein complex with associated 
endonuclease activity called RNase MRP (Lygerou et al, 1996). The gene associated with the 
mutation that led to aberrant 5.8S rRNA species extended at their 3’-end was cloned and 
designated Rrp4 (rRNA processing defective). The discovery that this protein was associated 
with 3’-5’ exoribonuclease activity led to the hypothesis that Rrp4 is responsible for generating 
the mature 3’-end of the 5.8S rRNA species (Mitchell et al, 1996). Analogous to Pop1, the Rrp4 
protein appeared to be a constituent of a 300-400 kDa protein complex, as determined by 
glycerol gradient sedimentation analysis. Aided by the advances in protein purification and 
protein identification by nanoelectrospray mass spectrometry, four other constituents of the 
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complex were readily identified: Rrp41, Rrp42, Rrp43 and Rrp44 (Mitchell et al, 1997). Analysis 
of their amino acid sequences showed that Rrp4, Rrp41, Rrp42 and Rrp43 shared homology 
to the bacterial exonuclease RNase PH, which is a relatively well-known protein belonging to 
the PDX superfamily of 3’-5’ phosphorolytic exonucleases (Table 1). 
The hallmark of a phosphorolytic enzyme is that it uses inorganic phosphate to attack the 
nucleotide-nucleotide bond, while a hydrolytic enzyme will activate a water molecule to 
establish this (schematically illustrated in Figure 1). As a result, phosphorolytic enzymes will 
release nucleotide diphosphates (NDPs), while hydrolytic enzymes will release nucleotide 
monophosphates (NMPs). An example of such a hydrolytic enzyme is the fourth identified 
component of the complex, Rrp44 (also called Dis3), which shares homology to the bacterial 
RNase R and RNase II, and is therefore placed in the RNR superfamily of exonucleases.
Screening the yeast genome for open reading frames (ORFs) encoding proteins with 
homology to RNase PH, allowed the identification of three additional proteins: Rrp45, 
Rrp46 and Mtr3 (Mian, 1997), which were later found to be constituents of the same complex 
(Allmang et al, 1999b). In the latter study, two additional protein subunits of the complex were 
identified: Rrp40 and Csl4 (an overview of all the different exosome components is given in 
Table 2). These two proteins were grouped together with Rrp4 in a separate superfamily of 
exonucleases (RRP4), because of their S1 and/or KH RNA binding domains and their lack 
of homology to any of the RNase PH-like proteins. Further evidence that these proteins are 
functionally related came from experiments in yeast, which demonstrated that all of them 
are essential for proper 3’ end formation of the 5.8S rRNA. For obvious reasons, this protein 
complex with exoribonuclease activity was designated ‘the exosome’. Shortly hereafter, 
the human exosome was identified as well, after Allmang and colleagues realized that a 
previously identified complex in humans, frequently targeted by autoantibodies in the serum 
of patients suffering from the polymyositis/scleroderma-overlap syndrome showed striking 
similarities with the yeast exosome (Allmang et al, 1999b; Brouwer et al, 2001). 
Table 1. Overview of exoribonuclease superfamilies.1 
Superfamily Exoribonucleases (examples) Activity
5PX Xrn1, Rat1 5’-3’ hydrolytic
DEDD RNase D, RNase T, Rrp6 (PM/Scl-100) 3’-5’ hydrolytic
PDX PNPase, RNase PH, ‘exosome ring’ 3’-5’ phosphorolytic
RNB RNase BN 3’-5’ hydrolytic
RNR RNase R, RNase II, Dis3, Dis3-like 1 3’-5’ hydrolytic
RRP4 Rrp4, Rrp40, Csl4 3’-5’ phosphorolytic2
1 Table is adapted from Zuo and colleagues (Zuo and Deutscher, 2001)
2 Only activity of the plant Rrp4 has been demonstrated
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Figure 1. Hydrolytic versus phosphorolytic exoribonuclease activity.
Although exoribonucleolytic RNA degradation can be performed in two different directions (either 3’ to 5’ or 5’ to 3’) 
and can involve many different enzymes, there are only two underlying mechanisms to establish this. In hydrolytic 
RNA degradation, a water molecule will be used for a nucleophilic attack on the RNA ribose-phophate backbone, 
and as a result will generate NMPs. Phosphorolytic RNA degradation entails the usage of inorganic phosphate to 
establish this, leading to the formation of NDPs.
Structure of the exosome
The complex formation of proteins with RNase PH-like domains (RPDs) and proteins 
containing S1 and/or KH RNA-binding domains was reminiscent of a protein complex 
originally identified in eubacteria, called polynucleotide phosphorylase, or PNPase (Figure 
2A). This complex is composed of three PNPase molecules, each containing two different 
RNase PH-like domains (RPD1 and RPD2), a S1 and a KH RNA binding domain (Symmons et 
al, 2000). Although each PNPase molecule has two RPDs, only one of them (RPD2) was found 
to be phosphorolytically active, in agreement with the lack of conservation of key residues 
in RPD1. RPD1 seems to be of structural importance, as the active sites as well as the RNA-
binding surfaces are formed at the interface between RPD1 and RPD2. This protein complex 
adopts a ring-like structure, formed by the alternating RPD1 and RPD2 domains, while the 
RNA-binding domains are positioned on one side of the ring.
Although PNPase was originally discovered as the first enzyme synthesizing RNA (Grunberg-
Manago et al, 1955), it later became clear that the primary function of PNPase, like that of the 
exosome, is the processing and degradation of RNA (Yehudai-Resheff et al, 2001). It is also 
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Table 2. Exosome core components and exosome-associated proteins and complexes.
Exosome core proteins
Protein name (subcellular localization1) Domain(s)2 Remarks
Archaea S. cerevisiae Human    
Rrp41
Rrp41 
Rrp46 
Mtr3
(N/C)
Rrp41 
Rrp46 
Mtr3
(N/C) RPD2
(Putative) 
phosphorolytic 
3’-5 exoribonuclease
Rrp42
Rrp42 
Rrp43 
Rrp45
(N/C)
Rrp42 
OIP2 
PM/Scl-75
(N/C) RPD1
(Putative) 
phosphorolytic 
3’-5 exoribonuclease
Rrp4
Rrp40
Rrp4 
Rrp40
(N/C)
Rrp4 
Rrp40
(N/C) S1, KH RNA binding
Csl4 Csl4 (N/C) Csl4 (N/C) S1 RNA binding
Exosome-associated proteins
Exonucleases
- Dis3 (N/C) Dis3 (N)
RNB 
 
PIN
Hydrolytic 
3’-5’ exoribonuclease 
Endonuclease
- - - Dis3-like 1 (C) RNB
Hydrolytic 
3’-5’ exoribonuclease
- Rrp6 (N) PM/Scl-100 (N/C) 35EXOc
Hydrolytic 
3’-5’ exoribonuclease
TRAMP complex
-
Trf4 
Trf5
(N) Trf4-2 (N) PAP Poly(A) polymerase
-
Air1 
Air2
(N) ZCCHC7 (N) Znf
RNA binding 
(Zinc finger)
- Mtr4 (N) Mtr4 (N) DEXDc DEAD-like helicase
NEXT complex
- - - RBM7 (N) RRM RNA binding
- - - ZCCHC8 (N) Znf
RNA binding 
(Zinc finger)
- - - Mtr4 (N) DEXDc DEAD-like helicase
Ski complex
- Ski2 (C) SkiV2 (C/N) DEXDc DEAD-like helicase
- Ski3 (C) Ski3 (C/N) TPR
Protein-protein 
interactions?
- Ski8 (C) Ski8 (C/N) WD40
Protein-protein 
interactions?
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CBCA complex
- Cbc2 (C/N) CBP20 (C/N) RRM (capped) RNA binding
- Cbc1 (C/N) CBP80 (C/N) MIF4G Structural protein
- - - ARS2 (C/N) -
Protein-protein 
interactions
Ccr4-Not complex
- Not(1-5) (C/N) Cnot(1-5) (C/N) - -
- Ccr4 (C/N) Cnot6 (C/N) LRR Deadenylase
- Caf1 (C/N) Cnot7 (C/N) - Deadenylase
- Caf40 (C/N) Cnot9 (C/N) - -
- Caf130 (C/N) Cnot10 (C/N) - -
Others
- Rrp47 (N) C1D (N) -
Interacts with Rrp6 
(PM/Scl-100)
- MPP6 (N) MPP6 (N) -
Interacts with Rrp6 
(PM/Scl-100)
AU-binding proteins
- - - KSRP (C/N) KH Destabilization
- - -
AUF1/ 
hnRNP D
(C/N) RRM
Stabilization /
destabilization
- - - TTP (C/N)
CCCH zinc 
finger
Destabilization
- - - RHAU (C/N) DExH/D
RNA helicase /
destabilization
- - - HuR (N) RRM Stabilization
1 Subcellular localization of the protein (C = cytoplasm, N = nucleus)
2 RPD1/2 (RNase PH-like domain 1/2), S1 (RNA-binding domain, S1), KH (K Homology domain), RNB (catalytic 
domain of ribonuclease II), PIN (PilT N terminus), 35EXOc (3’ to 5’ exonuclease domain), PAP (polynucleotide 
adenylyltransferases polymerase), Znf (Zinc finger domain), DEXDc (Helicase-like, DEXD box c2 type domain), TPR 
(Tetratricopeptide repeat domain), WD40 (WD40-repeat-containing domain), RRM (RNA recognition motif domain), 
MIF4G (Middle domain of eukaryotic initiation factor 4G), LRR (leucine-rich repeats), CCCH zinc finger (Zinc finger, 
CCCH-type domain), DExH/D (DEXH box helicase, DNA ligase-associated domain).
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noteworthy that the above-mentioned RNase PH can be found in a similar barrel-shaped 
complex, consisting out of six RNase PH subunits, each containing a single RNase PH domain, 
although in comparison with the PNPase complex the S1 and/or KH RNA binding domains 
appear to be absent from the RNase PH complex (Ishii et al, 2003).
The structures of the eubacterial exoribonuclease complexes suggest that there appears 
to be a reoccurring theme in the structure of complexes that control 3’-5’ degradation of 
RNA. Considering that 3’-5’ degradation is the main route for RNA turnover in bacteria and 
the fact that PNPase is present in the chloroplasts and mitochondria of higher eukaryotes, 
it can be hypothesized that RNase PH, PNPase and the exosome are evolutionary related 
complexes (Lin-Chao et al, 2007). This hypothesis was extended by Van Hoof and Parker (van 
Hoof and Parker, 1999), who also described similarities with a complex involved in the correct 
processing and degradation of proteins, the proteasome. The individual components that 
make up the proteasome were each found to be essential, as depletion of one resulted in 
the failure in the assembly of the whole complex, thereby abrogating its function. A similar 
explanation could therefore be applied to the observations that depletion of each individual 
subunit of the exosome complex resulted in defects in 3’ end formation of the 5.8S rRNA, 
Figure 2. Comparison of the bacterial PNPase with the archaeal and eukaryotic exosome complexes.
Schematic representation of three structurally similar protein complexes involved in RNA processing and 
degradation. (A) In PNPase, the RPD1 and RPD2 domains are clustered together with the RNA binding domains S1 
and KH into one single PNPase protein. Three of these PNPase molecules are used to form the donut-shaped protein 
complex. (B) In the archaeal exosome, the RPD domains are found in two different proteins: Rrp41 and Rrp42. As a 
result, three Rrp41/Rrp42 dimers are used to construct the ring structure, while the S1 and KH binding domains are 
represented by the Rrp4 and Rrp40 proteins that are clustered on one side of the donut structure, guiding substrate 
RNAs towards the catalytic center of the exosome formed by the Rrp41-Rrp42 dimer. (C) The eukaryotic exosome has 
a similar configuration in terms of domain organization, with the difference that 6 different proteins are used to form 
the ring-structure. Please note that the human nomenclature has been used in this illustration (also see Table 2).
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indicating that each subunit might be important for the structural integrity of the complete 
complex.
Initial results supporting the idea that the exosome adopts a PNPase-like structure came 
from electron microscopy (EM) studies with the yeast exosome, which was consistent with 
such a model (Aloy et al, 2002). More direct evidence came from two-hybrid studies with the 
human exosome, showing interactions between six of the RNase PH-domain-containing 
proteins: Rrp41, Rrp42, OIP2 (Rrp43), Rrp45, Rrp46 and Mtr3 (Raijmakers et al, 2002), 
suggesting that these proteins indeed form a ring-like structure. After another 3 years, the first 
crystal structure of an intact exosome complex, from the archaeon Sulfolobus solfataricus, 
was solved (Lorentzen et al, 2005).
Analogous to PNPase, the ring-like structure of the archaeal exosome complex is composed 
of proteins containing RPDs (Figure 2B). Unlike PNPase however, the ring-structure is not 
formed by oligomerization of one single protein, but by a set of two different proteins, Rrp41 
and Rrp42, which trimerize to form the ring. The RPD of Rrp41 shares sequence similarities 
with the RPD2 of PNPase, while the RPD of Rrp42 is more similar to the RPD1 of PNPase, 
resulting in a PNPase-like ring with alternating RPD1 and RPD2 domains. The archaeal 
exosome also harbors S1 and KH RNA-binding domains, which are found in two associated 
proteins, Rrp4 and Csl4, positioned on one side of the ring-like structure (Buttner et al, 2005; 
Lorentzen et al, 2007; Navarro et al, 2008).
Not long after the crystal structure of the archaeal exosome, the crystal structures of the yeast 
and human exosome complexes were resolved (Liu et al, 2006), and these displayed many 
similarities with the archaeal exosome and PNPase complexes. The ring-structure of the 
eukaryotic exosome is composed of six different proteins. Based on sequence conservation 
and comparison with the archaeal Rrp41 and Rrp42 proteins, these six proteins can be divided 
into 2 groups. One group (Rrp41, Rrp46 and Mtr3) is very similar to the RPD2-containing, 
archaeal Rrp41 protein, whereas the other group is more similar to the RPD1-containing, 
archaeal Rrp42 protein (Rrp42, OIP2 and PM/Scl-75). These six proteins constitute the ring-
structure, whereas the S1 and KH RNA binding domains are found in three different proteins 
that cap the ring-structure, Rrp4, Rrp40 and Csl4 (Figure 2C). In contrast to the archaeal 
exosome, these three proteins were found to be essential for the structural integrity of the 
complex. This feature explains why depletion of each of the exosome subunits in eukaryotes 
resulted in similar defects in 3’-end maturation of the 5.8S rRNA.
Activity of the exosome
The structural similarities between the exosome and PNPase, as described above, strongly 
suggested that its mode of action would be similarly as well. Indeed, initial data supporting 
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this idea came from studies on the archaeal exosome (Lorentzen et al, 2005). While the 
individual components (Rrp41, Rrp42, Rrp4 and Csl4) were found to be catalytically inert, 
reconstitution of the Rrp41-Rrp42 dimer from S. solfataricus showed that phoshorolytic 
exoribonuclease activity was indeed associated with the dimer. More specifically, the activity 
seemed to originate from the RPD2 domain of Rrp41. Mutations in this domain were sufficient 
to abrogate the activity of the dimer, whereas similar mutations in the RPD1 domain of Rrp42 
did not interfere with this particular activity. Analogous to PNPase, where the active site is 
formed by the interface of the two RPD domains, Rrp42 seems to be of structural importance 
for the activity of the archaeal exosome. This indicates that the hexameric ring-structure is 
phoshorolytically active, harboring three active sites residing in the three Rrp41-Rrp42 dimers 
that are present in the ring-structure. 
The RNA binding proteins (Rrp4, Csl4, or combinations hereof) probably play a role in the 
modulation of the exosome’s exoribonuclease activity and contribute to the substrate 
specificity of the exosome (Buttner et al, 2005; Ramos et al, 2006). Recently, it was shown 
that Rrp4 of S. solfataricus has a preference for RNA substrates containing a homopolymeric 
tail of adenosine residues at their 3’ end, whereas Csl4 prefers RNA substrates lacking such 
a tail (Roppelt et al, 2010). In addition, the RNA-binding proteins may contribute to the 
unwinding of secondary structures in RNA substrates, which otherwise would prevent access 
to the narrow channel in the ring-structure (Evguenieva-Hackenberg et al, 2008). These data 
support a model where substrate RNA is recruited by the RNA binding proteins, which guide 
the substrate into the central channel of the ring-structure, where it will be degraded by the 
Rrp41-Rrp42 dimer. A similar mechanism for RNA degradation by the bacterial PNPase has 
also been suggested (Shi et al, 2008).
It is noteworthy to mention that the archaeal exosome also displays polyadenylation 
activity, depending on the availability of nucleotide diphosphates (NDPs), similar to what 
was originally demonstrated for PNPase (Mohanty and Kushner, 2000). The 3’-end tailing of 
RNA substrates with a homopolymeric tract of adenosine residues appears to be a recurring 
mechanism for enhanced 3’-5’ RNA decay in various species. Examples of this include the 
tailing of RNA substrates by the TRAMP-complex, which functions in nuclear RNA quality 
control (see below) and the transient polyadenylation of rRNA species discussed in Chapter 
4.
In 2006, the activity of the yeast and human exosome complexes was studied by reconstitution 
experiments (Liu et al, 2006). The reconstituted human exosome complex was initially found to 
be phosphorolytically active, but this appeared to be due to contamination of the bacterially 
expressed protein subunits with PNPase, which copurified with these exosome components. 
Given the structural similarities shared by the yeast and human exosome complexes with 
the archaeal exosome and PNPase, it was rather surprising that the reconstituted yeast 
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and human exosome complexes were shown to be devoid of any catalytically activity. 
Nevertheless, this is in agreement with the poor conservation of several residues in the yeast 
and human Rrp41 proteins (Figure 3) that are involved in the coordination of the inorganic 
phosphate needed for the nucleophilic attack of the substrate RNA (Figure 1) (Dziembowski et 
al, 2007; Lorentzen and Conti, 2005). Exosome complexes from higher eukaryotes thus seem 
to have lost their ability to degrade RNA in a phosphorolytic fashion. An exception to this is 
the plant exosome, which displays phosphorolytic activity, consistent with the conservation 
of phosphate coordinating residues in Rrp41 (Figure 3) (Chekanova et al, 2000). 
The lack of activity found for the yeast and human exosome complexes complicated the 
interpretation of previous results, which showed that depletion of any of the exosome subunits 
had similar effects on 5.8S rRNA maturation and cell viability. Furthermore, experiments with 
the yeast exosome had shown that exoribonuclease activity was associated with the complex. 
An explanation for these paradoxical results came from experiments showing that exosomes 
from higher eukaryotes serve as a scaffold for the association of hydrolytic ribonucleases, 
which are responsible for the exosome-associated exoribonuclease activity.
Figure 3. Conservation of important functional residues in Rrp41 in different species.
Sequence alignment of part of the Rrp41 protein from Arabidopsis thaliana (At), Sulfolobus solfataricus (Ss), 
Saccharomyces cerevisiae (Sc), Homo sapiens (Hs) and Pyrococcus furiosis (Pf). Note the lack of conservation of some 
essential residues involved in phosphate binding (highlighted in black) in the human and yeast Rrp41. 
Exosome-associated proteins and protein complexes
Dis3
An obvious candidate providing the yeast exosome with ribonuclease activity was Rrp44, 
which copurified with the exosome (Mitchell et al, 1997), but was found to be not required for 
the reconstitution of the exosome core (Liu et al, 2006). It should be stressed that, throughout 
this thesis, the term ‘exosome core protein’ is exclusively reserved for the proteins that 
constitute the ring-structure (Rrp41-like and Rrp42-like proteins) and the RNA binding 
proteins that cap this structure (Rrp4, Rrp40, Csl4). 
Rrp44 appeared to be a homologue of the fission yeast Dis3 protein (Chromosome disjunction 
protein 3), which was originally identified as an essential protein for mitotic progression, 
(Kinoshita et al, 1991). Sequence analysis showed that Rrp44/Dis3 was homologous to the 
bacterial RNase R and RNase II, important 3’-5’ exoribonucleases belonging to the RNR 
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family of processive, hydrolytic exoribonucleases (Table 1). The term processive stands for 
the ability of an enzyme to remain attached to its substrate, performing multiple rounds 
of substrate conversion, whereas a distributive enzyme dissociates after only one round of 
catalysis (Von Hippel et al, 1994).
Yeast Dis3 can be found in both the cytoplasm and the nucleus, where is has been shown 
to associate with the exosome core complex (Synowsky et al, 2009). The activity of Dis3 
correlated well with the activity associated with the yeast exosome, and substitution of 
the wild-type Dis3 with a catalytically inactive mutant of the protein resulted in an inactive 
exosome complex (Dziembowski et al, 2007). These results strongly suggested that Dis3 was 
responsible for the majority of the activity of the yeast exosome. Surprisingly, the yeast Dis3 
protein appeared to be capable of degrading RNA substrates in two different ways. Besides its 
exoribonuclease activity, which is associated with the centrally located RNB domain, it was 
shown to possess endoribonuclease activity, for which the PIN domain is required (Lebreton 
et al, 2008; Schaeffer et al, 2009). This PIN domain also mediates the interaction between 
Dis3 and the exosome, allowing it to bind to one side of the exosome core structure (opposite 
to the side where Rrp4, Rrp40 and Csl4 are attached) (Bonneau et al, 2009; Hernandez et 
al, 2006; Schneider et al, 2009). Based on these findings, a model for RNA degradation by 
the eukaryotic exosome has been proposed (Bonneau et al, 2009; Malet et al, 2010). In this 
model, an RNA substrate will be recruited by the RNA-binding proteins, guided to the central 
channel of the complex, and after passing through this channel will be degraded by Dis3. This 
mechanism also allows the degradation of structured RNA substrates in which the exosome 
facilitates in the unwinding of the substrate before it gets degraded by Dis3 (Bonneau et al, 
2009). It is noteworthy to add that Dis3 can unwind and degrade structured RNA substrates 
itself without the help of the exosome core. When challenged with a structured RNA substrate 
with a sufficiently long 3’-overhang, Dis3 utilizes the energy of several rounds of nucleotide 
hydrolysis of this ‘free’ 3’ end to unwind structured regions (Lee et al, 2012).
Several observations indicated that the role of Dis3 in the function of the human exosome 
is different. Although the human homologue of yeast Dis3 was shown to rescue the growth 
defect phenotype in yeast, induced by depletion of Dis3 (Shiomi et al, 1998), Dis3 was never 
found to be stably associated with the human exosome core complex (Allmang et al, 1999b; 
Chen et al, 2001; Lejeune et al, 2003; Lim et al, 1997). Also the subcellular localization of 
Dis3 is partially different between the two species. Whereas yeast Dis3 can be found in the 
nucleus as well as the cytoplasm, human Dis3 seems to be confined to the nucleoplasm 
(Staals et al, 2010; Synowsky et al, 2009; Tomecki et al, 2010). This raised the question which 
proteins contributed to the activity of the cytoplasmic exosome in human and possibly other 
mammalian cells.
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PM/Scl-100 (Rrp6)
Before the association between PM/Scl-100 and the human exosome was demonstrated, its 
orthologue in yeast, Rrp6, was already known for its involvement in the maturation of rRNA. 
Similar to the experiments leading to the discovery of the exosome, the depletion of PM/Scl-
100 (Rrp6) resulted in the accumulation of a 5.8S rRNA precursor, which was extended at the 
3’ end (Briggs et al, 1998).
PM/Scl-100 (Rrp6) is a hydrolytic 3’-5’ exoribonuclease with structural homology to the 
bacterial RNase D and is therefore placed in the DEDD family of exoribonucleases (Table 1). 
The name for this family is derived from the 4 negatively charged residues (3 aspartic acids 
and 1 glutamic acid) that are each part of different sequence motifs of the protein. These 
residues are crucial for the coordination of divalent metal cofactors (Mg2+ and/or Mn2+), 
which facilitate the activation of a water molecule needed for the hydrolytic attack of the 
nucleotide-nucleotide bond (Midtgaard et al, 2006; Steitz and Steitz, 1993). 
Yeast Rrp6 contains a nuclear localization signal and immunofluorescence experiments 
demonstrated that it accumulates in the nucleoli. In this subnuclear compartment also 
a high concentration of exosome complexes has been found. The same holds true for its 
human counterpart PM/Scl-100, although the latter has also been reported to localize to 
the cytoplasm (Lejeune et al, 2003; van Dijk et al, 2007). Interestingly, plants express three 
different forms of this protein, each having a completely different subcellular localization 
(Lange et al, 2008).
The nuclease activity of PM/Scl-100 (Rrp6) is used in many RNA processing and degradation 
pathways, in which it generally acts in association with the exosome core structure. 
Experiments using a truncated version of Rrp6, which prevents the binding to the exosome 
core, have shown that the interaction is not essential for all of its biological activities (Callahan 
and Butler, 2008). The activity of PM/Scl-100 (Rrp6) is heavily influenced by the binding of 
two other proteins: Rrp47 (C1D in humans) and MPP6, especially when rRNA maturation is 
considered (Schilders et al, 2005; Schilders et al, 2007; Stead et al, 2007). These and other 
studies gave rise to the idea that PM/Scl-100 (Rrp6) might have exosome-independent roles 
as well (Callahan and Butler, 2008; Graham et al, 2009).
Although Rrp6 is a hydrolytic exoribonuclease like Dis3, they show some interesting 
differences between their modes of action and substrate specificities. First, Rrp6 is a 
distributive enzyme, whereas Dis3 was shown to act in a processive fashion. In addition, in 
vivo experiments have shown that Rrp6 has difficulties degrading structured areas of an RNA 
substrate, while Dis3 doesn’t seem to be hampered by this (Liu et al, 2006). The association 
of these two different ribonucleases thus provides the eukaryotic exosome with a broad 
repertoire of exoribonucleolytic activities. Distributive and processive ribonucleases often 
act in concert with each other (Deutscher, 2006; Dziembowski et al, 2007; Li et al, 1998).
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TRAMP complex
As mentioned above, 3’ poly(A) tailing followed by 3’-5’ degradation of an RNA substrate is a 
recurring phenomenon throughout many domains of life. In bacteria for instance, a complex 
called the degradosome is an assembly of different proteins that facilitate this process: a 
DEAD-box helicase called RhlB, the endonuclease RNase E, enolase and the abovementioned 
PNPase (Py et al, 1996; Raynal and Carpousis, 1999; Xu and Cohen, 1995). Degradation is often 
initiated by an endonucleolytic cleavage within the RNA substrate (RNase E), followed by 
polyadenylation to create a ‘landing-pad’ for exoribonuclease (PNPase) to begin degradation 
of the RNA body. RNA binding proteins and/or secondary structures, which might interfere 
with degradation, can be removed by the enzymatic function of the helicase (RhlB). A general 
model for this mechanism is depicted in Figure 4.
A similar system has been found in the nucleus of eukaryotes, where RNA degradation by 
the exosome is facilitated by the actions of the TRAMP complex, which harbors a similar 
‘repertoire’ of proteins needed to perform this: a poly(A) polymerase, either Trf4 or Trf5, 
the DEAD-box helicase Mtr4, and the RNA binding proteins Air1 and Air2 (Table 2). The 
TRAMP complex resides in the nucleus, where it is involved in RNA quality control and 3’-
end processing events (Kadaba et al, 2006; LaCava et al, 2005; Vanacova et al, 2005; Wyers 
et al, 2005). A human homologue of this complex (the NEXT complex) has recently been 
characterized, showing some interesting differences in terms of spatial distribution of its 
subunits when compared to its yeast counterpart (Lubas et al, 2011).
Other exosome-associated proteins
There are many other proteins and complexes that interact with the exosome. Several of 
these have been shown to aid the exosome in its role in cytoplasmic mRNA turnover. In 
yeast for instance, the Ski-complex (Ski2, Ski3 and Ski8) has been shown to be essential for 
exosome-mediated 3’-5’ decay of mRNAs (Anderson and Parker, 1998; Brown et al, 2000), 
probably by playing a role in substrate selection (Houseley et al, 2006). The Ski complex is 
positioned on top of the Rrp4/Rrp40/Csl4 ring structure, forming an extension of the exosome 
core channel. This couples the helicase activity of the Ski complex (Ski2) to the ribonuclease 
activities associated with the exosome (Halbach et al, 2013). Human homologues of Ski 
proteins have been identified, but experimental evidence linking them to mRNA turnover 
is limited. Paradoxically, the human Ski complex exists in the nucleus as well, suggesting 
that differences exist between the substrates of the human and yeast Ski complex (Zhu et al, 
2005).
Other proteins involved in exosome-mediated mRNA turnover are proteins which bind a 
specific sequence element in the 3’-UTR (3’-untranslated region) of some mRNAs, termed ARE 
(AU-rich element). AREs have a dramatic impact on the stability of the mRNA, depending on 
which ARE-binding proteins are present (Chen and Shyu, 1995; Mukherjee et al, 2002; Parker 
and Song, 2004). All currently known ARE-binding proteins that can bind to the exosome 
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are listed in Table 2. AREs as well as the ARE-binding proteins have been shown to recruit 
the exosome to the ARE-containing mRNAs (Chen et al, 2001; Gherzi et al, 2004). A similar 
mechanism was demonstrated for the ZAP protein. This protein specifically recognizes and 
binds viral RNA sequences and presents them to the exosome for degradation, implicating 
the exosome in viral resistance (Guo et al, 2007).
The Nrd1–Nab3–Sen1 (NNS) complex in yeast associates with AREs, where it serves as an 
important regulator of transcriptional termination (Creamer et al, 2011). The NNS complex 
copurifies with the nuclear exosome and TRAMP complexes, suggesting a role in the 
Figure 4. Model for polydenylation-stimulated 3’-5’ degradation of RNA.
Degradation of the RNA body is often initiated by an endonucleolytic cleavage event (step 2), after which the newly 
formed 3’ end will be using as starting point for exonucleolytic degradation. When degradation is stalled (eg. by 
encountering secondary RNA structures or RNA-bound proteins) a polyadenosine tail will be added (step 3). This tail 
will subsequently be used as a ‘landing pad’ for another round of exonucleolytic degradation (step 4).
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recruitment of RNA quality control factors (exosome and TRAMP) for degradation or trimming. 
With the exception of Sen1, no human homologues for the yeast NNS complex components 
have been found. However, recent copurification experiments with the human exosome and 
the abovementioned NEXT complex have identified the CBCA complex (cap-binding proteins 
CBP20 and CBP80 and arsenic-resistance protein ARS2), which is associated with the 5’ cap 
structure of nuclear mRNAs. Since CBCA was found to promote transcriptional termination, 
this finding hints at the coupling of transcriptional termination with RNA degradation and 
therefore might be functionally related to the activity of the yeast NNS complex (Andersen 
et al, 2013).
The exosome has also been reported to be associated with a protein complex that is often 
found at the 3’ end of RNAs: the Ccr4-Not complex. This latter complex has an important role 
in transcriptional regulation and mRNA decay (Ccr4 is the deadenylase that initiates mRNA 
decay by shortening of the poly(A) tail). It was postulated that the Ccr4-Not complex serves 
as a platform for bridging the nuclear exosome with the TRAMP complex, as Caf40 (one of the 
constituents of the Ccr4-Not complex) was found to be required for the interaction between 
Mtr4 and Rrp6 (Azzouz et al, 2009).
Functions of the exosome
Exosomes or exosome-like complexes (e.g. PNPase) are evolutionary highly conserved 
protein assemblies that are present in a broad range of different species, reflecting their 
central role in RNA metabolism. The complex seems to have adapted to the changing 
complexity in RNA processing and degradation events, given the still growing list of potential 
RNA substrates that have been identified over the years. With that said, it’s not unthinkable 
that virtually every RNA species will encounter the exosome somewhere in its lifecycle. Part 
of the explanation why the exosome is capable of handling so many different RNA species is 
the equally impressive list of known exosome-associated proteins and complexes (Table 2). 
Covering all known RNA species that are affected by the exosome would therefore be beyond 
the scope of this chapter. Instead, a brief overview of the most well established functions of 
the exosome, together with recent developments will be covered here. To keep everything 
in perspective, the ‘core activities’ of the exosome complex can roughly be divided into two 
major categories: complete RNA degradation and 3’-end processing.
RNA degradation is required in many different stages in the ‘lifecycle’ of an RNA molecule. 
Starting from the synthesis, the initial pre-RNA molecule often has to undergo several 
maturation events, in which parts of the pre-RNA molecule are cleaved off or excised, followed 
by the complete degradation of the released fragments. A good example is the degradation 
of the 5’ETS fragment resulting from the processing of the ribosomal RNA precursor (Allmang 
et al, 2000). Complete RNA degradation also occurs when errors during the maturation 
steps or other damaging agents lead to the formation of aberrant RNA molecules. Over 
the years, many examples showing the involvement of the exosome in the surveillance of 
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RNA molecules have been reported, including the clearance of hypomethylated tRNAs, 
improperly processed rRNAs (Allmang et al, 2000; Vanacova et al, 2005) and aberrant pre-
mRNA molecules (Houseley et al, 2006). These processes are often referred to as “RNA quality 
control”, in which the TRAMP complex, Rrp6 as well as Rrp44 play an important role. A role 
for Rrp6 during mRNA transcription has recently been established, where it was shown that 
Rrp6 ensures the tethering of the transcript to the DNA until full pre-mRNA processing has 
occurred (de Almeida et al, 2010).
Even when aberrant mRNAs escape early quality control mechanisms, additional 
cytoplasmic quality control mechanisms (Isken and Maquat, 2007), involving the exosome, 
prevent these abnormal mRNAs from doing damage. These mechanisms are often activated 
upon events that occur during the translation process of these aberrant mRNAs. In NMD 
(nonsense-mediated decay), aberrant mRNAs containing a premature stop codon will cause 
the stalling of the ribosome at an unusual location, e.g. distant from the poly(A) tail and/
or the presence of exon junction complexes upstream of the stop codon. These serve as 
important cues for recognition by the Upf proteins, which in turn recruit enzymes to promote 
the initial endonucleolytic cleavage (SMG6 in humans), resulting in 3’ fragments which will 
be degraded by Xrn1 and 5’ fragments that are degraded by the exosome in concert with the 
Ski complex (Eberle et al, 2009; Kervestin and Jacobson, 2012; Mitchell and Tollervey, 2003). 
In NSD (nonstop decay) and NGD (no-go decay), the ribosome will also stall at either the 
poly(A) tail (due to the lack of a stop codon) or at internal locations (due to inhibitory mRNA 
structures, rare codons, etc) respectively (Doma and Parker, 2006; Frischmeyer et al, 2002). 
In both cases, the stalled ribosomes will be sensed by the Hbs1-Dom34 protein complex 
(Carr-Schmid et al, 2002; Saito et al, 2013). These proteins are known to interact directly with 
the “A” site of the stalled ribosome, which is believed to stimulate cleavage of the mRNA 
substrate by a currently unknown endoribonuclease, again followed by degradation of the 
resulting fragments by Xrn1 and the exosome. Since many components of the NSD and NGD 
pathways seem to overlap, it is currently under discussion whether these pathways should 
be considered as separate entities (Shoemaker and Green, 2012). 
Even when an mRNA molecule has been properly processed, it will eventually be broken 
down by the exosome when it reaches the end of its lifespan (Schaeffer and van Hoof, 2011; 
van Dijk et al, 2007). Although ‘normal’ mRNA turnover can also be achieved by decapping, 
followed by seemingly uncontrolled 5’-3’ degradation by Xrn1, it has been shown that the 3’-
5’ degradation route, involving the exosome, is more tightly regulated (Garneau et al, 2007). 
Sequential or structured elements located in the 3’UTR (e.g. AREs) as well as the length of the 
poly(A) tail can serve as important regulatory signals for exosome-mediated degradation of 
these molecules. 
The enzymatic activities of ribonucleases do not always result in the degradation of the 
RNA substrate. In some cases, only partial degradation is required, which is referred to as 
(exonucleolytic) processing or trimming. Some steps in rRNA maturation, for instance, require 
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the complete degradation of released RNA fragments (e.g. the excised 5’ETS fragment), 
while other steps require the trimming of only a part of the pre-RNA sequence. In one of 
the final steps in the maturation of the 5.8S rRNA the molecule is still extended at its 3’ end. 
Removal of this sequence by the exosome has been shown to be dependent on Dis3, Rrp6, 
Mtr4 and Rrp47 in yeast (Allmang et al, 1999a; de la Cruz et al, 1998; Mitchell et al, 1997), as 
demonstrated by the accumulation of 3’ extended 5.8S rRNA molecules in the absence of 
these proteins. While the same repertoire of proteins have been shown to be involved in the 
processing of pre-rRNAs in humans, the exact mechanism and proteins involved are thought 
to be slightly different (Schilders et al, 2007; Sloan et al, 2013). Of course, 3’ processing in not 
restricted to the maturation of rRNAs, as the 3’ processing of snRNA and snoRNAs was also 
shown to be dependent of the exosome (Mitchell et al, 2003; van Hoof et al, 2000). Similar 
to the rRNAs, the absence of especially Rrp6 and Mtr4 resulted in 3’ polyadenylated sn(o)
RNA species, suggesting that the biosynthesis of these RNA species includes the formation 
of transient, TRAMP-induced, polyadenylated pre-sn(o)RNA intermediates, which are then 
targeted for processing by the exosome (LaCava et al, 2005). 
More recent work has shown that the exosome is also responsible for the removal of non-
coding RNA transcripts, that arise from transcription at noncanonical regions in the genome 
(such as intergenic and heterochromatin regions), which were previously considered to be 
transcriptionally silent. Nowadays, aided by the advances in sequencing-technologies, it is 
generally accepted that as much as 90% of the human genome is transcribed (Wilhelm et al, 
2008). Examples of such transcripts include the CUTs (cryptic unstable transcripts) in yeast, 
and PROMPTs (promotor-upstream transcripts) in humans (Neil et al, 2009; Preker et al, 
2008). Their expression levels are very low and they are rapidly degraded, which explains why 
they weren’t identified before. Their detection was facilitated by silencing several exosome 
and exosome-associated components, which points to an important role for the exosome in 
the regulation of their expression levels (Gudipati et al, 2012; Schmidt et al, 2012; Schneider 
et al, 2012).
Outline of this thesis
Roughly 15 years have passed since the discovery of the RNA exosome complex. During this 
period, our knowledge about its structure and function in different species has enormously 
increased. Nevertheless, there are still many aspects left uncovered considering the 
enzymatic activities associated with exosome, particularly the mammalian exosome. As 
has been described in this chapter, while the overall structure of the exosome complex is 
evolutionary highly conserved, the nature and distribution of catalytic subunits varies 
to a large extent among different species. The main aim of the research described in this 
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thesis was to provide more insight into the function of the exosome in human cells and the 
regulation of its activities.
In Chapter 2 the discovery of the human exosome will be covered from a medical perspective. 
The implications of autoantibodies targeting various components of the exosome complex in 
autoimmune disease patients will be addressed. In addition, a putative link between aberrant 
expression of exosome subunits and/or auxiliary proteins and cancer will be discussed.
In Chapter 3 the identification and functional characterization in human cells of a newly 
identified exosome-associated exoribonuclease, Dis3-like 1, will be described. In contrast to 
Dis3, Dis3-like 1 showed a stable interaction with the human exosome and was shown to 
contribute to the activity of the exosome complex. In addition to Dis3-like 1 another gene 
homologous to Dis3 was identified in the human genome and the corresponding protein was 
termed Dis3-like 2.
The studies in Chapter 4 are focused on the biological role of Dis3-like 1. The results indicated 
that at least one of the functions of this newly discovered protein in human cells is its role 
in polyadenylation-stimulated rRNA degradation in the cytoplasm. Although examples of 
polyadenylation-stimulated RNA degradation are fairly well known to occur in the nucleus, 
this is the first example of a similar RNA degradation mechanism operating in the cytoplasm. 
Since the human exosome core appears to function as a scaffold for the stable association 
of at least two exoribonucleases (Dis3-like 1 and PM/Scl-100) and the transient or weak 
association of Dis3, the relative contribution of each of these enzymes to the activity of the 
complex as a whole was investigated and the results of these experiments are described in 
Chapter 5. These not only indicated that the expression levels of these three exoribonucleases 
can affect each other, but also provide evidence that their association with the exosome 
complex might be mutually exclusive. We also show evidence that the activity of PM/Scl-
100 can be modulated by proteins (other than Dis3 and Dis3-like 1) that co-purify with the 
exosome.
Since previous observations indicated that both Dis3 and Dis3-like 2 have no or only a very 
weak interaction with the exosome core, the studies in Chapter 6 and Chapter 7 address 
their biological function independent of the exosome. Microarray analyses revealed that 
depletion of Dis3 results in a set of affected mRNAs that differs from that resulting from 
depletion of other exosome(associated) proteins. Furthermore, we show that Dis3 associates 
with proteins involved in pre-mRNA splicing and processing. The role of Dis3-like 2 was 
studied in transiently transfected human cells and the effect on cell viability and morphology 
were determined. Based upon the results and currently available literature, we discuss the 
possible cellular role of Dis3-like 2.
Finally, the results of all chapters will be recapitulated in Chapter 8, followed by a more 
general discussion of the impact of these findings on our current understanding of the 
exosome, its enzymatic activity and its involvement in biochemical processes.
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Abstract
Long before the RNA degrading exosome was first described in the yeast Saccharomyces 
cerevisiae, the use of autoantibodies found in the sera of certain autoimmune patients allowed 
the identification of a complex of polypeptides which later appeared to be the human exosome. 
Today, the most extensively documented association of the exosome with disease is still its 
targeting by the immune system of such patients. The highest frequency of autoantibodies to 
components of the exosome complex is found in polymyositis-scleroderma overlap patients 
and therefore the exosome is termed PM/Scl autoantigen in the autoimmune field. More 
recently, one of the core components of the exosome was identified as a protein associated with 
chronic myelogenous leukemia. In this Chapter we will describe the identification of the PM/Scl 
autoantigen from a historical perspective, discuss our current knowledge on the occurrence of 
autoantibodies to exosome components in autoimmune diseases and end with the data that 
connect the exosome with cancer.
Introduction
As described in the other chapters of this book, the exosome is implicated in the processing/
maturation and degradation of many different species of RNA. The exosome complex is 
evolutionary conserved and can therefore be found in virtually all eukaryotic and archaeal 
forms of life, although the composition of the complex might differ to some extent from 
one species to another. In eubacteria a similar complex in terms of structure and function 
can be discerned, which is called the degradosome. The presence of exosome or exosome-
like complexes in these different species suggests that it fulfills an essential role in RNA 
metabolism. In agreement with the assumption that eukaryotic cells can probably not 
survive without a functional exosome, studies in yeast and humans have shown that an 
intact exosome core is required for normal cell growth (Allmang et al, 1999; Mitchell et al, 
1997; van Dijk et al, 2007).
The discovery of the human exosome complex was facilitated by its association with 
autoimmunity. A response of the immune system to self-components is observed in a 
plethora of diseases, in particular connective tissue diseases. The autoimmune response 
can be directed to a variety of biomolecules, including proteins, nucleic acids and lipids. 
In most cases, it is neither known how immunological tolerance to self-components is 
broken, nor whether the immune response plays a pathophysiological role or is merely an 
epiphenomenon. Autoimmunity is generally detected by the appearance of autoantibodies 
in the serum of patients. Autoantibodies in a distinct group of autoimmune patients target 
components of the exosome complex and these autoantibodies have been instrumental 
in the identification of a complex of proteins that was later found to represent the human 
exosome complex.
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Identification of the PM/Scl complex
As already mentioned above, the first indication of the existence of a human exosome 
complex dates back from 1977 when Wolfe and colleagues showed that autoantibodies in 
the sera of patients suffering from certain muscle disorders were capable of precipitating an 
antigen from a calf thymus extract as determined by an immunodiffusion assay (Wolfe et al, 
1977). This antigen was initially called “PM-1”, as 17 out of the 28 sera (61%) that were scored 
as ‘positive’ (in terms of successfully precipitating the antigen) were derived from patients 
that were diagnosed with polymyositis.
Polymyositis, literally meaning “many muscle inflammations”, is a progressive, chronic 
disorder that belongs to the group of connective tissue diseases (CTD), along with other 
diseases including dermatomyositis (DM) and systemic sclerosis (SSc, also referred to as 
scleroderma, Scl). Symptoms of PM include weakening and/or loss of mass of the muscles, 
which is particularly evident in the legs, shoulders and pelvis of the patient, thereby severely 
hampering the patient’s abilities in everyday’s activities such as climbing stairs, standing up 
or even walking. While some of these PM-symptoms are shared with DM and SSc, the latter 
two disorders have more prominent visual effects on the skin, such as the appearance of rash, 
hardening of the skin and disposition of calcium under the skin (Figure 1). When patients 
have symptoms of both SSc and PM or DM, the disorder is referred to as polymyositis/
scleroderma-overlap syndrome (PM/Scl). A total of 8 patients suffering from this overlap 
syndrome were also included in Wolfe’s study and all but one of these appeared to contain 
anti-PM-1 antibodies, indicating that these autoantibodies are more common in this group of 
patients. More importantly however, the disease-specificity of the autoantibodies indicated 
that they might be exploited as a biomarker for clinical diagnosis, which was not yet available 
for these patients at that time. In view of the strongest association of the autoantibodies 
Figure 1. Clinical features of scleroderma and polymyositis.
A) Sclerodactyly, a typical symptom often seen in patients suffering from scleroderma, which is characterized 
by thickening and tightening of the skin. B) Muscle fibers of a polymyositis patient, showing the infiltration of 
inflammatory cells (a.o. lymphocytes) in the endomysium.
 36
with PM/Scl patients, the antigen was renamed “PM/Scl-antigen” in 1984. In the same period 
other research groups confirmed the high prevalence of these autoantibodies in patients 
suffering from the PM/Scl-overlap syndrome (Reichlin et al, 1984; Treadwell et al, 1984).
An obvious next step was the identification and characterization of the molecules that make 
up this particular antigen. By immunoprecipitation experiments it was demonstrated that 
the PM/Scl-antigen consists of at least 11 polypeptides, with relative molecular masses 
ranging from 20,000 to 110,000. Subsequently, it took about 5 years before two of the major 
autoantigenic proteins targeted by the sera of PM/Scl-patients were identified and their 
cDNAs were cloned (Alderuccio et al, 1991; Bluthner and Bautz, 1992; Ge et al, 1992). The 
identified proteins were named according to their relative molecular mass as determined by 
SDS-PAGE: a Mr 75,000 protein designated PM/Scl-75 and a Mr 100,000 protein designated PM/
Scl-100. It should be noted that the PM/Scl-75 protein migrates aberrantly in SDS-PAGE gels, 
most likely due to the clustering of charged amino acids in its C-terminal region (Raijmakers 
et al, 2003). In addition, four isoforms of the PM/Scl-75 protein have been described. The 
original cDNA reported by Alderuccio and coworkers (Alderuccio et al, 1991) was probably 
incomplete in the region corresponding to the N-terminus, which was substantiated by the 
lack of association with the exosome complex in two-hybrid experiments (Raijmakers et al, 
2002). By screening human EST databases sequences encoding 84 additional amino acids in 
the N-terminal region were found. Importantly, the polypeptide corresponding to the longer 
isoform did show two-hybrid interactions with components of the exosome core complex 
(Raijmakers et al, 2003). Another variation in the PM/Scl-75 sequence is resulting from an 
alternative splicing event, which leads to the incorporation of a 17 amino acids encoding 
optional exon in the C-terminal region of the protein.
When the yeast exosome complex was identified (Mitchell et al, 1997) and Allmang and 
colleagues found that two of its protein components, Rrp45 and Rrp6, were homologous 
to the human PM/Scl-75 and PM/Scl-100 proteins, respectively (Allmang et al, 1999), 
the suggestion was raised that the PM/Scl complex might in fact represent the human 
counterpart of the yeast exosome. This was confirmed by the cloning of cDNAs encoding 
the other components of the human exosome, which was based upon either the homology 
with their yeast counterparts or the copurification with the human exosome during affinity-
purifications (Brouwer et al, 2001; Chen et al, 2001).
Autoantibodies to the exosome / PM/Scl-antigen
Originally, the detection of autoantibodies in patient sera was mainly performed by 
immunodiffusion (or the related technique counterimmunoelectrophoresis) and by indirect 
immunofluorescence (IF). With the latter technique a typical nucleolar staining pattern 
was indicative for the presence of anti-PM/Scl autoantibodies and therefore anti-PM/Scl 
autoantibodies were categorized as anti-nucleolar antibodies (ANoA), together with anti-Th/
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To (antibodies to protein components of the RNase MRP and RNase P particles) and anti-U3 
(antibodies to proteins of the U3 snoRNP particle, in particular to fibrillarin). Although this 
method is not very specific for the detection of anti-PM/Scl autoantibodies, ANoA and ANA 
(anti-nuclear antibodies) are at least indicative for many CTD, especially since they are 
usually absent from healthy controls (Reimer et al, 1988; von Muhlen and Tan, 1995). For this 
reason, this technique was often used as an initial screening method, which was followed 
by either immunodiffusion (ID), immunoprecipitation (IP), immunoblotting (IB) or enzyme-
linked immunosorbent assays (ELISA).
A combination of the data from many studies addressing anti-PM/Scl reactivity in patient sera 
by either ID, IF and/or IP showed that this reactivity can be found in 31% of PM/Scl patients 
(Table 1). The frequency of anti-PM/Scl reactivity in patients diagnosed with PM, DM and SSc 
was 8%, 11% and 2%, respectively.
The cloning of cDNAs encoding individual protein subunits of the exosome and the 
production of the corresponding recombinant proteins in various expression systems 
created new possibilities to characterize the anti-PM/Scl autoimmune response and to 
screen patient sera for the occurrence of anti-PM/Scl autoantibodies. This facilitated the 
detection of autoantibodies to individual protein components of the exosome, e.g., by ELISA. 
Since IP assays can be quite laborious, especially when large cohorts of patients have to 
be analyzed and due to the poor recognition of the main antigens (PM/Scl-75 in particular) 
Table 1. Anti-PM/Scl reactivity in PM, DM, Scl, PM/Scl-overlap and nondifferentiated idiopathic 
inflammatory myopathy (IIM) patients monitored by ID, IF and/or IP
Study IIM PM DM Scl PM/Scl Method
Wolfe
(1977) 9/14 (64) 1/6 (17) 7/8 (88) ID
Treadwell
(1984) 2/22 (9) 2/32 (6) 9/77 (12) ID
Reichlin
(1984) 9/114 (8) ID
Reimer
(1988) 8/646 (1) IF/IP
Reichlin
(1988) 8/168 (5) ID
Oddis
(1992) 5/106 (5) 6/359 (2) 10/41 (24) ID/IF
Hausmanowa
(1997) 0/19 (0) 0/21 (0) 19/25 (76) ID
O’Hanlon
(2006) 65/603 (11) 13/227 (6) 19/177 (11) 32/101 (32) ID
Selva-O’Callaghan
(2006) 10/88 (11) 1/27 (4) 8/59 (14) IP
Total 89/991 (10) 33/477 (8) 28/263 (11) 16/1037 (2) 77/252 (31)
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by the patient sera on IB, ELISA has become the method of choice to detect anti-exosome 
autoantibodies. During the last decade also a number of exosome-associated proteins, 
that are not considered to be part of the exosome core complex, but (transiently) associate 
with a subset of the exosome, have been identified and their cDNAs have been cloned and 
expressed (Chen et al, 2001; Lehner and Sanderson, 2004; Schilders et al, 2007a; Schilders 
et al, 2005; Schilders et al, 2007c). A number of these proteins have been used as well to 
investigate whether they are also targeted by autoantibodies in (anti-PM/Scl-positive) 
patient sera (Table 2). A schematic overview of the targeting of exosome core components 
and of exosome-associated/auxiliary proteins by autoantibodies (as determined by ELISA) in 
PM/Scl-overlap sera is given in Figure 2.
The majority of anti-PM/Scl-positive patients appeared to have autoantibodies directed 
against PM/Scl-100 and/or PM/Scl-75 (Table 3). The other exosome core components are less 
frequently targeted, with the exception of Rrp4, which is recognized by 64% of the anti-PM/
Scl-positive patients (Brouwer et al, 2002; Raijmakers et al, 2004). A combination of ELISA 
data for PM/Scl-100 and PM/Scl-75 leads to similar sensitivity scores as the conventional ID, 
IF, IB and IP assays (approximately 31% of PM/Scl patients are positive). After mapping a 
major autoepitope of PM/Scl-100 (Bluthner et al, 2000), a synthetic peptide corresponding 
to this epitope, designated “PM1-alpha”, was produced to set up an ELISA, which allowed 
the detection of autoantibodies in 55% of the PM/Scl-overlap patients (Mahler et al, 2005). In 
addition, the C1D protein, a RNA-binding protein which binds to PM/Scl-100 and participates 
in exosome-mediated pre-rRNA processing, was found to be a major autoantigen in PM/Scl 
patients (Schilders et al, 2007a; Schilders et al, 2007c).
Because many of the autoantibody studies described above have not yet been replicated 
with other cohorts of patients, the frequencies by which these antibody specificities occur 
should be interpreted with care. It is known that ethnic differences and genetic variation 
Table 2. Anti-exosome(-associated) protein reactivity in PM, DM, Scl and PM/Scl-overlap patients 
monitored by ELISA.a,b
Antigen
Diagnosis PM/Scl-75 PM/Scl-100 MPP6 C1D Mtr4 Ski2 hSki8
PM 0–3 2–8 0 5 2 5 0
DM 2–3 2–6 2 0 0 2 2
Scl 10 2–13 0 0 0 0 0
PM/Scl 27–28 23–55 0 23 7 0 3
a Reactivity values are given in percentages.
b References used for PM/Scl-75: (Brouwer et al, 2002; Raijmakers et al, 2004; Schilders et al, 2007a), PM/Scl-100: 
(Brouwer et al, 2002; Raijmakers et al, 2004; Schilders et al, 2007a), MPP6, C1D, Mtr4, Ski2 and hSki8: (Schilders et al, 
2007a)
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Figure 2. Targeting of exosome and exosome-associated proteins by autoantibodies from PM/
Scl-overlap patients. 
Schematic structure of the human exosome. The nine core subunits assemble into a ring-like structure (central). RPD1 
and RPD2 refer to two groups of RNase PH domains; KH, S1 and ZN to RNA-binding domains. Exosome-associated/
auxiliary proteins and protein complexes that have been reported to interact with the exosome core are shown at 
the periphery. Proteins for which the presence of autoantibodies in PM/Scl sera has been investigated are indicated 
by the schematic antibody structures. Numbers (in percentages) represent the frequency of autoantibodies in 
patient sera. Numbers between brackets represent the frequencies for sera that were preselected based upon the 
reactivity with either PM/Scl-75 or PM/Scl-100.
Table 3. Anti-exosome core protein reactivity in anti-PM/Scl-positive PM, DM, Scl and PM/Scl-overlap 
patients monitored by ELISA.a
Antigen
Diagnosis PM/Scl-75 PM/Scl-100 hRrp4 hRrp40 hRrp41 hRrp42 hRrp46 hCsl4
PM nd nd nd nd nd nd nd nd
DM nd nd nd nd nd nd nd nd
Scl 64 100 64 0 0 36 0 0
PM/Scl 90 100 60 10 0 20 0 0
a Reactivity values are given in percentages.
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may affect the incidence of autoantibody production. The frequency of patients with anti-
PM/Scl reactivity, for example, appears to be quite variable, as this reactivity was not found 
in a large cohort of 275 Japanese patients (Kuwana et al, 1994). This may at least in part 
be due to the fact that the presence of anti-PM/Scl antibodies seems to be associated with 
certain MHC alleles, HLA-DRB1*0301, HLA-DQA1*0501 and HLA-DQB1*02,26,27 whereas HLA-
DRB1*15/*16 and HLA-DQA1*0101 might prevent the production of these autoantibodies 
(O’Hanlon et al, 2006).
Initiation of the anti-exosome / PM/Scl autoimmune response
It is still an open question what triggers the anti-PM/Scl response in the initial stages of 
these autoimmune diseases. Several studies have proposed a role for unusual protein 
modifications, in particular those occurring during apoptosis and necrosis, which might play 
a role in breaking immunological tolerance to these proteins (Hof et al, 2007; Utz et al, 2000). 
One of the core subunits of the exosome, PM/Scl-75, which is also one of the most frequently 
targeted proteins by anti-PM/Scl-positive sera, has been demonstrated to be cleaved by 
caspases in apoptotic cells (Schilders et al, 2007b). Moreover, PM/Scl-100 appeared to be 
cleaved by granzyme B in vitro (Casciola-Rosen et al, 1999). It is not known yet whether these 
changes lead to the formation of neo-epitopes. An alternative mechanism might be molecular 
mimicry, in which structural similarities between epitopes of foreign and self-proteins result 
in the cross-activation of autoreactive T or B cells by pathogen-derived peptides.
The targeting of multiple exosome subunits and exosome associated proteins is most likely 
the result of a phenomenon called intermolecular epitope spreading. When an immune 
response towards a particular protein is elicited, it can extend to another molecule that 
resides in the same complex. Data supporting this hypothesis regarding the human exosome 
is still scarce, although two bodies of evidence point in that direction. Firstly, immunization 
of rabbits with a synthetic peptide corresponding to a major epitope of PM/Scl-100 led to 
the generation of antibodies that targeted other components of the exosome complex as 
well (Mahler and Raijmakers, 2007). Secondly, the serum of a patient with high anti-PM/Scl 
reactivity was shown to stain a single, 100 kDa polypeptide in IB. Three months later, the 
serum was found to stain an additional, 29 kDa polypeptide in IB, which was suggested to 
correspond to an aberrant form of PM/Scl-75, but might be one of the other core components 
as well (Gutierrez-Ramos et al, 2008).
The human exosome and cancer
As already mentioned in the introduction, the viability of cells is severely impaired when the 
integrity of the exosome complex is disturbed. This strongly suggests that at least one of the 
functions of the exosome is essential to keep the cell in a proliferating state. On the other 
hand, when the activity of the exosome would be rate limiting in the maturation or turnover 
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of RNAs that are crucial for cell proliferation, an overactive exosome may lead to a higher 
rate of proliferation. Although rather speculative, this is supported by observations of Yang 
and coworkers who examined patients who received a donor lymphocyte infusion (DLI) as a 
treatment for chronic myelogenous leukemia (CML) (Yang et al, 2002). CML is characterized by 
the uncontrolled production of myeloid cells, resulting in a strong accumulation of these cells 
in the blood and is associated with a typical chromosomal translocation resulting in the so-
called Philadelphia chromosome. This translocation leads to the production of an aberrant, 
overactive tyrosine kinase fusion protein, Bcr-Abl, which is thought to affect several substrate 
proteins involved in cell division, DNA repair and genomic instability. Of all the known cases 
of adult leukemia in the Western countries, about 15 to 20% have been classified as CML 
(Faderl et al, 1999). Before the introduction of Imatinib, a drug that specifically counteracts 
the activity of the Bcr-Abl fusion protein, patients suffering from CML often received a bone 
marrow transplantation (BMT). The patients who relapsed after this transplantation were 
further treated with DLI, resulting in a durable remission of the disease in 70 to 80% of the 
cases (Collins et al, 1997). The success of this treatment is a result of a phenomenon called 
the graft-versus-tumor (GVT) effect, in which the infused lymphocytes attack any remaining 
cancerous cells in the bone marrow.
When Yang and colleagues used the serum of DLI-responding patients for an antibody-
based screening of a CML cDNA expression library, new putative tumor-related antigens 
were identified (Wu et al, 2000). Among these was a Mr 28,000 protein, which was designated 
CML28. Sequence analysis revealed that this protein is identical to hRrp46, a constituent of 
the exosome core complex (Figure 2), although the 5’ coding region of the CML28 is 33 amino 
acids longer than that of hRrp46. To confirm that hRrp46 is immunogenic in these patients, 
serum samples derived from a CML patient before and after BMT and DLI were analyzed with 
IB and ELISA using recombinant hRrp46. While anti-hRrp46 reactivity couldn’t be detected 
in healthy controls and in the CML patient prior to DLI, this reactivity significantly increased 
2 to 6 months post-DLI, after which the reactivity gradually declined to undetectable 
levels 2 years post-DLI. Moreover, the temporal pattern of anti-hRrp46 reactivity correlated 
well with the onset of cytogenetic remission, which is indicated by the disappearance of 
the Philadelphia chromosome. Since the patient didn’t appear to have any symptoms 
indicating the development of an autoimmune disease, the anti-hRrp46 reactivity seemed 
to be associated with tumor rejection instead. The immune response towards hRrp46 was 
shown to be a common feature of other types of cancer, such as lung and prostate cancer 
and melanoma, in which the antibodies could be detected in 10% to 33% of the cases. The 
anti-hRrp46 response might at least in part be due to the overexpression of hRrp46 in these 
different cancers, as it was demonstrated by northern blot hybridization and IB that highly 
proliferating cell lines express high levels of hRrp46 when compared to normal tissues or 
even stable-phase CML. These findings might also prove useful for the development of an 
antigen-specific immunotherapy and progress in the development of such strategies has 
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already been made (Mao et al, 2008; Xie et al, 2008; Zhou et al, 2006). The anti-hRrp46 immune 
response and elevated hRrp46 expression levels in cancer raise the question whether these 
phenomena are specific for hRrp46 or also occur for other exosome components. Further 
experiments will be required to clarify this issue.
Interestingly, the antimetabolite 5-fluorouracil, which is frequently used to treat solid 
tumors in a variety of cancers, was shown to inhibit the function of the exosome. Originally 
this drug was selected for its hypothetical ability to inhibit cell proliferation, presumably by 
causing thymidine starvation and thus negatively affecting DNA synthesis. However, Fang 
and coworkers reported that also rRNA processing was impaired by this drug (Fang et al, 
2004). The accumulated pre-rRNA precursors were similar to the precursors accumulating in 
exosome mutant yeast strains. Possibly related to these observations, it was demonstrated 
that the absence of Rrp6 (the yeast counterpart of PM/Scl-100) enhanced the 5-fluorouracil-
induced defects (Lum et al, 2004). Taken together, these results suggest that 5-fluorouracil 
exerts its effect on rRNA processing at least in part by inhibiting the exosome.
Conclusion
In view of the central role of the human exosome in the processing and degradation of many 
RNAs, it is intriguing to investigate to what extent a disturbance of its function can interfere 
with normal cellular physiology and is associated with diseases. The two best documented 
examples, autoimmunity and cancer, have been discussed in this chapter, although there are 
still many questions that need to be addressed. It is, for example, still unclear what causes 
the targeting of PM/Scl-75 and PM/Scl-100 by the immune system in patients suffering from 
the PM/Scl-overlap syndrome and why this response is particularly associated with this 
autoimmune disease. In view of the physical barrier of the plasma membrane, autoantibodies 
are not likely to interfere with the functions of the exosome in RNA metabolism, but once 
exosome components are released from (dying) cells the resulting immune complexes 
may contribute to the progression of autoimmunity and tissue damage. In case of cancer 
dysfunctioning of the exosome may play a direct role, but it is clear that more work has 
to be done to investigate the effects of increased or decreased exosome activity on cell 
proliferation. It is currently not known whether exosome core subunits other than hRrp46 
are overexpressed in solid tumors as well. Alternatively, a pool of non-exosome associated 
hRrp46 may exist and might have a completely other role independent of the exosome. In 
this respect, also the importance of the N-terminal extension, which may be specific for a 
particular isoform of hRrp46, needs to be studied.
The exosome is known to play an important role in the degradation of a special class of 
mRNAs, containing cis-acting adenylate-uridylate-rich sequence elements (AREs) in their 
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3′UTR. Transcripts containing such elements are often involved in important biological 
processes and their levels are therefore often tightly regulated. In theory, a perturbation of 
exosome function is likely to affect these levels and, as a consequence, might cause a wide 
variety of pathological conditions (Khabar, 2005).
In this Chapter we focused on human diseases, but one should realize that the exosome 
is expressed is many other species and thus might also here be associated with disease. 
In plants, for instance, it was found that the effects of deletion of a particular exosome 
component mimicked a disorder that induced cell death in the tip of the leafs when plants 
are inoculated with Blumeria graminis, a fungus that causes mildew on grasses and that is 
frequently used to infect plants in a laboratory setting. Intriguingly, the deleted exosome 
component was Rrp46 (Xi et al, 2009).
We conclude that although targeting of exosome components in autoimmunity is known for 
many years, our knowledge on the involvement of the exosome, of its individual components 
or of its auxiliary factors in other diseases is still in its infancy and much work needs to be 
done to obtain more insight in this topic.
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Abstract
The exosome is an exoribonuclease complex involved in the degradation and maturation of a 
wide variety of RNAs. The nine-subunit core of the eukaryotic exosome is catalytically inactive 
and may play an architectural role and mediate substrate binding. In Saccharomyces cerevisiae 
the associated Dis3 and Rrp6 provide the exoribonucleolytic activity. The human exosome-
associated Rrp6 counterpart contributes to its activity, whereas the human Dis3 protein is 
not detectably associated with the exosome. Here, a proteomic analysis of immunoaffinity-
purified human exosome complexes identified a novel exosome-associated exoribonuclease, 
hDis3L1, which was confirmed to associate with the exosome core by co-immunoprecipitation. 
In contrast to the nuclear localization of Dis3, hDis3L1 exclusively localized to the cytoplasm. 
hDis3L1 isolated from transfected cells degraded RNA in an exoribonucleolytic fashion, and 
its RNB domain appeared to mediate this activity. The siRNA-mediated knockdown of hDis3L1 
in HeLa cells resulted in elevated levels of poly(A)-tailed 28S rRNA degradation intermediates, 
indicating the involvement of hDis3L1 in cytoplasmic RNA decay. Taken together, these data 
indicate that hDis3L1 is a novel exosome-associated exoribonuclease in the cytoplasm of 
human cells.
Introduction
RNA is one of the most fundamental and versatile biomolecules present in the cell, with many 
different roles, including the translation of genetic information into proteins, the replication 
of DNA and structural roles in large complexes. Perhaps one of the key features which 
accounts for the diverse biological roles that can be performed by RNA is the fact that it can 
be heavily modified after synthesis of the original precursors. As such, proper maturation of 
RNA molecules is of crucial importance for its function and can involve many different steps, 
such as splicing, polyadenylation, capping, as well as cleavage and/or trimming by endo- 
and exoribonucleases. One of the main players in the latter is the exosome, a conserved 
protein complex with 3’ to 5’ exoribonuclease activity. 
Originally identified in yeast as a complex generating the 3’ end of the 5.8S rRNA in the 
nucleolus (Mitchell et al, 1997), it has become clear that the exosome complex is implicated 
in many processes of RNA metabolism. In the nucleoplasm and nucleolus, for instance, the 
maturation of many small RNAs (e.g. snRNAs and snoRNAs) is dependent on processing steps 
by the exosome. In addition, the exosome fulfills a role in degrading improperly processed 
RNAs (such as aberrant pre-mRNA and pre-tRNA species), as well as in the ‘normal’ turnover 
of cytoplasmic mRNAs (van Dijk et al, 2007), and it is involved in specific mRNA decay 
pathways, including non-stop decay and nonsense mediated decay (Schilders et al, 2006; 
van Hoof et al, 2002). 
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The doughnut-shaped core of the exosome consists of nine proteins, six of which are 
homologous to the 3’ to 5’ exonuclease RNase PH and three proteins with RNA binding 
domains (each containing a S1 RNA-binding domain and two of which contain an additional 
KH domain). While the archaeal and probably also the plant exosome core seem to have 
retained their activity during the course of evolution, reconstitution experiments showed 
that the core of the yeast and human exosome are catalytically inactive (Chekanova et al, 
2000; Liu et al, 2006; Lorentzen et al, 2005). However, two other types of hydrolytic RNases 
associated with exosome complexes in eukaryotes are thought to be responsible for the 
activity of the complex. Rrp6 (designated PM/Scl-100 in humans), an enzyme belonging to 
the RNase D family of hydrolytic exoribonucleases, associates with a subset of exosome 
cores and contributes to its activity (Brouwer et al, 2001b; Synowsky et al, 2009). Rrp6 has 
been reported to reside exclusively in the nucleus of yeast cells (Allmang et al, 1999b), 
whereas in human cells PM/Scl-100 was found both in the nucleus and cytoplasm (Brouwer 
et al, 2001a; Lejeune et al, 2003). Depletion of Rrp6 from cells has been shown to give rise 
to phenotypes markedly different from when core exosome components are depleted in 
various experimental setups, suggesting that its function is at least partially uncoupled to 
that of the core exosome (Callahan and Butler, 2008; Graham et al, 2009; van Dijk et al, 2007). 
Another hydrolytic exoribonuclease, Dis3 (also known as Rrp44), which belongs to the 
RNase R family of RNases, was recently shown to be essential for the activity of the yeast 
exosome (Dziembowski et al, 2007). In yeast, the Dis3 protein can be detected in both the 
nucleolus as well as the cytoplasm (Synowsky et al, 2009). Recently, Dis3 was found to display 
endonuclease activity as well, in agreement with the presence of a functional PIN domain 
in its N-terminal region (Lebreton et al, 2008; Schaeffer et al, 2009). The recently determined 
crystal structure of the yeast Dis3-Rrp41-Rrp45 complex led, in combination with the results 
of biochemical analyses, to a model in which RNA substrates thread through the central 
channel of the exosome core to reach the Dis3 exoribonuclease site (Bonneau et al, 2009).
Although a human homologue of Dis3 was described more than a decade ago and was shown 
to complement yeast Dis3 (Shiomi et al, 1998), a stable association of this protein with the 
exosome core could not be shown (Chen et al, 2001). During our studies to identify proteins 
stably associated with the human exosome core, we detected another homologue of the 
yeast Dis3 protein, designated Dis3-like exoribonuclease 1 (Dis3L1).  Here, we characterize its 
association with the exosome core, its subcellular localization and its enzymatic activities.
Results
Identification of Dis3L1 as a novel exosome-associated protein
To identify proteins associated with the core of the human exosome, which may be involved 
in its exoribonuclease activity or the regulation thereof, antibodies to a core component were 
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used to isolate exosome complexes by immuno-affinity chromatography. These complexes 
were isolated from total HeLa cell extracts using polyclonal anti-hRrp40 antibodies (Brouwer 
et al, 2001a). Proteins that remained bound to the immobilized antibodies at 1 M NaCl were 
eluted and analyzed by SDS-PAGE. Following Coomassie Brilliant Blue staining, the gel lane 
was cut in 19 slices, which were subjected to in-gel digestion and analyzed by nano-reversed 
phase liquid chromatography coupled to a high-resolution LTQ-Orbitrap mass spectrometer. 
Analysis of the resulting MS/MS spectra against the Swissprot database using Mascot 
revealed the presence of all nine core exosome subunits (Table 1), as well as two additional 
proteins, known to associate with the exosome: PM/Scl-100 and MPP6. MPP6 has previously 
been shown to be involved in the exosome-mediated maturation of the 5.8S rRNA (Schilders 
et al, 2005). The sequence coverage of the identified exosome proteins ranged from 7 to 44%. 
In accordance with previous results, no peptides indicating the presence of the human Dis3 
protein (hDis3) in the exosome preparation were detected. However, we identified with very 
high confidence (26% coverage and 29 unique peptides) a protein homologous to Dis3 that 
was designated Dis3-like exonuclease 1 (hDis3L1). 
In the genome of humans and other higher eukaryotes (including mice, zebrafish and 
frogs) in total three genes homologous to the yeast Dis3 protein are present: Dis3, Dis3-like 
exonuclease 1 (Dis3L) and Dis3-like exonuclease 2 (Dis3L2), of which only Dis3L1 was found in 
the immuno-affinity purified exosome fraction. Based upon cDNA sequence data 4 isoforms 
of hDis3L1 can be discerned, which are most likely resulting from alternative splicing events. 
The largest isoform (GenBank acc. nr. NM_001143688) consists of 1,054 amino acids with 
a calculated molecular mass of 120,787 Da. For the human Dis3L2 (hDis3L2) five potential 
Table 1. Exosome-associated proteins identified by LC-MS/MS in immunoaffinity-purified human 
exosome complexes. 
Gene Accession no.
Protein  
name(s)
MW 
(kDa)
Unique
peptides
Sequence 
coverage (%)
EXOSC1 Q9Y3B2 CSL4 21 kD 4 25
EXOSC2 Q13868 RRP4 33 kD 3 11
EXOSC3 Q9NQT5 RRP40 30 kD 15 38
EXOSC4 Q9NPD3 RRP41 26 kD 6 29
EXOSC5 Q9NQT4 RRP46 25 kD 4 14
EXOSC6 Q5RKV6 MTR3 28 kD 8 24
EXOSC7 Q15024 RRP42 32 kD 11 36
EXOSC8 Q96B26 RRP43 / OIP2 30 kD 11 33
EXOSC9 Q06265 RRP45 / PM/Scl-75 49 kD 5 12
EXOSC10 Q01780 RRP6 / PM/Scl-100 101 kD 5 7
MPHOSPH6 Q99547 MPP6 19 kD 6 44
DIS3L Q8TF46 hDis3L1 121 kD 29 26
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isoforms have been identified, the largest of which (GenBank acc. nr. NM_152383) contains 
885 amino acids with a calculated molecular mass of 99,210 Da. An alignment of the 
‘canonical’ isoforms of the three human Dis3 variants and their yeast equivalent (yDis3) 
is shown in Supplementary Figure S1. In terms of sequence conservation, hDis3 is more 
closely related to yDis3 (42% sequence similarity) than the two Dis3-like proteins (29% and 
26% for hDis3L1 and hDis3L2, respectively). To obtain insight into the domain structure of 
these proteins their amino acid sequences were analyzed by the online tool SMART (Letunic 
et al, 2009). This revealed the presence of several domains, some of which were, however, 
poorly conserved. Like many members of the RNase II/R-family of hydrolytic nucleases, the 
three hDis3 variants contain a highly conserved RNB domain (which is known to contain the 
exonuclease activity) and three OB-fold-type nucleic acid binding domains: two CSDs (cold 
shock domains) and one S1 RNA binding domain. The conservation of the latter domains is 
generally more evident at the secondary structure level than at the level of the amino acid 
sequence (Theobald et al, 2003). All β-strands and α-helixes detected in hDis3L1 with the 
PsiPred protein structure prediction tool are depicted below the alignment (Supplementary 
Figure S1). Typical for OB-fold-like domains are the five β-strands forming a β-barrel. Finally, 
a PIN (PilT N terminus) domain is present in the N-terminal regions of hDis3 and yDis3. PIN 
domains were originally thought to be involved in signaling events (Noguchi et al, 1996), but 
were recently shown to confer endonucleolytic activity. This was shown for several proteins 
involved in NMD and RNAi pathways, such as the SMG protein (Clissold and Ponting, 2000; 
Glavan et al, 2006) and yDis3 (Lebreton et al, 2008). PIN domains are characterized by two or 
three nearly invariant aspartic acid residues. Both hDis3 and yDis3 contain all three aspartic 
acids, whereas in hDis3L1 only two and in hDis3L2 only one of these residues are conserved 
(Supplementary Figure S1). The domain structure of yDis3, hDis3, hDis3L1 and hDis3L2 is 
schematically illustrated in Figure 1.
To confirm the interaction of hDis3L1 with the exosome, the full-length coding sequence 
of the largest isoform of hDis3L1 was cloned from a teratocarcinoma cDNA library and was 
inserted in different mammalian expression vectors. HEp-2 cells were transiently transfected 
with a construct expressing hDis3L1 fused to either an N- or C-terminal GFP tag. After forty-
eight hours, the fusion proteins were immunoprecipitated from cell lysates using anti-GFP 
antibodies and analyzed by SDS/PAGE and immunoblotting. The results showed that 
both the N- and C-terminally GFP-tagged hDis3L1 proteins were expressed, although the 
expression of the C-terminally tagged protein was less efficient. The association with the 
exosome core was monitored by anti-Rrp4 antibodies and showed the co-precipitation of 
Rrp4 with both hDis3L1 fusion proteins, but not with GFP alone (Figure 2), confirming the 
interaction between hDis3L1 and the core of the exosome complex. To rule out the possibility 
that this interaction is mediated by RNA, similar experiments were performed in which 
either the cell lysates or the immunoprecipitates were treated with nucleases (RNase A and 
micrococcal nuclease). The co-precipitation of hRrp4 was not affected by these treatments 
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Figure 1. Schematic structure of Dis3 and Dis3-like proteins in yeast and humans.
Schematic diagram of Saccharomyces cerevisiae Dis3 (yDis3), human Dis3 (hDis3), human Dis3-like 1 (hDis3L1) and 
human Dis3-like 2 (hDis3L2) with the identified domains indicated: the PIN domain, two cold shock domains (CSD1, 
CSD2), a RNB domain and a S1 RNA binding domain. Crackled boxes and question marks indicate domains with a 
low level of conservation (see Supplementary Figure S1 for details). The level of sequence similarity between the 
human Dis3 proteins and yDis3 is indicated on the right.
Figure 2. Association of hDis3L1 with the exosome core complex.
Total cell extracts were prepared from HEp-2 cells transiently transfected with expression constructs encoding 
EGFP, EGFP-hDis3L1 or hDis3L1-EGFP, after which immunoprecipitation was performed using polyclonal anti-GFP 
antibodies. Both the complete cell extracts (Lysate) and the anti-GFP (co-)precipitated proteins (IP) were separated 
by SDS-PAGE and analyzed by western blotting, using monoclonal anti-GFP antibodies and monoclonal anti-hRrp4 
antibodies to visualize the co-precipitation of the exosome core complex with hDis3L1. Monoclonal anti-γ-tubulin 
antibodies were used as loading control.
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(data not shown), indicating that the association of hDis3L1 with the exosome core is not 
bridged by RNA.
hDis3L1 is localized to the cytoplasm
To analyze the subcellular localization of hDis3L1, human HEp-2 cells were transiently 
transfected with constructs encoding either GFP-hDis3L1, hDis3L1-GFP or VSV-hDis3L1, 
the latter resulting in the formation of a N-terminally VSV-tagged (vesicular stomatitis virus 
G epitope) protein. The localization of tagged hDis3L1 was determined by fluorescence 
microscopy either directly (EGFP-tagged, Figures 3A, B) or indirectly (VSV-tagged, Figure 
3C) using anti-VSV-tag antibodies. All three tagged hDis3L1 proteins localized exclusively 
to the cytoplasm (Figures 3A-3C). To compare its localization with that of hDis3, we also 
transfected cells with N-terminally GFP-tagged hDis3, the localization of which was confined 
to the nucleoplasm (Figure 3D), in agreement with our previous observations (Schilders et 
al., manuscript in preparation). Because the localization of overexpressed, tagged proteins 
may not completely reflect the localization of the corresponding endogenous proteins, the 
subcellular localization of hDis3L1 was also determined by confocal immunofluorescence 
microscopy using antibodies to hDis3L1 (Figure 3E-G). Antibodies to exosome core 
component hRrp40 were used in parallel (Figure 3H-J). Although some staining of hDis3L1 
within the nucleus was observed, the results of these experiments confirm the cytoplasmic 
accumulation of hDis3L1. In agreement with previous observations, the highest concentration 
of hRrp40 was observed in the nucleoli.
hDis3L1 displays exoribonuclease activity
The lack of exoribonuclease activity associated with the core of the human exosome raised 
the question whether the exosome-associated hDis3L1 protein might be responsible for at 
least part of the activity of the human exosome. This would be consistent with the presence of 
the RNase II-type RNB domain in this protein. To test this hypothesis, RNA degradation assays 
were performed with GFP-hDis3L1 immunoaffinity-purified from transiently transfected 
HEp-2 cells. Following immunoprecipitation with anti-GFP antibodies, the precipitate 
was incubated for 2 hours with a radiolabeled RNA substrate in the presence of various 
concentrations of Mg2+, which is known to be involved in the nucleophilic attack by these types 
of hydrolytic enzymes (Frazao et al, 2006). Denaturating gel analysis of the reaction products 
(Figure 4A) showed that the substrate RNA indeed was converted to mononucleotides, 
more specifically nucleotide monophosphates, by EGFP-hDis3L1-containing precipitates, 
whereas no activity was found in EGFP precipitates. The activity appeared to be dependent 
on the Mg2+ concentration with an optimum at about 0.05 mM, which is very similar to the 
optimal Mg2+ concentration described for yeast Dis3 (Dziembowski et al, 2007). To further 
demonstrate that the mononucleotide products were resulting from the presumed 3’-5’ 
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Figure 3. Localization of hDis3L1 and hDis3 in HEp-2 cells.
HEp-2 cells were transiently transfected with expression constructs encoding EGFP-hDis3L1 (A), hDis3L1-EGFP 
(B), VSV-hDis3L1 (C) or EGFP-hDis3 (D). Forty-eight hours after transfection the cells were fixed and EGFP-fusion 
proteins were visualized directly by fluorescence microscopy. The VSV-tagged hDis3L1 protein was visualized by 
incubating the cells with monoclonal anti-VSV-tag antibodies, followed by Alexa Fluor 555-conjugated goat anti-
mouse antibodies and fluorescence microscopy. (E-J) Fixed HEp-2 cells were incubated with polyclonal antibodies 
to hDis3L1 (F-G) or to hDis3 (I-J) and bound antibodies were visualized by Alexa Fluor 488-conjugated secondary 
antibodies and confocal immunofluorescence microscopy. Nuclei were visualized by Hoechst staining (E and H). (G) 
and (J) show the merged images of Hoechst and antibody staining. Bar: 10 µm. 
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exoribonuclease activity of EGFP-hDis3L1 the radiolabeled substrate was pre-incubated with 
DNA oligonucleotides complementary to either the 5’ or the 3’ terminal part of the substrate. 
Since blocking of the 3’ end, in contrast to that of the 5’ end, impaired the degradation of the 
substrate RNA (data not shown), the results of these experiments are consistent with 3’-5’ 
exoribonuclease activity.
Since the Dis3 protein in yeast contains endonucleolytic activity as well, mediated by the 
PIN domain, a similar activity assay was performed to investigate whether also hDis3L1 
acts as an endoribonuclease. These experiments were performed in the presence of Mn2+, 
rather than Mg2+, because this was previously shown to be required for the endonucleolytic 
activity of PIN domain-containing proteins. The results showed that under these conditions 
no endonucleolytic activity could be detected in these EGFP-hDis3L1 precipitates 
(Supplementary Figure S2).
To investigate whether the exoribonuclease activity associated with hDis3L1 is also associated 
with the exosome core, similar activity assays were performed, but now with material 
immunoaffinity-purified with antibodies to exosome core component hRrp40. In addition, 
the lysates used for these experiments were prepared from cells treated with a hDis3L1-
specific siRNA or with a control siRNA. If hDis3L1 is responsible for the exosome-associated 
exoribonuclease activity, knocking-down the expression level of hDis3L1 was expected to 
reduce this activity. In agreement with previous observations, exosome complexes isolated 
with the anti-hRrp40 antibodies displayed exoribonuclease activity (Figure 4B). The siRNA-
mediated depletion of hDis3L1 (the efficiency of which is shown in Supplementary Figure 
S3) led to a reduced exoribonuclease activity of anti-hRrp40 precipitates, strongly suggesting 
that hDis3L1 indeed contributes to the activity of the human exosome. 
The RNB domain of hDis3L1 is mediating its exoribonuclease activity
The identification of a RNB domain in hDis3L1 (described above) suggested that this domain 
might be necessary for its exoribonuclease activity. To investigate this in more detail, one the 
most highly conserved residues in this domain, the aspartate at position 486 was replaced 
by an asparagine (D486N). Substitution of the corresponding residue in other RNB domains 
has been demonstrated to inhibit their exonuclease activity without interfering with RNA 
binding, as was initially found for RNase II (Amblar and Arraiano, 2005). This residue also 
corresponds to the D551 in the yeast Dis3 protein. Substitution of D551 of yeast Dis3 abolished 
its exoribonuclease activity, whereas the endonuclease activity remained unaffected 
(Dziembowski et al, 2007). Likewise, two additional hDis3L1 mutants were generated in which 
the two conserved aspartates in the putative PIN-domain were substituted for asparagines 
(D62N and D166N). The expression of EGFP-fused hDis3L1 mutants in transfected HEp-2 
cells was monitored by western blotting, revealing similar expression levels for all hDis3L1 
constructs (Figure 4C). A ribonuclease assay with the immunoaffinity-purified hDis3L1 
mutants (Figure 4D) showed that the D486N mutant was completely inactive, in contrast 
to the wild type protein and the PIN domain mutants, which showed similar levels of 
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Figure 4. In vitro RNA degradation by hDis3L1.
(A) HEp-2 cells were transfected with expression constructs encoding EGFP-hDis3L1 or EGFP and after 48 hrs cell 
lysates were subjected to immunoprecipitation with anti-GFP antibodies. Precipitated proteins/complexes were 
incubated with a radiolabeled RNA substrate (Input) and the reaction products were subsequently analyzed by 
denaturing polyacrylamide gel electrophoresis followed by autoradiography. The incubations were performed in 
the presence of increasing concentrations of Mg2+. (B) A similar assay was performed with endogenous exosome 
complexes after precipitation with anti-hRrp40 antibodies or antibodies from normal rabbit serum (NRS) antibodies 
and lysates from cells which transfected with siRNAs downregulating either EGFP (used as a control) or hDis3L1. (C) 
Expression efficiency of EGFP-tagged hDis3L1 proteins monitored by western blotting using anti-GFP antibodies. 
WT: wild-type hDis3L1. D62N, D166N, D486N: hDis3L1 amino acid substitution mutants. Anti-γ-tubulin antibodies 
were used as a loading control. (D) Activity assay as described above (A) with immunoprecipitated hDis3L1 mutants 
D62N, D166N, D486N in the presence of 0.05 mM Mg2+. Precipitates from cell lysates containing EGFP and wild type 
(WT) hDis3L1 were used as negative and positive control, respectively.
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exonucleolytic degradation of the substrate RNA. These results indeed indicate that the RNB 
domain is involved in exonucleolytic RNA degradation by hDis3L1.
The abrogation of the exonucleolytic activity by the RNB domain mutation confirms that the 
activity observed in the in vitro ribonuclease assay is due to the presence of hDis3L1 and 
is not caused by a contaminating ribonuclease, which may non-specifically co-purify with 
hDis3L1.
Figure 5. Cytoplasmic accumulation of adenylated degradation intermediates upon hDis3L1 knock-
down.
(A) Cytoplasmic RNA from cells in which the indicated proteins were silenced by RNAi was subjected to oligo(dT) 
RT-PCR labeling, followed by fractionation by denaturing polyacrylamide gel electrophoresis and autoradiography. 
A schematic representation of the labeling procedure is shown on the left. First, cDNA was generated using a d(T)9-
adapter primer. Products from these reactions were amplified by PCR using a [32P]-labeled forward (F) primer 
corresponding to a sequence element of the 28S rRNA and a reverse primer corresponding to the adapter sequence. 
Material from a control reaction, in which the reverse transcriptase was omitted (-), is shown in lane 5. The positions 
of dsDNA markers are indicated on the left of the gel. For normalization, RT-PCR products obtained with PCR primers 
specific for the B2M gene are shown in the lower panel. (B) A similar oligo(dT) RT-PCR labeling experiment as in panel 
A, but now the isolated RNA was incubated with oligo(dT) and RNase H prior to the RT reactions. RNA isolated from 
cells in which hXrn1 was knocked-down, which like silencing of hDis3L1 leads to accumulation of poly(A) containing 
degradation intermediates, was used as a control to show that treatment with RNase H in the absence of oligo(dT) 
(lane 6) did not lead to the disappearance of the intermediates.
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hDis3L1 is involved in rRNA degradation
The cytoplasmic localization of hDis3L1 suggested that it might be involved in the 
exoribonucleolytic degradation of RNAs in the cytoplasm. To investigate this possibility, the 
effect of hDis3L1 depletion on ribosomal RNA was studied. Degradation of rRNA in human 
cells involves the formation of truncated, transiently poly(A)-tailed molecules (Slomovic 
et al, 2006). An oligo(dT)-primed RT-PCR labeling procedure allows the detection of these 
truncated, poly(A)-tailed molecules derived from cytoplasmic 28S rRNA (Slomovic et al, 
2010). hRrp40, PM/Scl-100 and hDis3L1 were knocked-down and the effect of reduced 
levels of these proteins on the 28S rRNA degradation intermediates was determined by 
the RT-PCR procedure, which is schematically illustrated in Figure 5A. Controls for the cell 
fractionation are shown in Supplementary Figure S4, panel A). Western blotting or RT-PCR 
quantification, in case appropriate antibodies were lacking, showed a strong reduction 
of the silenced proteins (Supplementary Figure S4, panel B). The RT-PCR products were 
analyzed by denaturing gel electrophoresis, which showed that knocking down hDis3L1 
resulted in the accumulation of truncated 28S rRNA fragments, whereas no or only a very 
weak accumulation of these molecules was observed when hRrp40 or PM/Scl-100 were 
knocked down (Figure 5A). To verify whether the accumulated products were not artifacts of 
nonspecific reverse transcription, the purified RNA purified was incubated with RNase H and 
oligo(dT) before the oligo(dT)-primed RT reaction. In this way, no cDNA can be produced as 
this treatment removes the poly(A) tails that are needed for the subsequent oligo(dT)-primed 
cDNA synthesis. The results of this experiment showed that this treatment indeed reduced 
the observed amplified signals to background levels (Figure 5B).
These results strongly suggest that hDis3L1 plays a role in the degradation of rRNA and 
possibly other RNAs in the cytoplasm of human cells.
Discussion
The evidence that the core of the eukaryotic exosome complex lacks exoribonuclease 
activity raised the question which proteins are responsible for this activity of the exosome. 
Paradoxically, the canonical human homologue of one of the main exosome-associated 
exoribonucleases in the yeast Saccharomyces cerevisiae, Dis3, does not detectably associate 
with the core of the exosome. In this study, a proteomic approach led to the identification 
of a novel human Dis3-like exonuclease (hDis3L1), which is stably associated with human 
exosome complexes. The sequence of the Dis3L1 protein was first added to the databases 
in 2002, which may explain why it was not found in previous proteomic analyses of purified 
exosome complexes (Chen et al, 2001). The failure to detect the association of hDis3 with 
the exosome complexes in the study of Chen and collaborators and also in other studies 
(Allmang et al, 1999a; Raijmakers et al, 2002) suggested that hDis3 is either weakly associated 
with the exosome core or not al all. The identification of hDis3L1 as an exosome-associated 
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exoribonuclease indeed suggests that hDis3L1 shares more functional features with the yeast 
Dis3 protein than hDis3. 
The ribonuclease assays presented in this study show that hDis3L1 is a Mg2+-dependent 
exoribonuclease and that this activity is dependent on its RNB domain. On the other hand, 
no endoribonuclease activity was observed under conditions identical or similar to those 
previously applied to study the endoribonuclease activity of the yeast Dis3 protein (Lebreton 
et al, 2008; Schaeffer et al, 2009). The failure to detect this activity is consistent with the 
relatively poor conservation of the PIN domain in hDis3L1, in which one of the three highly 
conserved aspartic acids is not present. These aspartic acids have been demonstrated to be 
crucial for the endonucleolytic potential of PIN domains, as substitution of only one of these 
residues can severely reduce this activity (Glavan et al, 2006; Lebreton et al, 2008). 
Since hDis3L1 appears to accumulate in the cytoplasm, its subcellular localization only 
partially overlaps with that of the core exosome components, which are found in both the 
cytoplasm and the nucleus. Although the cytoplasmic accumulation of hDis3L1 was observed 
both with ectopically expressed GFP- and VSV-tagged proteins and with a polyclonal antibody 
to hDis3L1, our results to not exclude the possibility that a specific isoform of hDis3L1 
displays another subcellular distribution. The sequence databases provide evidence for 
the existence of 4 isoforms, which most likely result from alternative splicing events. Future 
experiments will have to clarify potential differences between their localization and function. 
The results of our localization studies not only suggest that hDis3L1 is specifically associated 
with cytoplasmic exosome complexes, but also implicate that the RNA substrates for hDis3L1 
are restricted to the cytoplasm. Paradoxically, the yeast exosome-associated Dis3 protein 
is found both in the cytoplasm and in the nucleus (Synowsky et al, 2009). In view of the 
observations that the exosome core itself is catalytically inactive, it is tempting to speculate on 
the differentiation between ribonucleases associated with the nuclear and cytoplasmic core 
complexes. PM/Scl-100, which seems to be more concentrated in the nuclear compartment, 
might be more important for the nuclear functions of the exosome, whereas hDis3L1 might 
be more important for its cytoplasmic activities (such as the turnover of rRNAs and mRNAs). 
Interestingly, hDis3 appears to be mainly nucleoplasmic, suggesting that the function of the 
Dis3 protein in yeast is performed by separate homologous proteins, hDis3 and hDis3L1, in 
the nucleus and cytoplasm, respectively. In the nucleus, hDis3 seems to act independently 
of the core of the exosome, although an instable association that is not resistant to cell lysis 
and fractionation can not be excluded (see also Supplementary Figure S5). The relationship 
with the third human member of the Dis3 protein family, hDis3L2, is currently enigmatic. The 
proteomic data suggest that also this protein is not stably associated with the core of the 
exosome, but more studies will be required to elucidate its function. 
Besides differences in subcellular localization, the capacity of different exoribonucleases to 
degrade RNA substrates completely or to process RNA substrates to the mature 3’ end may 
differ from one enzyme to another. Indeed, it has been suggested previously that one enzyme 
may take over from another to remove the last few nucleotides from a RNA substrate and the 
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dependence on the activity of the TRAMP complex appears to be different for the yeast Dis3 
and Rrp6 proteins (LaCava et al, 2005).
The stable association of hDis3L1 with the human exosome suggests that it acts in concert 
with the core of the exosome in the degradation of cytoplasmic RNAs. Depletion of hDis3L1 
led to a strong reduction of the exoribonuclease activity of immunoaffinity-purified exosome 
complexes, indicating that hDis3L1 is indeed mediating part of the RNA-degrading activity of 
the exosome. This does, however, not exclude the possibility that a subset of hDis3L1 is not 
exosome-associated and degrades RNAs independently of the exosome. Interestingly, the 
binding of yeast Dis3 to the exosome core is mediated mainly by the PIN domain (Schneider 
et al, 2009) and in view of the structural similarity it is likely that the interaction of hDis3L1 and 
the human exosome core is mediated by the same element. The exosome core may function 
to bind RNA substrates in its central channel and to lead these RNAs to the exoribonuclease 
site of hDis3L1 (Bonneau et al, 2009). 
One of the RNA substrates that are degraded by the exosome-associated hDis3L1 appeared to 
be 28S rRNA. The degradation of this RNA proceeds through polyadenylated intermediates, 
which accumulated upon hDis3L1 knock-down. Although these molecules were detected in 
the cytoplasmic fraction, our data do not rule out the possibility that they are generated 
in the nucleus and enter the cytoplasm in the hDis3L1 knock-down cells. The depletion of 
one of the exosome core components had a less pronounced effect on the accumulation of 
these molecules, which may indicate that the association of hDis3L1 with the exosome core 
is either not necessary for this activity or that the knock-down of PM/Scl-100 and hRrp40 
was not efficient enough to produce a similar level of accumulation. Further studies will 
be required to investigate the requirement of the exosome core in hDis3L1-mediated RNA 
degradation in more detail, to shed more light on the ratio between exosome-associated and 
free hDis3L1, and to identify additional cellular RNA substrates for hDis3L1.
Recently, we were informed about an independent study by other investigators, who also 
identified hDis3L1 (termed hDis3L in their study) as an exoribonuclease associated with the 
cytoplasmic exosome (Tomecki et al, 2010). The results of this study confirm our conclusions 
on the subcellular localization, exosome-association and enzymatic activities of hDis3L1.
It is clear that more studies have to be performed to elucidate the possible differences 
between the nucleases associated with the nuclear and cytoplasmic exosome. The data 
presented in this study demonstrate that hDis3L1, rather than hDis3, is an exoribonuclease 
which is stably associated with exosome core complexes and this protein is mainly localized 
in the cytoplasm of human cells.
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Materials and methods
Purification of exosome complexes 
Polyclonal anti-hRrp40 (H70) antibodies, affinity-purified from rabbit serum H70 (Brouwer et 
al, 2001a) were coupled to protein A-agarose beads (Kem-En-Tec, Denmark) by incubation for 
2 hours at room temperature in PBS. After washing the beads three times with 0.2 M sodium 
borate, pH 9.0, the beads were incubated twice with 20 mM DMP (dimethyl pimelinidate 
dihydrochloride [Sigma]) in 0.2 M sodium borate, pH 9.0, by end-over-end rotation for 30 
minutes. DMP was inactivated by washing the beads four times with 0.2 M ethanolamine, pH 
8.0, after which the beads were washed three more times with PBS.
Five billion HeLa cells were resuspended in 6 volumes of lysis buffer (25 mM Tris-HCl, pH 7.5, 
100 mM KCl, 1 mM dithiotreitol (DTT), 2 mM EDTA, 0.5 mM PMSF, 2 mM Na3VO4, 2 mM NaF, 10 
mM NaHPO4, 0.05% NP-40, containing a protease inhibitor cocktail [Complete, Roche]), and 
incubated for 30 minutes on ice. After sonication (3 times 30 seconds at 0 ºC), cell lysates 
were centrifuged at 100,000g for 1 hour at 4 ºC and the supernatants were used immediately 
or stored at -70 ºC. 
The anti-hRrp40 beads were washed twice with wash buffer (PBS, 0.35 M NaCl, 0.05% NP-40), 
followed by washing with elution buffer A (0.1 M glycine-HCl, pH 2.5, 0.05% NP-40, 0.5 M NaCl) 
and two additional wash steps with wash buffer. Subsequently, HeLa S100 extract (1×109 cell 
equivalents) was added and incubated overnight at 4 ºC by end-over-end rotation. The beads 
were then washed twice with wash buffer, once with wash buffer containing 1 M NaCl, and 
again three times with wash buffer. Bound proteins were eluted by applying elution buffer A. 
Eluted fractions were neutralized immediately by adding 1M Tris base and the proteins were 
concentrated by acetone precipitation. Precipitated proteins were dissolved in SDS sample 
buffer, separated by 12% SDS-PAGE and stained with colloidal Coomassie Brilliant Blue. 
LC-MS/MS
The gel containing the immunoaffinity-purified proteins was cut into 19 slices, proteins were 
reduced with 1,4-dithiothreitol (6.5 mM) and alkylated with iodoacetamide reagent (54 mM). 
After thorough washing, the gel slices were rehydrated in trypsin solution (10 ng/µl) on ice. 
After addition of 30 µl of NH4HCO3 (50 mM, pH 8.5), samples were digested for 16 h at 37 °C. 
The supernatant of the digest was collected and the gel slices were washed for 15 min in 5% 
formic acid at room temperature, after which the supernatant was combined with the earlier 
fraction and stored at –20º C. All LC-MS/MS analyses were performed on an LTQ-Orbitrap 
mass spectrometer (Thermo, San Jose, CA) connected to an Agilent 1200 series nano LC 
system. Peptides were fractionated on C18 with a multi-step gradient of 0.6% HAc (solution 
A) and 0.6% HAc/80% acetonitrile (ACN) (solution B). The mass spectrometer was operated 
in the data-dependent mode to automatically switch between MS and MS/MS. Raw MS data 
were converted to peak lists using Bioworks Browser software, version 3.1.1. The spectra 
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were searched with Mascot against all human proteins in the Swissprot (v56.2) database with 
a precursor mass tolerance of 15 ppm and a product mass tolerance of 0.9 Da with trypsin 
as an enzyme, allowing 2 miscleavages. Peptide identifications were accepted with a Mascot 
score greater than 25 and a p value smaller than 0.005, corresponding to 1% false discovery 
rate as determined by decoy database searching.
cDNA cloning and generation of the hDis3L1 expression constructs
The complete coding sequence of the largest isoform of hDis3L1 (GenBank accession 
number: NM_001143688) was isolated from a teratocarcinoma cDNA library by PCR 
using the following oligonucleotides: 5’ - GGATCCCTCGAGATGCTGCAGAAGCGGGAGAA - 3’ 
and 5’ - GTCGACTCACCCGGGTATTCCATAATTGTTTGAAAC - 3’. The resulting amplicon of 
3229 basepairs was subsequently cloned into the pCR4-TOPO vector according to the 
manufacturer’s guidelines (Invitrogen). The sequence of the selected clone was confirmed 
by DNA sequencing. N-terminal EGFP- and VSV-tagged hDis3L1 expression constructs and a 
C-terminal EGFP-tagged expression construct were made by subcloning the coding sequence 
into the pEGFP-C3 (Clontech), pCI-neo-5’-VSV (Promega) and pEGFP-N2 vectors (Clontech), 
respectively, using the restriction enzyme combinations: Xho I/Sal I, Xho I/Sal I and Xho I/
Sma I, respectively.
Transient transfection of HEp-2 cells and fluorescence microscopy
To express tagged hDis3L1 in a human cell line, 4 x 106 HEp-2 cells were transfected with 20 
µg of plasmid DNA in 1 ml DMEM supplemented with 10% FCS by electroporation at 260V and 
950µF using a Gene-Pulsar II (Bio-Rad). To increase expression levels, 5 mM sodium butyrate 
was added to the medium 24 hours after transfection. Forty-eight hours after transfection the 
cells were harvested by trypsinization, resuspended in lysis-buffer (25 mM Tris-HCl, pH 7.5, 
100 mM KCl, 1 mM EDTA, 0.5 mM PMSF, 0.05% NP-40, 1 mM DTT) and sonicated 3 times 30 
seconds on ice.  To study the subcellular localization of hDis3L1 and hDis3, HEp-2 cells were 
transfected in a similar fashion, seeded on glass coverslips and fixed after forty-eight hours 
with 3.7% paraformaldehyde. EGFP fusion proteins were visualized directly, while the VSV-
tagged proteins were detected indirectly by incubation with a monoclonal anti-VSV antibody 
after permeabilization of the cells, followed by Alexa Fluor 555-conjugated goat anti-mouse 
antibodies (Invitrogen). Incubations with antibodies were performed in PBS supplemented 
with 1% sheep serum. The localization of EGFP- and VSV-tagged proteins was monitored 
by fluorescence microscopy. For the localization of the endogenous proteins hDis3L1 and 
hRrp40, HEp-2 cells were seeded on glass coverslips and fixed with methanol. Antibody 
incubations (anti-hRrp40; anti-hDis3L1, H00115752-B01P (Abnova)) were performed as 
described above with the exception that Alexa Fluor 488-conjugated goat anti-rabbit or anti-
mouse secondary antibodies (Invitrogen) were used for the detection of hRrp40. The nuclei 
of the cells were stained by incubation with the Hoechst 33342 (Invitrogen), diluted in PBS, 
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for 3 minutes. Images were made on a confocal laser scanning microscope (TCS SP2 AOBS 
System, Leica-microsystems).
siRNA treatment
siRNAs were purchased from Eurogentec. The sequences of the siRNAs for EGFP and 
hDis3L1 are 5’ - CCAUGUAACCGUAAGAAUAdTdT - 3’ and 5’ - CGAGAAGCGCGAUCACAUGdTdT 
- 3’, respectively. Transfection of HEp-2 cells with these siRNAs was performed essentially as 
described previously (Schilders et al, 2005).
Immunoprecipitation
Polyclonal rabbit anti-GFP antibodies or polyclonal rabbit anti-hRrp40 antibodies were 
coupled to protein A-agarose beads (Kem-En-Tec, Denmark) in IPP500 (500 mM NaCl, 10 mM 
Tris-HCl, pH 8.0, 0.05% NP-40) at room temperature for 1 h. Beads were washed once with 
IPP500 and twice with IPP150 (150 mM NaCl, 10 mM Tris-HCl, pH 8.0, 0.05% NP-40). HEp-
2 cell extract was incubated with the antibody-coupled beads for 2 h at 4°C. After washing 
the beads twice with IPP150 (or IPP1000 for the anti-hRrp40-coupled beads), bound proteins 
were either eluted with sample buffer for SDS-PAGE analysis, or were washed two more times 
with RNA degradation assay buffer (described below). 
Immunoblotting
For the detection of proteins on western blots, polyclonal rabbit antibodies (anti-GFP, anti-γ-
tubulin, GTU-88 [Abcam]), polyclonal mouse antibodies (anti-hDis3L1) or monoclonal mouse 
antibodies (anti-hRrp4, 15B3 [ModiQuest], anti-GFP, JL-8 [BD Biosciences]) were diluted 
in blocking buffer (5% skimmed milk, PBS, 0.05% NP-40). Blots were incubated with these 
antibodies for 1 hour at room temperature. Bound antibodies were detected by incubation 
with IRDye 800CW-conjungated polyclonal goat anti-mouse or goat anti-rabbit antibodies 
(Li-Cor) for 1 hour in blocking buffer and visualization using an Odyssey® Infrared Imaging 
System (Li-Cor).
In vitro RNA degradation assays
RNA degradation assays were performed using a radiolabeled 267 nucleotide RNA substrate, 
which was obtained by in vitro transcription in the presence of 32P α-UTP. This substrate RNA 
contained the human 5.8S rRNA sequence and the most 5’ 100 nucleotides of ITS2 (Schilders 
et al, 2005). After gel-purification of the RNA substrate, it was incubated for 2 hours with the 
immunoprecipitated material at 37˚C in RNA degradation buffer (20 mM HEPES, pH 7.5, 
50 mM KCl, 1 mM DTT, 1 mM Na2HPO4) containing different concentrations of Mg
2+ or Mn2+. 
Reactions were stopped by the addition of RNA-loading buffer (9 M urea, 0.1% bromophenol 
 66
blue, 0.1% xylene cyanol), supplemented with 20% v/v phenol. Samples were analyzed by 
denaturing polyacrylamide gel electrophoresis followed by autoradiography.
In vivo 28S rRNA degradation analysis
HeLa cells were grown as a monolayer at 37°C, 5% CO2 in DMEM (Sigma) supplemented 
with 10% fetal calf serum, 2 mM L-glutamine, and penicillin–streptomycin (Slomovic 
et al, 2008). Cells were transfected with 400 pmole siRNA duplex (PM/Scl-100: 5’ – 
GUUUCGAGAGAAGAUUGAUdTdT – 3’, hRrp40: 5’ – CACGCACAGUACUAGGUCAdTdT – 3’) using 
lipofectamine 2000 (Invitrogen). After 24 h, cells were detached with trypsin and replated, 
followed 24 hours later by a second transfection with 800 pmole siRNA. 72 hours after the 
initial transfection, cytoplasmic fractions were obtained from HeLa cells as previously 
described (van Dijk et al, 2007). To assess accumulation of truncated adenylated 28S rRNA, 
oligo(dT)-primed cDNA was subjected to 25 PCR cycles with a 28S rRNA specific forward 
primer coupled with the adapter oligo as follows: 1 min 95°C, 1 min 58°C and 1 min 72°C. 
Products of this PCR were used as templates in a second round of PCR-labeling using the 
same 28S rRNA primer which was 5’ end [32P]-labeled by polynucleotide kinase and γ-[32P]
ATP and the adapter. This second round was performed as described above but consisted of 
5 cycles and was followed by 10 min of extension at 72°C. PCR-labeled products were resolved 
by 6% denaturing PAGE and autoradiography. Ethidium bromide-stained DNA markers were 
run on the same gels and used as length markers.
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Figure S1. Yeast and human Dis3 and Dis3-like sequence alignment.
A multiple alignment of the amino acid sequences of yeast Dis3 (yDis3), human Dis3 (hDis3), human Dis3-like 1 
(hDis3L1) and human Dis3-like 2 (hDis3L2) was generated by the MUSCLE algorithm (Edgar, 2004). The secondary 
structure of hDis3L1, as predicted by PsiPred, is depicted below the sequence alignment; β-strands are represented 
with green arrows and α-helices with red bars. Protein domains predicted by SMART are indicated by colored boxes 
surrounding the sequences. The graphical presentation of the alignments was generated with Jalview (Waterhouse 
et al, 2009) using the default color scheme used for alignments in Clustal X.
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Figure S2. hDis3L1 lacks endonuclease activity.
(A) HEp-2 cells were transfected with expression constructs encoding EGFP or EGFP-hDis3L1 and after 48 hrs cell 
lysates were subjected to immunoprecipitation with anti-GFP antibodies. Precipitated material was incubated 
with a radiolabeled substrate RNA (Input) and the reaction products were subsequently analyzed by denaturing 
polyacrylamide gel electrophoresis followed by autoradiography. The incubations were performed in the presence 
the indicated concentrations of Mn2+. (B) Ribonuclease assay as described above (A), but with immunoprecipitated 
hDis3L1 mutants D62N, D166N, D486N (in addition to the wild type protein) in the presence of 1 mM Mn2+. 
Mononucleotide degradation products, most likely resulting from low levels of exoribonuclease activity, are 
indicated.
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Figure S4. Analysis of cell fractionation and efficiency of knock-down for cells used to study cytoplasmic 
rRNA degradation.
(A) Following cell fractionation, RNA purified from the cytoplasmic and nuclear fractions was stained with EtBr and 
the rRNA and tRNA distribution was compared with that of total cellular RNA. Tot., total cell RNA; Cyt., cytoplasmic 
RNA; Nuc., nuclear RNA. In addition, the RNA samples were subjected to northern blot hybridization using a probe 
for the nuclear U2 snRNA. The positions of the various RNAs are indicated. (B) The efficiency of siRNA-mediated 
silencing of exosome subunits hDis3L1, hRrp40 and PM/Scl-100 was monitored by RT-PCR using RNA isolated from 
the respective cells. RT-PCR analysis of β-actin mRNA was performed in parallel to control for equal amounts of 
starting material with the RNA from mock and siRNA-transfected cells.
Figure S3. SiRNA-mediated hDis3L1 knock-down.
The lysates from HEp-2 cells transfected with siRNAs for EGFP or hDis3L1 that were used for the activity assay, as 
depicted in Figure 4B, were analyzed by incubating western blots with anti-hDis3L1 and anti-hRrp4 antibodies. Anti-
γ-tubulin antibodies were used as a loading control.
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Figure S5. hDis3 does not stably interact with the exosome core.
Anti-hRrp40 antibodies were used to precipitate exosome complexes from a HEp-2 cell lysate in the presence of 
NaCl concentrations ranging from 25 mM to 150 mM, as indicated. The coprecipitation of hDis3 and hRrp4 (exosome 
core control) was monitored by western blotting using polyclonal and monoclonal antibodies, respectively, to these 
proteins. In the ‘Input’ lane the total cell lysate was loaded.
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Abstract
Polyadenylation of RNA is a posttranscriptional modification that can play two somewhat 
opposite roles: stable polyadenylation of RNA encoded in the nuclear genomes of eukaryote 
cells contributes to nuclear export, translation initiation, and possibly transcript longevity as 
well. Conversely, transient polyadenylation targets RNA molecules to rapid exonucleolytic 
degradation. The latter role has been shown to take place in prokaryotes and organelles, as 
well as the nucleus of eukaryotic cells. Here we present evidence of hetero- and homopolymeric 
adenylation of truncated RNA molecules within the cytoplasm of human cells. RNAi-mediated 
silencing of the major RNA decay machinery of the cell resulted in the accumulation of these 
polyadenylated RNA fragments, indicating that they are degradation intermediates. Together, 
these results suggest that a mechanism of RNA decay, involving transient polyadenylation, is 
present in the cytoplasm of human cells.
Introduction
RNA polyadenylation occurs throughout the biological world. Stable poly(A) is associated 
with the mature 3′ end of most mRNAs encoded in the nuclear genome of eukaryotes. It is 
important for nuclear export and efficient translation initiation and may also contribute to 
transcript longevity (Edmonds, 2002). In turn, mRNA degradation in the cytoplasm usually 
initiates with deadenylation of the stable poly(A) tail, followed by either further degradation 
of the mRNA body by the exosome (3′–5′ pathway) or removal of the 5′ cap and subsequent 
5′–3′ degradation by hXrn1 (exoribonuclease 1; 5′–3′ pathway) (Doma and Parker, 2007; 
Garneau et al, 2007; Houseley and Tollervey, 2009).
Unlike stable poly(A), transient poly(A) is not associated with the mature 3′ end of the 
transcript. RNA decay pathways that use transient poly(A) include a stage in which poly(A) 
or poly (A)-rich tails are added to the 3′ ends of truncated degradation intermediates and 
are believed to assist exoribonucleases in their rapid degradation. As the tail addition can 
occur after endonucleolytic cleavage of the RNA or repetitive adenylation and 3′-5′ digestion, 
it often appears to be at “internal” positions relative to the full RNA sequence (Deutscher, 
2006; Slomovic et al, 2006b). The term “transient” is used because the short-lived tail is 
degraded along with the RNA fragment. Transient poly(A) was first disclosed in Escherichia 
coli and then in additional bacteria, organelles, archaea and, eventually, in yeast and human 
nuclei (Deutscher, 2006; Houseley and Tollervey, 2009; Slomovic et al, 2008b; Vanacova and 
Stefl, 2007; Wilusz and Wilusz, 2008). In all systems in which truncated, polyadenylated RNA 
fragments were initially detected, they were later found to be correlated to poly(A)- assisted 
RNA decay (Houseley and Tollervey, 2009; Slomovic et al, 2008b; Wilusz and Wilusz, 2008).
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In yeast nuclei, transient poly(A) was found to play a role in RNA quality control wherein 
polyadenylation, initiated by the TRAMP complex, targets incorrectly folded tRNA molecules 
to degradation by the nuclear exosome (LaCava et al, 2005; Vanacova et al, 2005). In human 
cells, cotranscriptionally cleaved 3′ regions of an introduced β-globin gene and a class of 
short, highly unstable RNAs, dubbed PROMPTs (promoter upstream transcripts), were 
found to be adenylated and accumulated when the exosome was downregulated (Preker 
et al, 2008; West et al, 2006). It has recently become clear that almost the entire genome is 
transcribed, which results in the production of antisense and noncoding RNAs (Arigo et al, 
2006; Lykke-Andersen and Jensen, 2006; Preker et al, 2008; Thiebaut et al, 2006; Wyers et al, 
2005). These cryptic unstable transcripts were found to undergo rapid poly(A)-assisted decay 
as well (LaCava et al, 2005; Vanacova et al, 2005; Wyers et al, 2005). However, although such 
nuclear mechanisms have been reported, poly(A)-assisted RNA decay has not been found in 
the cytoplasm of eukaryote cells.
Previously, we isolated truncated, poly(A)-tailed ribosomal RNA molecules from total RNA of 
human cells (Slomovic et al, 2006a). Interestingly these tails were either of homopolymeric 
[poly(A)] or heteropolymeric [poly(A)-rich] nature. The heteropolymeric extensions were 
dominantly adenylated but contained other nucleotides as well and resembled the poly(A)-
rich tails produced in bacteria, chloroplasts, and archaea (Slomovic et al, 2006b; Slomovic et 
al, 2008b). However, neither the cellular location nor the function of these adenylation events 
was deciphered.
Here, we show the presence of truncated mRNAs and rRNAs, bearing homopolymeric or 
heteropolymeric tails, in the cytoplasm of human cells. RNAi-mediated silencing of 3′-
5′ exoribonucleases and hXrn1 resulted in the accumulation of these molecules in the 
cytoplasm, strongly suggesting that poly(A)- assisted RNA decay occurs in the cytoplasm of 
human cells.
Results
Fragmented 28S rRNA molecules containing homo-or heteropolymeric tails are 
present in both the cytoplasm and nucleus of human cells
In earlier work, we detected truncated 28S and 18S rRNAs containing homo- or 
heteropolymeric tails (Slomovic et al, 2006a). It was plausible that these rRNA fragments are 
degradation intermediates of the nuclear process mentioned earlier, but a second option 
could not be ignored: transient, perhaps degradation-assisting, adenylation of RNA within 
the cytoplasm, coexisting with the stable poly(A) tails that characterize this cellular location. 
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Hence, our first goal was to determine whether these tailed, truncated molecules are present 
in the nucleus, cytoplasm, or both.
RNA and protein were obtained from cytoplasmic and nuclear fractions which were prepared 
from HeLa cells. A clear fractionspecific distribution of mature rRNA and pre-rRNA (and tRNA) 
was observed upon ethidium bromide staining of total, cytoplasmic, and nuclear RNA (Figure 
S1). To assess purity of fractions, Northern blots and immunoblots were prepared, and Figure 
1A shows that the RNA and protein markers were detected exclusively in the corresponding 
fractions. Next, the presence of fragmented polyadenylated 28S rRNA was evaluated by 
oligo (dT) RT-PCR. The results disclosed 28S rRNA fragments, with either homo- or 
heteropolymeric extensions in both the nucleus and cytoplasm (Figure 1B). To our knowledge, 
this is the first detection of internally adenylated RNA in the cytoplasm of human cells. 
To evaluate the truncated molecules in both fractions by means unbiased to poly(A) 
extensions, circularized reverse transcription (cRT) was applied to the same region of 28S 
rRNA (Figure 1C). Truncated molecules were successfully isolated from both the cytoplasmic 
and nuclear fractions. Although most fragments were tail-less, a small number had extensions 
of 1 to 4 nt; however, there are cases in which it is not clear whether the adenosine is part of 
the encoded sequence or was posttranscriptionally added. These molecules could reflect 
oligo(A) addition, or could be either at a stage before tail synthesis or amid 3′-5′ degradation. 
Therefore, as in many previous studies of transient adenylation, biased methods such as 
oligo(dT) RT-PCR are necessary to view long internal tails and assess their nt composition, 
which can often lead to the identity of the polyadenylating factor (Slomovic et al, 2008a; 
Slomovic et al, 2008b).
Truncated, intron-Less β-actin transcripts harboring homo- or heteropolymeric tails
To check if, in addition to rRNA, mRNA can undergo this process, the presence of truncated 
adenylated β-actin mRNA molecules was analyzed using oligo(dT) RT-PCR. Gene-specific 
primers were applied; some of which targeted the mRNA sequence immediately upstream of 
introns, potentially allowing the isolation of both spliced and unspliced adenylated β-actin 
fragments. As shown in Figure 2A, truncated adenylated β-actin fragments were isolated and 
similar to rRNA, both homo- and heteropolymeric tails were observed. Also, such molecules 
were obtained from both nuclear and cytoplasmic fractions (Table S1). No introns were 
present among the isolated sequences, disclosing that these are (partially, if not fully) spliced 
transcripts. These results show that like rRNA, mRNA can undergo transient adenylation.
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Figure 1. 28S rRNA fragments with homo- or heteropolymeric poly(A) tails in the cytoplasm and nuclei 
of human cells.
(A) Fractionation purity was determined by Immunoblots (IBs) and RNA blots using fraction-specific markers: C, 
cytoplasm: GAPDH. N, nucleus: histone H3 (H3), fibrillarin, and U2/U3/U5-snoRNAs. T, total cell RNA/proteins. (B) 
Oligo(dT) RT-PCR isolation of truncated, adenylated 28S rRNA molecules from cyt (above) and nuc (below) fractions. 
28S rRNA is schematically presented with arrows indicating primer locations and vertical lines showing tail sites 
and content (Table S1). (C) cRT-PCR isolation of truncated 28S rRNA molecules from cyt (above) and nuc (below) 
fractions. Cases in which it is not known whether the “A” is encoded or added posttranscriptionally are marked with 
an asterisk (Table S2).
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Figure. 2. Homo- or heteropolymeric poly(A) tails in eukaryotic and viral (pre-)  mRNAs.
(A) Spliced β-actin fragments with homo- or heteropolymeric poly(A) tails, isolated from human cells. Primary β-actin 
mRNA is schematically presented (introns in black, exons in gray). Lengths of each exon/intron are shown. Homo- 
and heteropolymeric tails are presented above and below the gene, respectively (Table S1). (B) Oligo(dT) RT-PCR 
isolation of truncated, adenylated VV RNA molecules [G8R (a viral mRNA) and GFP (integrated into the viral genome)] 
from HeLa cells 4 h after transfection (Table S3).
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Truncated vaccinia virus RNAs bearing homo- or heteropolymeric tails were 
isolated from infected cells.
In addition to the fractionation purity assays (Figure 1A), to further ensure that the RNA 
molecules obtained from cytoplasmic fractions as described earlier were not intermediates 
of a nuclear process that had “leaked” to the cytoplasm, either in vivo or during our 
experimental procedures, we adopted an additional approach: vaccinia virus (VV) belongs 
to the poxvirus family and contains a doublestranded DNA genome, encoding more than 
200 proteins. Poxviruses are unique among most DNA viruses in that they do not enter the 
nucleus during their entire life cycle (Broyles, 2003). To check if viral RNA is subjected to 
transient adenylation within the cytoplasm, RNA was purified from infected HeLa cells and 
analyzed for the presence of truncated, polyadenylated transcripts of genes encoded in the 
viral genome. Figure 2B displays the results of the analysis of G8R mRNA, an intermediate 
viral gene and GFP mRNA, produced from a GFP gene inserted into the viral genome 
(Hsiao et al, 2006). Truncated transcripts originating from these genes, with either homo- 
or heteropolymeric tails, were detected. These results provide additional support that a 
mechanism involving transient RNA polyadenylation is present in the cytoplasm and applies 
not only to rRNA, but mRNA as well. Accordingly, the next step was to check if there is a link 
between this type of RNA adenylation and RNA decay, as in all previously studied systems in 
which such molecules were found.
Are the truncated, polyadenylated transcripts degradation intermediates?
In all systems in which truncated, adenylated RNA molecules were detected, they were later 
shown to be intermediates in a poly(A)- assisted RNA decay pathway. We asked if the tails 
observed here, in the cytoplasm, are indeed telltale signs of such a process. If so, inhibition 
of exonucleolytic activity would result in their accumulation, as observed in bacteria, plant 
mitochondria, and the nuclei of yeast and human cells (Kushner, 2004; Preker et al, 2008; 
West et al, 2006; Wyers et al, 2005). To this end, we used RNAi to knock down (KD) hXrn1 
and the exosome subunits. For the latter, PM/Scl-100, an exoribonuclease associated with 
the exosome and hRrp41, an exosome core protein, were targeted. Immunoblots disclosed 
significant KD of the targeted proteins (Figure 3A). A reduction in exosome activity was 
validated by 5.8S rRNA precursor accumulation in both the PM/Scl-100 and hRrp41-silenced 
cells (Figure 3B) (Preker et al, 2008; Stoecklin et al, 2006).
Degradation intermediates are nonabundant and rapidly degraded; hence it is beneficial 
to analyze highly expressed transcripts for such related molecules. Therefore, we chose to 
focus on the region of 28S rRNA from which adenylated fragments had been isolated by 
oligo(dT) RT-PCR, as described earlier. To visually evaluate fragmented, adenylated 28S 
rRNA accumulation, a radiolabeling assay was applied; loading amounts were normalized 
according to B2M mRNA via RT-PCR (Figure 4A). Following oligo (dT) reverse transcription, the 
same primers with which the truncated molecules were previously isolated were used but this 
time, an extra PCR-stage in which the products were labeled via a 5′ end [32P] 28S rRNA primer, 
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was included. Fractionation on denaturing polyacrylamide gel, allowed sensitive assessment 
of accumulation of the labeled amplification products. As the truncated molecules were 
polyadenylated at varying sites along the 28S rRNA (Figure 1B), and the extensions were of 
different lengths, accumulation did not result in a single band, but a smeared signal instead. 
Substantial accumulation of truncated 28S rRNA fragments was observed in the lanes 
representing the RNAi silencing of PM/Scl- 100 and hXrn1 (Figure 4B). Although PM/Scl-100 
(Rrp6 in yeast) has been reported to exist in the cytoplasm, it is mainly found in the nucleus 
of human cells in association with the nuclear exosome (Lykke-Andersen et al, 2009; van Dijk 
et al, 2007). Therefore, the corresponding signal in this lane is most likely the result of the 
accumulation of nucleus-localized degradation intermediates. In contrast, accumulation of 
truncated 28S rRNA fragments was much less drastic in the hRrp41-silenced cells.
hXrn1 plays a central role in 5′-3′ RNA degradation in the cytoplasm. Counter intuitively, its 
silencing resulted in significant accumulation of the polyadenylated molecules. A cytoplasmic 
localization of these transcripts is implied by that of hXrn1 but the obvious question is why 
the inhibition of a 5’-3’ exonuclease results in the accumulation of degradation intermediates 
Figure 3. RNAi-mediated silencing of exosome subunits, hXrn1, hXrn2, and Lsm1.
(A) Efficiency of silencing was measured via immunoblot with specific antibodies. (B) Loss of exosome activity was 
validated by the accumulation of the 5.8S rRNA precursor as detected by Northern blot. (C) KD efficiency of RNAi-
silenced proteins for which antibodies were not available was monitored by RT-PCR. Immunoblots and RT-PCR were 
normalized with β-actin.
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Figure 4. Adenylated 28S rRNA 
degradation intermediates 
significantly accumulated in cells 
upon RNAi silencing of major 
exonucleases.
(A) Schematic presentation of PCR-
labeling assay to detect accumulation 
of adenylated, truncated 28S rRNA 
molecules after exonuclease KD. 
Briefly, following oligo(dT) RT of RNA 
from different KD cells, PCR with [32P]-
labeled gene-specific primer (asterisk; 
same as used to isolate molecules 
as shown in Figure 1B) and adapter 
oligo was performed. (B) RNA purified 
from the mock and KD HeLa cells was 
subjected to this analysis to assess 
the accumulation of polyadenylated, 
fragmented 28S rRNA. The migration 
of DNA markers is shown to the left 
(nucleotide numbers). (C) Cytoplasmic 
or nuclear RNA from cells in which 
the indicated proteins were silenced 
by RNAi, was subjected to oligo(dT) 
RT-PCR labeling. A control, with 
reverse transcript was omitted from 
the reaction, is shown in the far right 
lane of each panel. (D) To verify that 
the PCR products originated from 
polyadenylated transcripts, a control 
was performed in which the poly(A) 
tails of the cytoplasmic fractions were 
removed by incubation with oligo(dT) 
and RNase H before oligo(dT)-primed 
RT-PCR labeling. This resulted in 
reduction of amplification signals to 
background levels, as compared with 
the hXrn1 sample that was treated with 
RNase H but without oligo(dT) [lane 
labeled hXrn1 (-)].
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with 3’ end poly(A) tails. This issue will be addressed in the Discussion. Together, the 
information obtained using this assay suggests that the isolated polyadenylated 28S rRNA 
fragments are indeed degradation intermediates. To definitively determine cellular location, 
the analyses described here were repeated after fractionation of the nucleus and cytoplasm. 
Also, to further investigate whether the exosome core is involved in this process, several 
additional subunits and exoribonucleases were down-regulated.
RNAi silencing of exoribonucleases confirmed that poly(A)-assisted RNA decay 
exists in the cytoplasm of human cells
To confirm that degradation of transiently adenylated RNA occurs in the cytoplasm of human 
cells, the analysis was repeated after nuclear and cytoplasmic fractions were prepared. Two 
additional exosome core components, hRrp40 and PM/Scl-75, and two exoribonucleases, 
hDis3 and hDis3L1, were knocked down. hDis3 is a homologue of the yeast Dis3 protein; a 
hydrolytic 3′-5′ exoribonuclease with additional endonuclease activity that is associated 
with the exosome in both the nucleus and cytoplasm in yeast. This protein serves as the 
only catalytic subunit in the cytoplasmic yeast exosome (Dziembowski et al, 2007; Lykke-
Andersen et al, 2009). While this work was in progress, an additional Dis3 homologue in 
human cells, hDis3L1, was discovered, and unlike hDis3, was found to be strongly associated 
with the exosome core and to localize to the cytoplasm. Therefore, it is the more likely Dis3 
orthologue in human cells and its silencing was included (Staals et al, 2010). Two additional 
enzymes were silenced: hXrn2 and Lsm1. The former is a major, nucleus-localized 5′-3′ 
exonuclease and so its KD could be anticipated to cause accumulation in the nucleus but not 
in the cytoplasm (Houseley and Tollervey, 2009). The Lsm proteins play a role similar to the 
bacterial Hfq proteins, involved in bacterial mRNA decay via tail addition. Lsm1 is associated 
with hXrn1, decapping enzymes (Dcp1/Dcp2), and mRNA decay in the cytoplasm. Also, it was 
shown to be directly involved in histone mRNA oligo(U)-mediated decay. Thus, the effect of 
its RNAi silencing was evaluated as well (Mullen and Marzluff, 2008). RT-PCR quantification, 
for lack of appropriate antibodies, showed significant reduction in the mRNA levels of the 
silenced proteins (Figure 3C).
No accumulation was observed in the cytoplasm of cells silenced of the exosome 
components, hRrp40 or PM/Scl-75, and only minor accumulation could be observed in 
their nuclear fractions (Figure 4C). In contrast, KD of either hDis3 or hDis3L1 resulted in 
distinct cytoplasmic accumulation of truncated 28S rRNA fragments, suggesting that these 
two proteins are involved in the degradation process. As anticipated, hXrn1 and PM/Scl- 
100 silencing caused substantial accumulation in the cytoplasmic and nuclear fraction, 
respectively, and KD of hXrn2 resulted in accumulation only in the nuclear fraction. Silencing 
of Lsm1 did not result in accumulation within either fraction. To be sure that the labeled 
products observed in the gel were indeed obtained by the amplification of polyadenylated 
28S rRNA molecules and not artifacts of nonspecific reverse transcription, RNA purified from 
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the cytoplasm was incubated with RNase H and oligo(dT) before the oligo(dT)-primed reverse 
transcription (Figure 4D). This way, all poly(A) tails would be removed and no cDNA would be 
produced during the subsequent oligo(dT)-primed RT. Indeed, this treatment reduced the 
observed amplified signals to the background level. It is especially evident when comparing 
the result obtained for RNA purified from hXrn1-silenced cells that was either incubated with 
RNase H alone or with RNase H together with oligo(dT) (Figure 4D).
Together, these results confirm that rRNA can be transiently adenylated, not only in the 
nucleus of human cells, but in the cytoplasm as well, and this is linked to rRNA decay. In 
the cytoplasm, the involved exoribonucleases include hDis3L1, hDis3, and hXrn1, as the 
adenylated degradation intermediates accumulate upon their down-regulation.
Exosome or hPNPase silencing does not cause a decrease in the percentage of 
hetero-adenylated clones
At this stage, we attempted to identify the enzyme responsible for the addition of the 
tails, in particular those of heteropolymeric nature. PNPase and the archaeal exosome are 
responsible for both hetero-tailing and degrading bacterial, organellar, and archaeal RNA 
(Slomovic et al, 2008b). The structurally similar eukaryotic exosome was initially a candidate 
for the hetero- activity observed here and if it were responsible for producing the hetero-tails, 
a shift in favor of the homoextensions would be expected to occur upon its KD. However, the 
exosome was reported to lack phosphorolytic activity (Lykke-Andersen et al, 2009) and in 
agreement with this, we found that the percentage of homo- tails within the total amount of 
isolated and sequenced clones did not increase upon KD of exosome subunits, hRrp41, PM/
Scl-100, and PM/Scl-75 (Figure 5).
PNPase is present in human cells (hPNPase) and phosphorolytically active (Portnoy et al, 
2008). Although localized to the mitochondrial intermembrane space (IMS) (Chen et al, 2007), 
we considered the possibility that hPNPase, similar to other IMS proteins such as cytochrome 
C and endonuclease G (Widlak and Garrard, 2005), could be liberated from this compartment 
and enter the cytoplasm(and/or nucleus), where it could polymerize hetero- tails. However, 
no increase in homo- tail rate was observed in cells with constant hPNPase shRNA silencing 
either (Slomovic and Schuster, 2008).
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Discussion
Poly(A)-assisted RNA decay occurs in the cytoplasm of human cells.
A nuclear RNA surveillance mechanism involving polyadenylation and rapid degradation of 
nonfunctional, antisense, and noncoding RNAs has been described in yeast and human cells 
(Houseley and Tollervey, 2009; Neil et al, 2009; Proudfoot and Gullerova, 2007; Thompson 
and Parker, 2007; Vanacova and Stefl, 2007; Xu et al, 2009). We initially assumed that the 
truncated, polyadenylated rRNA molecules that we had previously detected in human cells 
(Slomovic et al, 2006a) are solely related to this process, but in this study we found that 
transient adenylation can occur in the cytoplasm as well, as such molecules were detected 
in cytoplasmic fractions. However, in yeast, unstable transcripts derived from intergenic 
regions (i.e., nuclear) were reported to be stabilized upon inhibition of Xrn1 and Dcp1 (i.e., 
cytoplasmic). In such a case, export from the nucleus would be entailed (Thompson and 
Parker, 2007). To ensure this was not the case in our work, besides assays that demonstrated 
fractionation purity, both at protein and RNA levels, additional cytoplasmic localization 
evidence was obtained by analyzing the RNA of VV, a virus that spends its entire life cycle 
in the cytoplasm. Analysis of the β-actin transcript was applied as well, demonstrating that 
endogenous mRNA can undergo this process.
Figure. 5. Percentage of homopolymerically tailed molecules isolated from HeLa cells with RNAi 
silencing of exosome components or hPNPase, cells infected with VV, and yeast.
Percentage of homopolymerically tailed molecules among the total number of sequenced molecules isolated 
from HeLa cells did not increase upon RNAi silencing of: hRrp41, PM/Scl-75, PM/Scl-100, or hPNPase (28S rRNA 
was analyzed). In VV-infected cells, the viral G8R RNA was analyzed, and in S. cerevisiae, 25S rRNA, CYH2 and Actin1 
(Tables S3, S4, and S5).
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If indeed the observed molecules are degradation intermediates of poly(A)-assisted RNA 
decay, we expected to observe their accumulation upon exoribonuclease down-regulation. 
Silencing of three of the nine exosome core proteins caused only slight accumulation of 
adenylated rRNA in the nucleus and no noticeable accumulation in the cytoplasm. PM/Scl-
100 silencing resulted in accumulation only in the nuclear fraction and therefore, although 
reported to partially reside in the cytoplasm of human cells, PM/Scl-100 does not seem to 
be involved in this cytoplasmic process (Lejeune et al, 2003; Schmid and Jensen, 2008; van 
Dijk et al, 2007). Conversely, RNAi silencing of the two Dis3 (Rrp44) homologues, hDis3 and 
hDis3L1, resulted in cytoplasmic accumulation of truncated adenylated rRNA. The fact that 
silencing of hDis3, the previously identified yeast Dis3 orthologue (Schmid and Jensen, 2008), 
had this effect, suggests that this Dis3 family member, although most likely not associated 
with the exosome, acts as a 3′-5′ exonuclease. hDis3L1, however, is most likely associated 
with the cytoplasmic exosome core (Staals et al, 2010), and the accumulation of truncated 
adenylated rRNA in the cytoplasm upon its silencing suggests either exosome involvement 
in this process (despite no such effect when silencing core subunits) or a level of exosome-
independent activity of hDis3L1. In previous studies, although substantially knocked down 
by RNAi (validated by assessment of 5.8S rRNA processing), not all exosome subunits that 
were silenced caused a substantial effect on AU-rich element (ARE)–mediated decay, and a 
similar situation could occur in this case (Stoecklin et al, 2006). hXrn2 KD led to accumulation 
within the nucleus but not in the cytoplasm, in correlation with its cellular localization.
Lsm1 silencing did not result in the accumulation of adenylated rRNA fragments. This result is 
somewhat surprising, as Lsm1 is known to play a central role in mRNA degradation following 
stable poly(A) tail shortening . Also, recent work disclosed a novel oligo(U)-mediated histone 
mRNA decay pathway with Lsm1 as an integral component (Mullen and Marzluff, 2008). There, 
its silencing greatly stabilized histone mRNA (i.e., hampered its degradation), as did that of 
Xrn1 and Dcp2. Here, its apparent uninvolvement in poly (A)-mediated rRNA decay could be 
interpreted as the following: Lsm1 is known to recruit the decapping enzymes and allow Xrn1 
5′-3′ degradation after the cap is removed. However, rRNA (uncapped) was the focus of the 
assay presented here. The poly (A)-mediated decay of rRNA may differ from that of mRNA 
(capped). First, Lsm1 could well be involved in cap removal of mRNA, allowing hXrn1 activity. 
Second, hXrn1 may not be involved in mRNA decay. Third, in any case, in previous work, we 
traced truncated adenylated 28S rRNA molecules to an endonucleolytically cleaved region of 
the 28S transcript (Slomovic et al, 2006a). Multiple endonucleolytic cleavage events of rRNA 
or mRNA before transient tail addition, as in other poly(A)-mediated RNA decay pathways, 
could provide bare 5′ (and 3′) ends, thereby bypassing the need to decap the molecule 
(Slomovic et al, 2006a). More studies are needed to characterize any differences between 
poly(A)-mediated rRNA and mRNA decay.
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Why did silencing of hXrn1 result in the accumulation of truncated transcripts, 
adenylated at the 3′ end?
If the tails observed here provide the same function as in all known cases of transient 
adenylation, to assist in 3′-5′ degradation, why did inhibition of hXrn1’s 5′-3′ activity result in 
the accumulation of these 3′ tailed molecules? Perhaps this case resembles ARE-mediated 
mRNA decay in the sense that, although AREs are present in the 3′ UTR, Xrn1 is required to 
fully degrade the substrates (Stoecklin et al, 2006). Also, oligo (U)-mediated histone mRNA 
degradation was shown to include degradation from both the 5′ and 3′ ends of the transcript 
(Mullen and Marzluff, 2008). Moreover, if endonucleolytic cleavage events were to precede 
poly (A) tail addition, hXrn1 would be a likely candidate to degrade the distal cleavage 
products, starting from their unprotected 5′ ends. 
Interestingly, recent studies have questioned the necessity of polyadenylation of nuclear 
exosome substrates by Trf4/5 of the TRAMP complex, as a polyadenylation-defective form of 
Trf4 (Trf4-DADA) can activate exosomal degradation of RNA substrates and rescue the lethality 
of Trf4/5 double mutants (San Paolo et al, 2009; Wyers et al, 2005). This suggests that the 
general addition of poly(A) tails to nuclear degradation intermediates may only be necessary 
to promote the degradation of certain structured RNAs. If cytoplasmic poly(A)- assisted RNA 
decay is similar in this manner, more weight would be placed on the 5′-3′ pathway; hence, 
hXrn1’s involvement.
Which enzyme produces the homo- and heteropolymeric tails?
Neither hPNPase nor exosome silencing caused an increase in the percentage of homo-
tailed molecules within the total amount isolated and sequenced. Theoretically, this could 
indicate two alternatives: (i) neither enzyme produces the heteropolymeric tails or (ii) one of 
the enzymes produces both homo- and heteropolymeric tails. The latter scenario is highly 
unanticipated as, traditionally, polyadenylating enzymes in such pathways are known to 
synthesize a single type of tail, as far as nucleotide composition. Furthermore, the exosome’s 
reported lack of phosphorolytic activity and “inconvenient” IMS localization of hPNPase 
agree with their lack of involvement. Possible candidates, especially for producing the 
observed A/U-rich heteropolymeric tails, could be among the seven noncanonical poly(A) 
polymerases recently identified in human cells, as nc-PAPs have been shown to add either 
As or Us (Heo et al, 2009; Martin and Keller, 2007; Mullen and Marzluff, 2008). However, many 
of the isolated heteropolymeric sequences are A/G-rich and could possibly be produced by 
a different factor. Initial results obtained by RNAi silencing of the seven human ncPAPs are 
yet inconclusive in terms of their possible involvement in the transient tail addition (Figure 
S2 and Table S6). Degenerative or overlapping activities may necessitate combinatorial 
RNAi KD of these proteins in future analysis. Interestingly, only homopolymeric tails were 
found in Saccharomyces cerevisiae (Figure 5), suggesting that the component responsible for 
heteropolymeric tails is not present in S. cerevisiae. Clear identification of the polyadenylating 
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elements involved will assist in understanding the apparently complex model that governs 
this pathway.
In summary, in this work, we revealed transient homo- and heteropolymeric adenylation 
of rRNA and mRNA fragments within the cytoplasm of human cells. The adenylated rRNA 
fragments accumulated upon KD of RNA degradation machinery, showing that they are 
intermediates in an RNA decay process that involves transient poly(A). Although much 
remains to be done to decipher the specific functionality of the two tail types, the enzyme(s) 
that produce them, and the precise mechanism of decay, we have identified a number of 
exonucleases involved in their degradation. 
Materials and methods
Cells
HeLa and HEp-2 cells were grown as a monolayer at 37 °C, 5% CO2, in DMEM (Sigma) 
supplemented with 10% FCS, 2 mM L-glutamine, and penicillin– streptomycin (Slomovic and 
Schuster, 2008). Growing and infection of cells with recombinant viruses containing GFP was 
performed as described (Hsiao et al, 2006).
Transient siRNA application
Cells were transfected with 400 pmol siRNA duplex (Table S7) using Lipofectamine 2000 
(Invitrogen). After 24 h, cells were detached with trypsin and replated, followed 24 h later by 
a second transfection with 800 pmol siRNA. Seventy-two hours after the initial transfection, 
total RNA was harvested with MasterPure kit (Epicentre) or total protein was harvested with 
an SDS-lysis buffer (1% SDS, 10% glycerol, and 0.1 M DTT).
Cell fractionation
Nuclear and cytoplasmic fractions were obtained from HeLa cells as previously described 
(van Dijk et al, 2007). Briefly, detached cells were washed in PBS solution, resuspended in lysis 
buffer, incubated on ice for 10 min, and centrifuged for 10 min at 3,000 × g. The supernatant 
(cytoplasmic fraction) was transferred to a new tube and the pellet (nuclear fraction) was 
resuspended in lysis buffer and lysed via sonication. Following centrifugation at 12,000 × g for 
10 min at 4 °C, RNA was purified from both fractions by the MasterPure kit (Epicenter).
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Random-primed RT-PCR and Northern blots
Random-primed RT was performed on 3 μg total RNA using AffinityScript RT (Stratagene) with 
500 ng random primers (Amersham Biosciences) and normalized with β-actin by PCR. RNAi 
silencing efficiency was measured via semiquantitative RT-PCR using random primed cDNA. 
RNA blot was performed as described previously (Slomovic and Schuster, 2008). The [32P] 
uniformly labeled antisense riboprobe (beginning at +1 of the mature 5.8S rRNA and ending 
48 nt downstream of its 3′ end) was used. The Northern blot to validate cell fractionation was 
probed with a [32P]-labeled U2, U3, or U5 snoRNA oligonucleotide (Table S7). 
Western blot analysis
Proteins were analyzed by 8% to 10% SDS/PAGE gel, transferred to a nitrocellulose membrane, 
blotted with appropriate antibody (Table S7), and normalized with actin rabbit polyclonal 
antibody (Santa Cruz Biotechnology).
Oligo(dT) RT-PCR isolation and sequencing of truncated polyadenylated RNA
Briefly, cDNA was generated with dT10-adapter. PCR was applied to cDNA with a gene-specific 
primer and adapter followed by T/A cloning and sequencing (Slomovic et al, 2008a). 
PCR labeling assays
For all reactions RNA amounts were measured with ND-1000 NanoDrop and cDNA was 
normalized according to B2M. The normalized oligo(dT)-primed cDNA was then subjected to 
25 PCR cycles with a 28S rRNA-specific forward primer coupled with adapter oligo. Products 
were used as templates in a second round of PCR-labeling using the same 28S rRNA primer, 
which was 5′-end [32P]-labeled by PNK and γ-[32P]ATP, and the adapter. The second round 
lasted five cycles followed by 10 min extension at 72 °C. PCR-labeled products were resolved 
by 6% denaturing PAGE and autoradiography. EtBr-stained DNA and [32P]-labeled RNA 
molecules were run on the gels as length markers. 
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Supplementary Figures
Figure S1. The distribution of rRNAs and tRNAs in the cytoplasm and nucleus.
Following fractionation, RNA purified from the cytoplasm and nucleus was stained with EtBr and the profile (rRNA 
and tRNA distribution) was compared between the two fractions and total RNA. T, total cell RNA; C, cytoplasmic RNA; 
N, nuclear RNA.
Figure S2. RNAi-mediated silencing of the seven-member ncPAP family in HeLa cells: HS1–HS7.
HeLa cells were transfected with siRNA targeting each of theseven human noncanonical PAPs. RT-PCR was used to 
evaluate KD of the expression levels of the targeted mRNAs in the RNAi cells compared with the mock transfection 
cells.
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Supplementary Tables
Table S1. Truncated, polyadenylated 28S rRNA and β-actin mRNA molecules isolated from HeLa cells 
using oligo(dT) RT-PCR.
Fraction Gene Clone Poly(A) site Tail length and  content
Cytoplasm 28S rRNA 1 1565 A7GA9CA7GA3CA2CA12GA10
2 1615 A5UGA7GA5GA2GA4UA4GA8GA4
UA2UGA5CAGA7GA2GA8UA11
3 1679 A2GA2GA9
4 1695 A80
5 1698 A46
6 1699 A16
7 1777 A97
8 4598 A3GA3UA3UA2UA11
9 4607 A12
10 4610 A8UA9
11 4620 A3UA3UA20
12 4623 A3CA8
13 4640 A8UA14
14 4646 GA12GA2GA7GA2UA9
15 4699 A15
16 4700 A2GAGAGA2GA2G6A2GAGA2GAG5
A6GA4G2AGA4GA2GA9
17 4700 A20
18 4701 A6UA5GAGA10GA6UAGA21
Nucleus 1 1615 GA2GA3GA2CA3GAGA2GAGAGA3A2
G4A4G2A3GA4GA3GA9
2 1685 A2GA3G3AGAGAGA2G2A7G2AG2AUA3
GAG2AGA4G2AGA4G2AG2A8
3 1700 A12
4 4599 A17
5 4620 A3GAUGAGA3GA6GAG2A4G2A2GA3GA6
G2A2UAGA2G2ACAGA
G2A6UGAG2A4GA4GAG2A6UGA2G2
AGA14GA11
6 4623 A32GA37
7 4623 A11
8 4634 A12
9 4656 C2G2UA26
10 4678 UAU2A15
11 4681 A11GA11
12 4687 A12
Total β-actin 1 1875 A61
2 1877 A3UA2UA17
3 1878 A19
4 1879 A59
5 1879 A10
6 1881 ACA3UA29UA52
7 1885 A23
8 1887 A15
9 1903 AU3A4UA12
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Fraction Gene Clone Poly(A) site Tail length and  content
10 1910 A12
11 1927 GA6GA38GA58
12 1948 CA65UA42
13 2093 A14
14 2207 A10GA8GA11GAAACA8GAGA9
GAGA5GA12GA21GA20
15 2258 A10
16 2259 A18
17 2259 U4A5GA4UA10
18 2259 A3GA2GAGA9G2A5GA9GAUA3G2A10
19 2260 A19
20 2261 A19
21 2266 A25
22 2266 A3UA4U2A20
23 2277 A79
24 2425 A15
25 2468 CA3GA19
26 2492 A4UACA5UA11
27 2556 A14
28 2923 A55
29 2923 A30
Cytoplasm 1 1876 A10
2 1901 A61
3 1976 A22
4 2005 A10
5 2923 A18
6 2923 A10
Nucleus 1 1873 A2GA81
2 1901 UA14CA25
3 1901 A25
4 1911 A11
5 2921 CA15
6 2923 A38
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Table S2. Truncated, 28S rRNA molecules isolated from cytoplasmic or nuclear fractions from HeLa 
cells using circularized RT-PCR.
Clone Fraction Start End Tail Comment
6 nuc 4345 4568 A or 4569 no A
49 4335 4594
66 4421 4553 A or 4554 no A
15 4523 4659
37 4528 4624
38 4519 4623 A or 4518 no A
40 4510 4758
44 4523 4659
46 4486 4766
97 4511 4624
99 4510 4623
100 4511 4702
104 4492 4623
109 4510 4660
112 4522 4623
114 4510 4620 A or 4621 no A
25 4522 4628
26 4461 4702
27 4416 4710
28 4457 4754
30 4451 4703 A or 4450 no A
31 4511 4624
33 4361 4658
19 cyt 4459 4552 A or 4458 no A
20 4321 4610
64 4435 4587
7 4510 4757
26 4511 4741
27 4501 4710
28 4519 4697 A or 4518 no A or 4698 no A
31 4526 4691 GAA
34 4510 4757
35 4520 4667
36 4492 4650
74 4448 4691 A or 4447 no A or 4692 no A
80 4524 4653 A or 4523 no A or 4654 no A
82 4522 4660 AA or 4662 no A
85 4526 4631 UAAA
86 4513 4666 or 4664 +GC
87 4456 4648
90 4522 4701
93 4521 4653
94 4524 4623
19 4522 4630
20 4510 4705
22 4455 4705
*In many cases it is not certain whether the observed adenosine is encoded in the corresponding transcript 
sequence (either at the 5’ or 3’ end of the sequenced molecule) or post-transcriptionally added.
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Table S3. Truncated, polyadenylated G8R (viral mRNA) and GFP (gene integrated into VV genome) 
molecules isolated from HeLa cells 4 h after VV infection using oligo(dT) RT-PCR.
Gene/clone Poly(A) site Tail length and content
G8R
1 164 A10U3A9UA39
2 166 A8U5A53
3 204 A8U2A10
4 210 UA32
5 214 A11
6 227 A96
7 233 U2A58
8 246 UCU2A11
9 255 AU2AUCUAUA3UA5U2A11
10 289 A15
11 293 A4UA26GA29
12 299 A21
13 301 A10UA5U3CA11
14 307 A22
15 348 UA38
16 365 A11GAUA4UA11
GFP
1 289 A11
2 298 A18
3 303 UA13
4 354 A15
5 367 U2A13
6 378 UA14
7 392 UA11
8 416 U2A14
9 496 A25
10 529 A10
11 561 A13
12 564 U2A10UA12
13 578 A10
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Table S4. Truncated, polyadenylated transcripts detected in S. cerevisiae.
Clone Gene Poly(A) site Tail length and content
1 CYH2 347 A13
2 Actin1 373 AGA12
3 Actin1 431 A10
4 Actin1 466 A11
5 Actin1 569 A11
6 25S rRNA 2082 A12
7 25S rRNA 2091 A10
8 25S rRNA 2147 A12
9 25S rRNA 2154 A10
10 25S rRNA 2159 A11
11 25S rRNA 2174 A14
12 25S rRNA 2192 A10
13 25S rRNA 2249 A15
14 25S rRNA 2269 A12
15 25S rRNA 2275 A14
16 25S rRNA 2275 A3UA25
17 25S rRNA 2302 A11
18 25S rRNA 2312 A13
19 25S rRNA 2313 A10
*CYH2-ribosomal protein gene CYH2.
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Table S5. Truncated, polyadenylated 28S rRNA molecules isolated from HeLa cells subjected to siRNA 
silencing of the proteins as indicated.
Clone RNAi- silenced gene
Poly(A) 
site Poly(A) tail length and content
1 mock 2540 UA20
2 mock 2586 A16
3 mock 4534 A14
4 mock 4536 A20UA2
5 mock 4598 AUA18
6 mock 4598 AG2AGA2GA3G3A9
7 mock 4598 A8GA2CA15
8 mock 4600 A12
9 mock 4600 A23
10 mock 4604 A26
11 mock 4617 A44
12 mock 4619 A9G2A4GAGAGAGA2UGA21
13 mock 4638 A12
14 mock 4645 A9
15 mock 4647 A14
16 mock 4653 A11
17 mock 4662 A17
18 mock 4669 AGA5GA13
19 mock 4681 GA4CA10G2A6CA4GA3GAG2AGAGA5CA10G2A10
20 mock 4691 GA11
21 mock 4692 A3GA11
22 mock 4692 A18
23 mock 4699 A20
24 mock 4701 A20
25 mock 4710 A2GA2G2AGCAGAGA3G3AG2AG2A2G2A3UA10GA22
26 mock 4713 AC2GA6GAG2A3GA2GAG3AUA3UGUCGACUCA3GAGA2UA6
1 hRrp41 4596 A17
2 hRrp41 4598 A21
3 hRrp41 4598 A4GA9
4 hRrp41 4598 A33
5 hRrp41 4598 AGA13
6 hRrp41 4598 A3GUGA9
7 hRrp41 4599 A14
8 hRrp41 4603 A23
9 hRrp41 4603 A13GA9
10 hRrp41 4605 A12GA14
11 hRrp41 4611 ACA12
12 hRrp41 4626 A22
13 hRrp41 4627 A4GA6GA11GA33
14 hRrp41 4647 ACGA26
15 hRrp41 4652 A10GA5CA8GA4UG2AG2A6GA3CA2GA2CA20
16 hRrp41 4686 A26
17 hRrp41 4693 A17GA3
18 hRrp41 4728 A4CA12
19 hRrp41 4729 A4GA2GA15
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1 PM/Scl-75 4547 AUA10
2 PM/Scl-75 4551 GA6GAG3AGAG3AGAGA5UA20
3 PM/Scl-75 4585 A19
4 PM/Scl-75 4586 A7UACA8
5 PM/Scl-75 4599 A54
6 PM/Scl-75 4599 GA7GA15
7 PM/Scl-75 4599 A10
8 PM/Scl-75 4599 A5CA6GA
9 PM/Scl-75 4601 A20
10 PM/Scl-75 4603 A16
Clone RNAi- silenced gene
Poly(A) 
site Poly(A) tail length and content
11 PM/Scl-75 4607 A7UA6GA7GA7UA17
12 PM/Scl-75 4609 A19
13 PM/Scl-75 4612 A26
14 PM/Scl-75 4619 A16
15 PM/Scl-75 4621 A12
16 PM/Scl-75 4676 AU4AUA2UA6CA8U2A5GA11
17 PM/Scl-75 4681 GA10GA9
18 PM/Scl-75 4687 A7GA5CA8
19 PM/Scl-75 4687 AGA8GA7
20 PM/Scl-75 4690 AGA8
21 PM/Scl-75 4691 A3G2A4CA3UA9
22 PM/Scl-75 4694 AGUAUA6GA4GA20GA2
23 PM/Scl-75 4696 AG3A3GAGAGAGAGAUAG2AG2A5GA8GAGA20
24 PM/Scl-75 4712 A5GA2GA40
1 PM/Scl-100 4533 A17
2 PM/Scl-100 4590 A5CA18
3 PM/Scl-100 4593 A12
4 PM/Scl-100 4594 A6UA9GA19
5 PM/Scl-100 4597 A18
6 PM/Scl-100 4598 A3GAUA12
7 PM/Scl-100 4598 ACA15
8 PM/Scl-100 4598 A10
9 PM/Scl-100 4599 A10
10 PM/Scl-100 4601 A16
11 PM/Scl-100 4603 A2GA17GA
12 PM/Scl-100 4603 A6GA15
13 PM/Scl-100 4604 AGA17
14 PM/Scl-100 4609 GAUA11
15 PM/Scl-100 4618 A2GA3GA2GAGAGA14
16 PM/Scl-100 4619 A20
17 PM/Scl-100 4620 A12
18 PM/Scl-100 4620 A17
19 PM/Scl-100 4621 A34
20 PM/Scl-100 4650 A29
21 PM/Scl-100 4674 U4A11GA15
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22 PM/Scl-100 4675 A37
23 PM/Scl-100 4681 GA2CGA10
24 PM/Scl-100 4692 A5GA5UGA3UAGCA6GA6CA6
25 PM/Scl-100 4692 A7CA8
26 PM/Scl-100 4693 A3UA2CUGA2CA4GA2CUA2CA18
27 PM/Scl-100 4697 A3UA2UA8UA12
28 PM/Scl-100 4698 A24
29 PM/Scl-100 4699 A8GA18
30 PM/Scl-100 4702 A13
31 PM/Scl-100 4702 A4GA2CA9
32 PM/Scl-100 4702 A7GA8GACA7
33 PM/Scl-100 4703 A4UA14
34 PM/Scl-100 4736 A33
1 hPNPase 4595 A19
2 hPNPase 4598 A15
3 hPNPase 4602 A4GA6GA14CA2GA8G2A18
4 hPNPase 4603 A2UA2GCA3GA3GA10
5 hPNPase 4603 A2CA12
6 hPNPase 4604 A2UA5UAGA9
7 hPNPase 4604 A2UGA5CGA2CA11
8 hPNPase 4604 AUA7GA3UA2CACGAUA6GA5GA3GA3GAGAG4A2G2AGAGUA3CA10
9 hPNPase 4605 AGA2GA2GAG2A4GA2GA2GACGAGA3UA13
10 hPNPase 4621 A11
11 hPNPase 4681 GCA9
12 hPNPase 4681 GA2CGAUA5UA16
13 hPNPase 4687 AGA12
14 hPNPase 4691 A10
15 hPNPase 4691 G5A3CA14
16 hPNPase 4692 A13
17 hPNPase 4692 ACA14
18 hPNPase 4693 A10
19 hPNPase 4694 A13
20 hPNPase 4694 A15
21 hPNPase 4697 A5U2GA2GA5GA20
*Tails with one non-A residue or less are termed homopolymeric.
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Table S6. Truncated, polyadenylated 28S rRNA molecules isolated from HeLa cells subjected to siRNA 
silencing of the proteins as indicated (Hs1-7 of the ncPAP family in human cells).
RNAi-silenced gene Tail site Tail sequence
mock 4598 A20
4664 A53
4598 A18
4692 A13G2A5
HS1 4740 UA12
4599 A12
4659 A5UACA10
4678 UA11
4679 A97
HS2 4598 A37
4681 A24GA21
4583 A4UCA2UA2UACGAUA5GA9CA9
HS3 4572 A17
4691 G2A2GA10
4676 AU8A2UA8UA10
HS4 4722 GA6UA6UA8
4621 A3GA2GA4UAUGNGA3CAC2UCGA3
UCAUA2UC3GC3NAUA15
4604 AGA2G2AG2A5GA7GAG2AGA2GA5GA2
GAG2AG3A3GA2GA2GAG2A3GA2GA4
GAG3AGA2G2A2GA2GA2G2A2GA5GA2
G3A2G2AGAGA6UA2GA2G2A17
4678 UA11
4604 A30
4722 A104
HS5 4640 A5UA13
4599 G3AG2A3GAGA4GAGA2G3A2GA2GA2GAG2A3
GA2GA2GA2GAG3AGA4GA2GA6GA3GA2UA10
4656 C2G2UA20GA22
4701 A12GA10
4603 A16
4594 A13
HS6 4696 A15
4756 C2A3GA2UA10
4670 A19GA8GUA4GA5GAUA4GA7GA10
4535 CA2UA18GA67
HS7 4619 C2A2UG2AGA75
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Abstract
The RNA exosome is a highly conserved protein complex with 3’-5’ exoribonuclease activity, which 
plays a pivotal role in the degradation and maturation of a wide variety of RNAs. The enzymatic 
activity of the human exosome originates from the association of at least three different 
exoribonucleases: hDis3, hDis3L1 (Dis3-like exonuclease 1) and PM/Scl-100. Here, we addressed 
the question to what extent these enzymes contribute to the activity of the human exosome. The 
results show that the activity of immunoaffinity-purified exosome complexes at relatively high 
magnesium concentrations is mediated by the association of PM/Scl-100, whereas the activity 
at low magnesium concentrations can be attributed to hDis3 and hDis3L1. The activity of 
PM/Scl-100 is dependent on the 35EXOc and HRDC domains, but does not require the association 
with the exosome core. Our data suggest that the activity of exosome-associated PM/Scl-100 is 
modulated by other proteins that co-purify with the exosome. Furthermore, the associations 
of hDis3L1 and PM/Scl-100 with the exosome core seem to affect each other as suggested by 
the results of siRNA-mediated knock-down experiments. Taken together, our data indicate that 
the activity of the human RNA exosome is dependent on several exoribonucleases, which may 
act in concert, but which may also be active in a mutually exclusive manner depending on the 
microenvironment.
Introduction
Proper RNA metabolism is a fundamental aspect of all cellular forms of life. Next to the role 
of RNA in conferring the transition of the genetic information embedded in the genome into 
functional proteins, cellular RNAs are widely used for many different purposes. Structural 
frameworks (e.g. rRNAs), enzymatic activity (e.g. ribozymes) and gene regulation (e.g. 
miRNAs) are just a few examples to illustrate this. Central to the homeostasis of all these 
different RNA species is a protein complex that has been conserved from archaea to higher 
eukaryotes: the exosome. 
The name for this protein complex is derived from the associated 3’-5’ exoribonuclease 
activity. The cellular role of exosome complexes can be divided into two types of processes: 
maturation of cellular RNAs such as the ribosomal 5.8S RNA, snRNAs and snoRNAs and 
degradation of all kinds of RNA transcripts (Lykke-Andersen et al, 2009). 
While its molecular composition might be different among species, the overall structure of 
the exosome is largely the same: a six-membered, donut-shaped ring, consisting of proteins 
that share homology with the RNase PH-like ribonucleases (Mitchell et al, 2003), and two or 
three other proteins with potential RNA-binding capacities that are stacked on one side of 
the donut (Liu et al, 2006; Raijmakers et al, 2002). Although eubacteria might not have an 
exosome complex per se, similar exoribonuclease complexes (e.g. RNase PH and PNPase) 
can be discerned. Given their structural similarities, it seems likely that these complexes are 
evolutionary conserved and have arisen from a common ancestor (Lin-Chao et al, 2007).
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The human core exosome adopts a similar structure; a ring of six different proteins (hRrp41, 
hRrp42, hMtr3, OIP2, hRrp46 and PM/Scl-75), which is stabilized by the association of the 
three RNA-binding proteins (hRrp4, hRrp40 and hCsl4). Since exosomes, or exosome-like 
complexes, seem to be conserved in terms of structure, it is likely that their mechanisms to 
recruit and degrade RNA substrates is conserved as well (Buttner et al, 2005; Lorentzen et al, 
2005). In the archaeal exosome model, substrate RNA is recruited by the RNA-binding proteins, 
which guide it into the central channel of the complex. Here, the active site is formed by the 
Rrp41-Rrp42 dimer, which has been shown to confer the phosphorolytic exoribonuclease 
activity associated with the complex. While this mechanism seems to hold true for the 
archaeal complex, eukaryotic exosome complexes (with the exception of plants) appear to 
have diverged from this way of degrading their RNA substrates, as the core of the yeast and 
human exosome were shown to be devoid of any ribonucleolytic activity (Dziembowski et al, 
2007; Liu et al, 2006). Instead, the eukaryotic exosome core appears to function as a scaffold 
for the association of one or more hydrolytic exoribonucleases, which dock to the complex 
and provide it with ribonuclease activity. In yeast, two of such anchoring exoribonucleases, 
Rrp6 (counterpart of human PM/Scl-100) and Dis3, have been identified. 
The Dis3 protein belongs to the RNR family of hydrolytic exoribonucleases (Mitchell et al, 
2003), which includes well known members, like RNase R and RNase II. The overall domain 
architecture of these enzymes is largely the same: a central exoribonuclease domain, flanked 
by several RNA-binding domains. In addition, the Dis3 protein contains an N-terminal PIN 
domain, which provides the enzyme with endoribonuclease activity as well (Lebreton et al, 
2008). This N-terminal region of Dis3 is also important for its binding to the core exosome 
(Schaeffer et al, 2012; Schneider et al, 2009). The Dis3 protein is ubiquitously expressed and 
its enzymatic activity was shown to be responsible for the majority of the activity associated 
with the yeast exosome (Dziembowski et al, 2007; Schaeffer et al, 2009). The human Dis3 
protein is somewhat different from its yeast counterpart, since it is exclusively located in the 
nucleoplasm and has a relatively weak association with the exosome. Human cells appear to 
express two additional Dis3-like exonucleases: hDis3L1 (Dis3-like exonuclease 1) and hDis3L2 
(Dis3-like exonuclease 2). Recent studies have shown that hDis3L1 stably associates with 
cytoplasmic exosome complexes and contributes to the exosome-mediated degradation of 
cytoplasmic RNA substrates (Slomovic et al, 2010; Staals et al, 2010; Tomecki et al, 2010). 
In contrast to hDis3 and hDis3L1, the hDis3L2 protein (covered in detail in Chapter 6) does 
not associate with the core exosome. Instead, this ribonuclease was found to interact with 
hXrn1 and colocalizes with P-bodies (cytoplasmic foci for the retention and degradation of 
translationally-inactive mRNAs) where it participates in a novel eukaryotic RNA degradation 
pathway, involving 3’ oligouridylation of substrate RNAs (Lubas et al, 2013; Malecki et al, 2013). 
One of these uridylated substrate RNAs is the pre-let-7 miRNA, a pluripotency factor in stem 
cells (Chang et al, 2013). This might be relevant for the discovery that germline mutations 
in the gene encoding hDis3L2 are the cause for the Perlman syndrome. It was shown that 
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inactivation of hDis3L2 resulted in mitotic abnormalities in human cell lines (Astuti et al, 
2012). 
Rrp6 (PM/Scl-100) is a hydrolytic enzyme belonging to the DEDD family of exonucleases, 
which also includes RNase D and RNase T (Mitchell et al, 2003). Most of our understanding 
of the functions of Rrp6 comes from studies in yeast, where the protein has been found to 
be essential for many functions that are attributed to the nuclear exosome. For instance, 3’ 
end formation of many non-coding RNAs, such as sn(o)RNAs and rRNAs are dependent on 
the activity of Rrp6 and for these processing events the binding of Rrp47 to Rrp6 seems to 
be crucial (Mitchell et al, 2003; Schilders et al, 2007b; van Hoof et al, 2000). In addition, Rrp6 
plays a central role in nuclear RNA surveillance, where it targets aberrant RNAs for complete 
degradation together with a non-canonical polyadenylation complex called TRAMP (LaCava 
et al, 2005). Rrp6 also appears to be involved in various pathways that regulate cellular mRNA 
levels, either by stimulating degradation of the mRNA body itself (Roth et al, 2005) or by 
tethering immature pre-mRNAs near or at the site of transcription (de Almeida et al, 2010).
As stated above, the yeast exosome is strongly dependent on Dis3 for its activity, although 
several nuclear processing events are performed in concert with Rrp6. Human exosome 
complexes also require PM/Scl-100 to perform these tasks. However, PM/Scl-100 is also 
found in the cytoplasm, suggesting that it might have additional, and possibly exosome-
independent roles (Callahan and Butler, 2008; Graham et al, 2009; Lejeune et al, 2003; van Dijk 
et al, 2007). The exosome-association of at least two distinct Dis3-like proteins underlines the 
idea that the activity of the human exosome complex is differently organized. This prompted 
us to study the contributions of hDis3, hDis3L1 and PM/Scl-100 to the activity of the human 
exosome in more detail.
Results
Exoribonuclease activity of PM/Scl-100
Even though the association of Rrp6 with the yeast exosome and its contribution to the 
exosome’s activity have been established for quite some time now, the activity of the 
human orthologue PM/Scl-100 has only recently been addressed (Januszyk et al, 2011). 
To further characterize the enzymatic properties of PM/Scl-100, the activity of this protein 
was studied in an in vitro RNase assay. The PM/Scl-100 protein was immunoprecipitated 
from HEp-2 cell extracts using polyclonal anti-PM/Scl-100 antibodies. Subsequently, the 
associated ribonuclease activity was determined by incubating the precipitated protein with 
a radiolabeled single-stranded RNA substrate of 37 nucleotides, derived from a linearized 
plasmid template. Because PM/Scl-100 belongs to the DEDD superfamily of exonucleases, 
its activity was expected to be dependent on the binding of divalent metal ions to the active 
site (Cudny et al, 1981). Different divalent metal ions (Zn2+, Mg2+, Mn2+ and Cu2+) were added 
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to the reaction mixture and the results showed that the highest activity was observed in 
the presence of Mg2+ (data not shown). The PM/Scl-100 exoribonuclease activity appeared 
to be stimulated by relatively high Mg2+ concentrations. Millimolar concentrations were 
required for the highest levels of substrate RNA degradation (Figure 1). The degradation 
products that were generated co-migrated with a nucleotide monophosphate marker in 
thin-layer chromatography (Supplementary Figure 1), which is consistent with a hydrolytic 
exoribonuclease activity, as expected for a member of the DEDD superfamily of RNases.
Figure 1. Mg2+-dependent exoribonuclease activity of PM/Scl-100. 
PM/Scl-100 was immunoprecipitated from a HEp-2 cell extract using a rabbit anti-PM/Scl-100 antiserum. Normal 
rabbit serum (NRS) was used as a control. The immunoprecipitate was incubated with a 37 nucleotide radiolabeled 
RNA substrate in the presence of different concentrations of Mg2+ (indicated in mM on top of the lanes). Reaction 
products were separated by denaturing polyacrylamide gel electrophoresis and visualized by autoradiography.
Association of PM/Scl-100 activity with the exosome core
To investigate whether a similar Mg2+-dependent exoribonuclease activity is associated with 
the exosome, exosome complexes were immunoaffinity-purified from HEp-2 cell lysates 
using antibodies to the exosome core component hRrp40 (Raijmakers et al, 2002) and used 
to study RNase activity in the presence of 5 mM Mg2+. Western blots demonstrated that the 
PM/Scl-100 protein was efficiently co-precipitated with the human exosome (Figure 2A; lane 
3) and indeed these complexes displayed exoribonuclease activity (Figure 2B; lanes 7-9). To 
investigate the contribution of PM/Scl-100 to the appearance of the degradation products, 
PM/Scl-100 levels were down-regulated by RNAi using a PM/Scl-100-specific siRNA prior 
to preparation of the cell lysate for immunoprecipitation. The reduction of the PM/Scl-100 
level was demonstrated by western blotting (Figure 2A; lanes 1-2). The results of the RNase 
assay showed that the down-regulation of PM/Scl-100 expression led to a reduced exosome-
associated exoribonuclease activity under these conditions, indicating that PM/Scl-100 plays 
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an important role in this activity (Figure 2B; compare lanes 4-6 with lanes 7-9). To investigate 
whether the exoribonuclease activity of PM/Scl-100 is dependent on the association with the 
exosome core, the activity of immunoprecipitates from normal HEp-2 cell lysates obtained 
by antibodies specific for PM/Scl-100 was analysed in parallel. Western blotting analysis 
revealed that the amount of PM/Scl-100 in these precipitates was much higher than that in 
the anti-hRrp40 precipitates, whereas the amount of exosome core, as visualized by anti-
hRrp4 antibodies, was lower (Figure 2A). The exoribonuclease activity displayed by the 
anti-PM/Scl-100 precipitate appeared to be higher than that observed with the anti-hRrp40 
precipitate (Figure 2B), strongly suggesting that the activity of PM/Scl-100 is not dependent 
on the exosome core. 
Structural elements of PM/Scl-100 required for its exoribonuclease activity
The amino acid sequence of PM/Scl-100 was analysed by the online SMART tool (Letunic 
et al, 2009), to obtain insight into its structural modules. As expected, this analysis revealed 
that its modular architecture is very similar to that of Rrp6: a central 3’-5’ exonuclease 
domain (35EXOc), a PMC2NT domain close to its N-terminus, and a HRDC domain close to 
the C-terminus of the 35EXOc domain (Figure 3A). Typical for the DEDDy subgroup of the 
DEDD-family of exonucleases, the 35EXOc domain of PM/Scl-100 has a highly conserved 
tyrosine, which is predicted to be positioned close to the active site (Y436) and is thought to 
coordinate the water molecule for the nucleophilic attack on the phosphodiester backbone 
of the substrate RNA (Steitz and Steitz, 1993). The PMC2NT domain is often found in 
conjunction with HRDC domains in 3’-5’ exoribonucleases. For Rrp6 it has been reported that 
this domain provides the interaction interface for Rrp47 (Stead et al, 2007), another protein 
involved in sn(o)RNA and pre-rRNA processing (Mitchell et al, 2003; Schilders et al, 2007b). 
The HRDC domain is believed to contribute to the recruitment to and proper positioning of 
the substrate RNA in the active site, as was originally proposed for bacterial RNase D (Zuo 
et al, 2005). Studies in yeast have shown that this domain seems to be required for some, 
but not all functions of Rrp6 (Phillips and Butler, 2003). A conserved amino acid in the HRDC 
domain, D525, has been shown to be involved in the contraction around the active site of 
Rrp6 upon substrate binding by forming hydrogen bonds with other conserved residues, 
Q184 and N193 (Midtgaard et al, 2006).
To investigate the importance of these elements for the exoribonuclease activity of 
PM/Scl-100, several VSV-tagged PM/Scl-100 expression constructs encoding single amino 
acid substitution mutants were generated: Q184A, N193A, Y436F and D525A. HEp-2 cells 
were transiently transfected with these constructs and the expression of the PM/Scl-100 
mutants was monitored by western blotting of cell lysates (Figure 3B). The results showed 
that all mutants as well as the VSV-tagged, wild type PM/Scl-100 protein were expressed, 
albeit with different efficiencies. The mutant proteins were immunoprecipitated by anti-
VSV-tag antibodies and their exoribonuclease activity was determined. Anti-PM/Scl-100 
antibodies were used to visualize the PM/Scl-100 mutants in the precipitates by western 
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Figure 2. Exosome-association of PM/Scl-100. 
(A) HEp-2 cells were transfected with siRNAs downregulating either EGFP (used as a control; lane 1) or PM/Scl-
100 (lane 2) and 48 hours after transfection cell lysates were subjected to immunoprecipitation using anti-hRrp40 
(lane 3) or anti-PM/Scl-100 antibodies (lane 4). Co-precipitated proteins as well as the efficiency of knockdown 
were determined by western blotting using anti-PM/Scl-100 and anti-hRrp4 antibodies (indicated at the right). (B) 
Ribonuclease activity was analysed by incubating equivalent amounts of the precipitated samples (obtained with 
antibodies and lysates from siRNA-treated cells as indicated on top of the lanes) with a 267 nucleotide, 5.8S rRNA-
containing radiolabelled RNA substrate in RNA degradation buffer containing 5 mM Mg2+ for the indicated periods 
of time. Reaction products were separated by denaturing polyacrylamide gel electrophoresis and visualized by 
autoradiography.
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blotting and anti-hRrp40 and anti-hRrp41 antibodies were used to demonstrate the co-
precipitation of the exosome core. The results demonstrated that none of these mutations 
abolished the interaction with the exosome core, since both exosome core subunits were co-
precipitated with similar efficiencies (Figure 3C). The exoribonuclease activity observed with 
the immunoprecipitated VSV-tagged, wild type PM/Scl-100 protein showed that the tag did 
not interfere with this activity (Figure 3D). All amino acid substitution mutations appeared to 
impair the activity of the PM/Scl-100 protein (Figure 3D). This not only confirmed that (part 
of) the exoribonuclease activity observed under these conditions is due to PM/Scl-100, but 
also indicates that all mutated residues are crucial for its exoribonuclease activity.
Human exosome-associated exoribonucleases
Although PM/Scl-100 appeared to be capable to exert its exoribonuclease activity 
independent of the exosome core, a subfraction of this protein acts in concert with the 
exosome. Previously, it has been shown that the exoribonuclease activity of hDis3 and 
hDis3L1 requires relatively low, submillimolar concentrations of Mg2+ (Staals et al, 2010; 
Tomecki et al, 2010). The differential requirement for Mg2+ of PM/Scl-100 and hDis3 or 
hDis3L1 allowed us to investigate the contributions of PM/Scl-100 on the one hand and 
hDis3 and hDis3L1 on the other hand to the exoribonuclease activity associated with the 
human exosome core. A concentration of 0.05 mM Mg2+ represents a condition with high 
hDis3 and hDis3L1 activity and very low PM/Scl-100 activity and at 5 mM Mg2+ mainly PM/
Scl-100 is active. The rather weak association of hDis3 with the exosome was exploited to 
distinguish between hDis3 and hDis3L1 activities. The results in Figure 4 show that exosome 
complexes, immunoaffinity-purified by anti-hRrp40, display ribonuclease activity over a wide 
range of Mg2+ concentrations, which is in agreement with the association of exoribonucleases 
with varying optimal Mg2+ concentrations. Treatment of the precipitates with increasing 
concentrations of KCl allowed the selective removal of hDis3 from the precipitates (Figure 
5A). hDis3 was barely detectable after treatment of the anti-hRrp40 precipitate with 150 mM 
KCl, whereas hDis3L1 and PM/Scl-100 remained bound to the exosome at concentrations 
up to 600 mM KCl. To investigate the contribution of these exonucleases to the activity of 
the human exosome, anti-hRrp40 precipitates pretreated with different KCl concentrations 
were used in RNase assays containing either 0.05 mM Mg2+ (Figure 5B) or 5 mM Mg2+ (Figure 
5C). Much of the activity detected at 0.05 mM Mg2+ appeared to be due to hDis3, as most 
activity was lost after treatment with KCl concentrations higher than 100 mM. The remaining 
activity can be attributed to hDis3L1, although some reactivity of PM/Scl-100 under these 
conditions cannot be excluded. In contrast, the exoribonuclease activity at 5 mM Mg2+ was 
not decreased after treatment with any of the KCl concentrations, in agreement with the 
relatively stable association of PM/Scl-100. Moreover, incubations of the precipitate with 300-
600 mM KCl appeared to enhance the activity slightly. Taken together, these data suggest that 
the majority of the exoribonuclease activity associated with the human exosome is due to 
hDis3 and PM/Scl-100 and that the cellular microenvironment may determine their relative 
contributions.
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Figure 3. Ribonuclease activity of PM/Scl-100 mutants. 
(A) Schematic representation of the PM/Scl-100 protein, showing the position of the PMC2NT (N-terminal domain 
in 3’-5’-exonucleases like polymyositis autoantigen 2), 35EXOc (3’-5’ exonuclease) and HRDC (helicase and 
RNase D carboxy-terminal domain) domains. The position of a putative nuclear localization signal (NLS) is also 
indicated. Arrows mark the positions of residues that were mutated (Q184A, N193A, Y436F, D525A). (B) HEp-2 
cells were transfected with constructs expressing either VSV-tagged wild-type PM/Scl-100 protein or single amino 
acid substitution mutants. Cells transfected with the ‘empty’ vector were used as a control (lane 1, VSV). Protein 
expression was verified by western blotting of cell lysates and detection by anti-VSV-tag antibodies. Anti-hRrp41 
antibodies were used to detect the exosome core. Anti-γ-tubulin antibodies were used as loading control. (C) Anti-
VSV antibodies were used to precipitate the tagged proteins from the extracts of the corresponding transfected 
cells. Immunoprecipitated PM/Scl-100 and the mutants thereof were visualized on western blot by anti-PM/Scl-100 
antibodies. Co-precipitation of exosome core subunits was determined by staining the blot with anti-hRrp40 and 
anti-hRrp41 antibodies. (D) The immunoprecipitated PM/Scl-100 mutants were incubated for 2 hours with the 5.8S 
rRNA-containing radiolabelled RNA substrate in RNA degradation buffer containing 5 mM Mg2+. Reaction products 
were separated by denaturing polyacrylamide gel electrophoresis and visualized by autoradiography.
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Influence of the depletion of one exoribonuclease on the association of another 
with the exosome core 
Previously published data suggest that the expression levels of hDis3, hDis3L1 and PM/Scl-
100 influence each other (Tomecki et al, 2010). To investigate the consequences of alterations 
in the association of these proteins with the exosome core on the exoribonuclease activity 
associated with the exosome, hDis3, hDis3L1 or PM/Scl-100 were down-regulated by siRNA-
mediated depletion. The KCl concentration in the experiments with lysates from these cells 
was kept at 50 mM to maintain the association of hDis3 with the exosome core. Western 
blotting confirmed the down-regulation of each of the exoribonucleases (Figure 6A). The 
knock-down of hDis3L1 resulted in a slight up-regulation of PM/Scl-100 and enhanced its 
association with the exosome. Vice versa, the down-regulation of PM/Scl-100 led to slightly 
increased hDis3L1 levels and elevated levels of exosome-associated hDis3L1. The depletion 
of hDis3 did not seem to have detectable effects on the levels of hDis3L1 and PM/Scl-100, 
nor did the down-regulation of either hDis3L1 or PM/Scl-100 result in notable changes in 
exosome-association by hDis3. The exosome-associated exoribonuclease activity of material 
Figure 4. Mg2+-dependent exoribonuclease activity of the human exosome complex.
Exosome complexes were immunoprecipitated by rabbit anti-hRrp40 antibodies from HEp-2 cell extracts and were 
incubated for 2 hours with the 5.8S rRNA-containingradiolabelled RNA substrate in the presence of various Mg2+ 
concentrations, as indicated above the lanes. Normal rabbit serum (NRS) was used as a control for background 
precipitation. Reaction products were separated by denaturing polyacrylamide gel electrophoresis and visualized 
by autoradiography.
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from the hDis3L1 siRNA-treated cells at 5 mM Mg2+ appeared to be slightly increased (Figure 
6B-C), in agreement with the elevated levels of PM/Scl-100 associated with the exosome. 
Similarly, down-regulation of PM/Scl-100 resulted in enhanced exoribonuclease activity at 
0.05 mM Mg2+ (Figure 6B-C), which is consistent with elevated levels of exosome-associated 
hDis3L1. Since previous results suggested only a minor contribution of hDis3L1 to the activity 
of the exosome core (Figure 5), these results indicate that either the increase of hDis3L1 
association is sufficient to achieve this level of activity or that the depletion of PM/Scl-100 
stimulates the activity of either hDis3 or hDis3L1. This might also explain the residual activity 
at 5 mM Mg2+ when PM/Scl-100 was depleted (Figure 6B; lane 8), although the activity both 
hDis3 and hDis3L1 was previously shown to be inhibited under these conditions (Staals et 
al, 2010; Tomecki et al, 2010). The observation that knock-down of one exosome-bound 
exonuclease resulted in an increase in the association of another one suggests that hDis3L1 
and PM/Scl-100 have overlapping, mutually exclusive binding sites on the exosome, or that 
the binding of one of these nucleases affects the binding affinity and/or the activity of the 
other.
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Figure 5. Differential stability of the association of hDis3, hDis3L1 and PM/Scl-100 with the exosome 
core. 
Exosome complexes were immunoprecipitated from HEp-2 cell extracts using anti-hRrp40 antibodies and the 
precipitates were washed with a buffer containing increasing concentrations of KCl (as indicated above the lanes; 
concentration in mM). Normal rabbit serum (NRS) was used as a control. (A) Precipitated exosomes were visualized 
by western blotting using anti-hRrp4 antibodies. Co-precipitation of hDis3, hDis3L1 and PM/Scl-100 was determined 
by staining the blot with the corresponding antisera (indicated on the right). (B and C) Ribonuclease activity 
of the immunoprecipitated exosome complexes was determined by incubation with the 5.8S rRNA-containing 
radiolabelled RNA substrate in RNA degradation buffer containing 0.05 mM (B) or 5 mM Mg2+ (C).
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Figure 6. Effects of hDis3, hDis3L1 or PM/Scl-100 knockdown on exosome-associated exoribonuclease 
activity. 
HEp-2 cells were transfected with siRNAs for hDis3, hDis3L1 or PM/Scl-100 (Schilders et al, 2007b) (indicated 
above the lanes). Forty eight hours after siRNA transfection exosome complexes were immunoprecipitated from 
cell lysates using anti-hRrp40 antibodies in a buffer containing 50 mM KCl. Normal rabbit serum (NRS) was used 
as an immunoprecipitation control. (A) hDis3, hDis3L1, PM/Scl-100 and hRrp4 were detected in the cell lysates 
(lanes 1-3) and the immunoprecipitates (lanes 5-8) by western blotting. Anti-γ-tubulin antibodies were used to 
visualize γ-tubulin as loading control. (B) Ribonuclease activity was determined by incubating equal amounts of the 
immunoprecipitated material with the 5.8S rRNA-containing radiolabelled RNA substrate in RNA degradation buffer 
containing 0.05 mM Mg2+ (lanes 1-4) or 5 mM Mg2+ (lanes 5-8). (C) The radioactivity of the degradation products in 
panel B was quantified by phosphorimaging. The data were normalized for the signals obtained with the material 
from control (EGFP) siRNA-treated cells.
Discussion
The catalytic subunits that determine the exoribonucleolytic activity of the RNA exosome 
vary markedly among species. In archaea, the core itself was shown to be enzymatically 
active and, perhaps for that reason, does not require the association of other (hydrolytic) 
enzymes (Lorentzen et al, 2005). Plants combine the activity of an active core (Chekanova 
et al, 2000) with three different versions of the Rrp6 protein, each with a specific subcellular 
localization (Lange et al, 2008). In budding yeast, the exosome core-associated Dis3 protein 
provides most of the activity to the catalytically inactive core, in concert with the nuclear 
Rrp6 protein. Mammals display yet another mode of exoribonuclease activity: the inactive 
core serves as a scaffold for the association of at least 3 distinct hydrolytic exonucleases: 
PM/Scl-100, hDis3, and hDis3L1. Here we determined the contribution of these enzymes to 
the activity of the human exosome.
PM/Scl-100 acts as a Mg2+-dependent hydrolytic exonuclease and displays this activity both 
in association with the exosome core and independently. The requirement of relatively high 
Mg2+ concentrations is similar to what has been observed previously for the orthologous 
yeast Rrp6 protein (Liu et al, 2006; Phillips and Butler, 2003). Yeast Rrp6 has been reported 
to be activated by Mn2+ and Zn2+ as well (Midtgaard et al, 2006), but PM/Scl-100 did not show 
substantial activity in the presence of these divalent cations. 
The results obtained with the PM/Scl-100 amino acid substitution mutants indicated that 
both the DEDDy motif and the elements that probably are involved in the recruitment and 
positioning of the substrate and/or the correct folding upon substrate binding are essential 
for the exonuclease activity of this enzyme. A mutation in the HRDC domain of the yeast Rrp6 
protein resulted in 5.8S pre-rRNA and pre-snoRNA 3’-end processing defects, although its 
exonuclease activity appeared to be unaffected (Midtgaard et al, 2006; Phillips and Butler, 
2003).
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Most of the RNase assays in our study were performed using a highly structured RNA substrate, 
5.8S rRNA extended at the 3’ end by the most 5′ 100 nucleotides of ITS2. In agreement with the 
results of a recent study (Januszyk et al, 2011) our data indicate that the activity of PM/Scl-100 
is not hindered by secondary structures present in the RNA substrate. The apparent capacity 
of PM/Scl-100 to degrade structured RNA substrates (Januszyk et al, 2011) raises the question 
why PM/Scl-100 is also found in association with the exosome core and to what extent this 
association affects the enzymatic activity and/or substrate specificity. One possibility is that 
exosomes facilitate the recruitment of RNAs that are designated for destruction or truncation 
and present them in the proper way to the exoribonuclease, as has been demonstrated for 
the yeast exosome (Bonneau et al, 2009). Alternatively, although substrate unwinding might 
not be necessary for complete degradation by PM/Scl-100 in vitro, a role for the exosome core 
in unwinding highly structured RNA substrates is feasible as well.
PM/Scl-100 has a high affinity for binding to the exosome core, as this protein was shown 
to coprecipitate with the exosome under relatively stringent conditions. Surprisingly, the 
PM/Scl-100-mediated exosome activity appeared to be slightly increased when the 
immunoaffinity-purified complexes were subjected to relatively high salt concentrations 
prior to the analysis of exoribonuclease activity. Since immunoblotting data showed that this 
is not due to higher amounts of PM/Scl-100, these observations suggest that the activity of 
exosome-associated PM/Scl-100 might be regulated by other protein(s). Potential candidates 
for modulating the activity of PM/Scl-100 are C1D, hMPP6 and hMtr4, which have previously 
been shown to be associated with PM/Scl-100 (Schilders et al, 2005; Schilders et al, 2007b). 
However, these three proteins are expected to stimulate the activity of PM/Scl-100, as was 
demonstrated for the 3’end processing of the 5.8S rRNA in vivo, raising the possibility that 
other protein(s) are responsible for this phenomenon. Interestingly, the increase in activity 
of PM/Scl-100 inversely correlates with the association of hDis3 with the exosome core. This 
suggests that also hDis3 may somehow modulate the activity of PM/Scl-100, when associated 
with the exosome. In yeast, the binding of Dis3 did not seem to affect Rrp6’s activity (Wasmuth 
and Lima, 2012). Further studies are required to clarify this issue.
The interaction of the human Dis3 with the exosome core is rather weak, especially when 
compared to its paralogue hDis3L1, suggesting that in human cells a substantial amount of 
hDis3 is not associated with the exosome core. In fact, the instability of the hDis3-exosome 
core association at physiological salt concentrations (~100 mM KCl) questions the biological 
significance of this interaction in human cells. Possibly, this association is rather dynamic and 
influenced by the microenvironment. In this respect it is important to note that the activity of 
the exosome in vitro at low magnesium concentration correlates with the association of hDis3. 
Moreover, knockdown of hDis3 resulted in reduced exosome activity under these conditions, 
substantiating that the human Dis3 may indeed provide an important contribution to the 
activity of the human exosome. In yeast, Dis3 has been shown to act as an endonuclease in 
addition to its function as an exonuclease (Lebreton et al, 2008; Schaeffer et al, 2009) and it 
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is likely that the human Dis3 protein displays the same activities. Since both PM/Scl-100 and 
hDis3L1 lack endonuclease activity, hDis3 is the only endonuclease currently known to be 
associated with the human exosome. 
Taken together, PM/Scl-100, hDis3 and hDis3L1 have been shown to associate with the 
human exosome and are therefore likely to contribute to the ribonuclease activity of the 
complex. It is still not known, however, whether these ribonucleases can bind the human 
exosome core simultaneously. Recently, the crystal structure of the yeast exosome core in 
complex with both Dis3 and the C-terminal region of Rrp6 has been solved, demonstrating 
that simultaneous binding of these two nucleases is possible (Makino et al, 2013). As 
observed before, Dis3 is binding to one side of the donut structure of the exosome core, the 
central channel of which is connected to a path that leads to the exonucleolytic active site 
of Dis3. Rrp6 is positioned at another region of the exosome core, where it wraps around 
Csl4 and contacts the donut-structure. RNA substrates may follow two (partially overlapping) 
paths through the exosome followed by degradation by either Dis3 or Rrp6. Interestingly, the 
activity of Dis3 was positively affected by the binding of Rrp6 (irrespective of the activity of 
Rrp6), resulting in a conformational change in the Csl4 protein, which directs RNA substrates 
through the central channel towards Dis3 (Makino et al, 2013; Wasmuth and Lima, 2012).
The exact positioning of hDis3, hDis3L1 and PM/Scl-100 on the human exosome has not 
been determined so far. It also remains to be demonstrated whether the binding of hDis3 
and hDis3L1 are mutually exclusive. Most likely the overall architecture is similar to that in 
yeast. The interaction of yeast Dis3 with the exosome core is mediated by its N-terminal 
region (Schaeffer et al, 2012; Schneider et al, 2009), which is conserved in the human Dis3 
and Dis3L1 proteins. In view of their structural similarity hDis3 and hDis3L1 probably bind 
to the same region and thus are not expected to bind to the exosome core simultaneously. 
Furthermore, the C-terminal region of Rrp6 was shown to bind to a region of the exosome 
core containing conserved surface patches (Makino et al, 2013). 
The results of the knock-down experiments suggest that alterations in the association of 
one of the exosome-associated ribonucleases may affect the level of association of another 
(Figure 6A). For instance, the knockdown of hDis3L1 led to an increased association of PM/Scl-
100 with the exosome core and resulted in more activity at high magnesium concentrations. 
Conversely, knockdown of PM/Scl-100 resulted in elevated levels of hDis3L1 association and 
enhanced activity at low magnesium concentrations. Upon depletion of hDis3 such alterations 
were not observed. Paradoxically, the activity of yeast Dis3 was found to be stimulated by the 
association of Rrp6 with the exosome core (Wasmuth and Lima, 2012), while our results are 
suggesting the opposite effect: stimulation of hDis3 and/or hDis3L1 activity when PM/Scl-100 
is depleted. It is difficult to explain these data based upon the predicted exosome complex 
architecture described above, for which mutual effects between hDis3 and hDis3L1 would 
be expected. It should, however, be noted that the N-terminal part of Rrp6 was lacking in 
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the analyses of the crystal structure of the yeast complex and it is possible that this domain 
is responsible for the observed effects. Additional studies will be required to clarify the 
interplay between the exosome core associated ribonucleases, which may be important for 
the regulation of exosome activity. In yeast for instance, Rrp6 is downregulated when cells 
progress through meiotic development to promote the stabilization of meiotic non-coding 
RNAs (Lardenois et al, 2011). In flies, it was shown that Rrp6 was dynamically redistributed 
in the cell during the different stages of mitosis, while exosome core subunits were found 
in close proximity to microtubuli during cell division (Graham et al, 2009). Furthermore, 
the interaction of the exosome with the complexes controlling the circadian clock is also 
indicative for temporal changes in the exosome-associated nuclease protein levels, which 
are needed for the degradation of specific RNAs in a periodical fashion (Guo et al, 2009). In 
conclusion, these results provide a rationale for the regulation of exosome activity in vivo and 
it is likely that this occurs by modulation of the association or activity of exosome-associated 
ribonucleases.
Materials and methods
Immunoprecipitation
Affinity purified polyclonal rabbit anti-PM/Scl-100 (“SN566”) or anti-hRrp40 (“H70”) antibodies 
(Brouwer et al, 2001) were coupled to protein A-agarose beads (Kem-En-Tec, Denmark) in 
IPP500 (500 mM NaCl, 10 mM Tris–HCl, pH 8.0, 0.05% NP-40) at room temperature for 1 h. 
Similar conditions were used to couple the monoclonal mouse anti-VSV antibodies (home-
made) to protein G-agarose beads (Kem-En-Tec, Denmark). Beads were washed once with 
IPP500 and twice with the appropriate IPP-solution (same as IPP500, but KCl instead of 
NaCl, in which the concentration of KCl is depending on the assay). HEp-2 cell extract was 
made by resuspending the cells in six volumes of lysis buffer (25 mM Tris–HCl, pH 7.5, 50 
or 100 mM KCl, 1 mM EDTA, 0.5 mM PMSF, 0.05% NP-40, 1 mM DTT), followed by sonication 
and centrifugation. The extract was incubated with the antibody-coupled beads for 2 h at 
4°C. After washing the beads twice with the appropriate IPP-solution, bound proteins were 
washed two more times with RNA degradation assay buffer (described below), after which 
the beads were split for SDS-PAGE and the RNase assay.
Western blot analysis
Proteins were size-separated by SDS-PAGE (containing 12.5% acrylamide) and transferred 
to nitrocellulose membranes followed by 1 h of blocking (5% skimmed milk, PBS, 0.05% 
NP-40). For the detection of proteins on western blots, polyclonal rabbit antibodies 
(anti-PM/Scl-100, anti-hRrp40, anti-hRrp41), polyclonal mouse antibodies (anti-hDis3L1), 
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monoclonal mouse antibodies (anti-VSV, anti-hRrp4, anti-γ-tubulin, anti-hDis3) or a human 
patient serum (“Ven96”) containing antibodies to PM/Scl-100 (Schilders et al, 2007a) were 
diluted in blocking buffer (5% skimmed milk, PBS, 0.05% NP-40). Blots were incubated with 
these antibodies for 1 h at room temperature. Bound antibodies were detected by incubation 
with IRDye-conjungated polyclonal goat anti-mouse, goat anti-rabbit or goat anti-human 
antibodies (Li-Cor) for 1 h in blocking buffer and visualized using an Odyssey Infrared Imaging 
System (Li-Cor). 
Mutagenesis of PM/Scl-100 
Point mutations in the coding sequence of the VSV-tagged PM/Scl-100 expression construct 
were introduced by site directed mutagenesis using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene) using the manufacturer’s recommendations and the following 
primers: 
(D525A) 5’CTCGCAGGGAAGCTGAAAGTTACGG 3’ 
and 5’CCGTAACTTTCAGCTTCCCTGCGAG 3’,
(Y436F) 5’AGATGCTCAGCTTCGCCCGGGATGA 3’
and 5’TCATCCCGGGCGAAGCTGAGCATCT 3’,
(Q184A) 5’CATCCGACCTGCGCTCAAGTTTC 3’
and 5’GAAACTTGAGCGCAGGTCGGATG 3’
(N193A) 5’GAGAGAAGATTGACGCTTCCAACACACC 3’
and 5’GGTGTGTTGGAAGCGTCAATCTTCTCTC 3’
RNase assays
RNase assays were performed using a radiolabelled 267 nucleotide RNA substrate, which 
was obtained by in vitro transcription in the presence of 32P α-UTP. This substrate RNA 
contained the human 5.8S rRNA sequence and the most 5’ 100 nucleotides of ITS2 (Schilders 
et al, 2005). The RNA substrate in Figure 1 was generated in a similar fashion, but with a 
XbaI-linearized pBS(-) plasmid as template for transcription by T3 RNA polymerase. After gel-
purification the RNA substrate was incubated for 2 h with the immunoprecipitated material 
at 37°C in RNA degradation buffer (20 mM HEPES, pH 7.5, 50 mM KCl, 1 mM DTT, 1 mM 
Na2HPO4) containing different concentrations of Mg
2+, as indicated. Reactions were stopped 
by the addition of RNA-loading buffer (9M urea, 0.1% bromophenol blue, 0.1% xylene cyanol), 
supplemented with 20% (v/v) phenol. Samples were analysed by denaturing polyacrylamide 
gel electrophoresis followed by autoradiography. The results were quantified by phosphor-
imaging, using Quantity One software (Bio-Rad).
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siRNA-mediated knock-down
siRNAs were purchased from Eurogentec. The sequences of the siRNAs used in this study are 
as follows: 
5’-CGAGAAGCGCGAUCACAUGdTdT-3’ (EGFP), 
5’-GCUGCAGCAGAACAGGCCAdTdT-3’ (PM/Scl-100), 
5’-GCCUACAGGUAGAGUUGUAdTdT-3’ (hDis3), 
5’-CCAUGUAACCGUAAGAAUAdTdT-3’ (hDis3L1). 
Transfection of HEp-2 cells with these siRNAs was performed essentially as described 
previously (Schilders et al, 2005).
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Abstract
Eukaryotic RNA degradation is mediated by a complex network of cooperating as well as 
independently operating enzymes. Although many different proteins and factors have been 
discovered over the years, the recurrent involvement of the RNA exosome makes it one of 
the most important protein complexes in RNA metabolism. Rather than degrading the RNA 
substrates itself, the eukaryotic exosome functions as a scaffold for the association of different 
exo- and endonucleases. Several exosome-associated nucleases have been identified and 
characterized, including PM/Scl-100 (or Rrp6), hDis3 and hDis3L1. The human genome encodes 
yet another protein with homology to Dis3-like ribonucleases, which is called hDis3L2. Here, we 
show that hDis3L2 is a cytoplasmic exoribonuclease that, in contrast to hDis3 and hDis3L1, is 
not detectably associated with the exosome. Furthermore, our data show that overexpression 
of hDis3L2 severely changes the cell morphology. The putative role of hDis3L2 in controlling 
important stages in cell division as well as the impact of hDis3L2 mutations on human health 
will be discussed.
Introduction
In the previous chapters it was shown that the human exosome functions as a scaffold for 
the association of different exoribonucleases. Both PM/Scl-100 and hDis3L1 have a strong 
affinity for binding the exosome and contribute to the activity that is associated with this 
complex. The interaction of hDis3 was found to be weaker and it is still not clear whether 
hDis3 is of major functional importance for exosome-mediated processes in human cells. In 
addition to these two Dis3(-like) proteins, the human genome appears to encode yet another 
protein with homology to the yeast Dis3, which is called hDis3L2. 
The hDis3 and hDis3L1 proteins and their association with the exosome have been 
characterized previously (Lykke-Andersen et al, 2011; Staals et al, 2010; Tomecki et al, 
2010), but the biochemical and biological features of hDis3L2 are still enigmatic. The first 
indications for a biological role of hDis3L2 were obtained in studies aimed at the gene(s) 
causing Perlman syndrome (a rare overgrowth disorder present at birth, which is frequently 
accompanied by a high risk of the formation of Wilms’ tumors in the kidney). Perlman 
syndrome patients appeared to express mutants of the hDis3L2 protein, resulting in a 
plethora of mitotic abnormalities (Astuti et al, 2012). These mutant hDis3L2 proteins are due 
to missense and splice-site mutations, as well as exonic deletions in the germline. One of 
the exonic deletions (exon 9) was recently shown to arise from two independent non-allelic 
homologous recombination events between two L1 elements, which belong to the family of 
long interspersed elements (LINEs), some of which are active retrotransposons in the human 
genome (Higashimoto et al, 2013).
The first Dis3 protein was identified in Schizosaccharomyces pombe in a study addressing 
conditional mutants with defects in sister (Dis) chromatid separation  (Ohkura et al, 1988). 
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The complete deletion of the Dis3 locus was found to be lethal. Furthermore, S. pombe 
Dis3 appeared to play a role in kinetochore formation and the subsequent interaction of 
the microtubule with the kinetochore, just prior to the anaphase (Murakami et al, 2007). It 
was suggested that S. pombe Dis3 mediates the silencing of the heterochromatic regions 
surrounding the centromere, which is important for these phenomena. In fact, temporal 
silencing of a particular RNA species by Dis3 has been shown to be a major cue for other 
fundamental cellular processes, as it appeared to be important for stages in development 
and meiosis as well (Cairrao et al, 2005; Hou et al, 2012; Wang et al, 2008). 
The involvement of these Dis3(-like) proteins in such fundamentally important cellular 
processes underlines the need to characterize these nucleases and their activities in detail. 
Here, we demonstrate that hDis3L2 is a cytoplasmic protein with exoribonuclease activity 
and provide indirect evidence that at least a subset of its RNA substrates is involved in 
controlling essential mitotic events. 
Results
The hDis3L2 gene is located on chromosome 2 and sequence databases indicate the existence 
of at least five transcript variants (accession numbers NM_152383.4, NM_001257281.1, 
NM_001257282.1, NR_046476.1 and NR_046477.1). The ‘canonical’ transcript encodes a 
polypeptide of 885 amino acids, with a calculated molecular mass of 99.3 kDa; the other 
transcripts represent shorter isoforms, which are truncated in the C-terminal region. The 
hDis3L2 amino acid sequence shows 23% identity with the yeast Dis3 sequence and orthologs 
can be found in most eukaryotic species, including fungi, mammals, vertebrates and possibly 
plants as well. The protein was initially believed to be absent in the fungal kingdom, since 
no Dis3L2 orthologs were found in the yeast Saccharomyces cerevisiae. However, BLAST 
database searches have recently indicated that S. cerevisiae is just one of the few examples 
in the fungal kingdom without a clear Dis3L2 ortholog, emphasizing the dangers of focusing 
on one particular model organism (Malecki et al, 2013). 
Pfam database searches revealed the presence of a RNB domain in Dis3L2, which was 
originally identified in Escherichia coli RNase II, suggesting a role for this protein in RNA 
degradation. A comparison with the other two human Dis3(-like) proteins revealed some 
interesting differences. Both hDis3 and hDis3L1 contain three OB-fold-containing domains 
(CSD1, CSD2 and S1), but only the CSD2 domain can be discerned in the hDis3L2 protein 
(Chapter 3, Supplementary Figure S1). Furthermore, the N-terminal region of hDis3L2 does not 
contain a PIN(-like) domain, like hDis3 and hDis3L1, although the latter was recently shown 
to lack PIN domain-associated endoribonuclease activity (Staals et al, 2010; Tomecki et al, 
2010). The PIN domain was also shown to mediate the interaction of Dis3 with the exosome in 
yeast, suggesting that hDis3L2 is incapable to associate with the exosome complex. Instead, 
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protein-protein interaction databases (Peri et al, 2004; Stark et al, 2006) point to interactions 
of hDis3L2 with COPS6 (signalosome complex subunit 6), FEZ1 (fasciculation and elongation 
protein zeta-1), VIM (vimentin), CBX2 (chromobox protein homolog 2) and UBC (ubiquitin C), 
although the biological significance of these interactions remains to be investigated.
Since the presence of an RNB domain suggests a potential role in RNA degradation, we set 
out to investigate whether hDis3L2 has ribonuclease activity. The coding sequence of the 
canonical hDis3L2 isoform was isolated from a HEp-2 cDNA library by PCR (the isolation from 
HeLa and human teratocarcinoma cDNA libraries failed). The hDis3L2 coding sequence was 
cloned into two mammalian expression vectors, either in-frame with an N-terminal VSV-G 
tag or fused to the 3’ end of an EGFP-encoding sequence. The integrity of the constructs was 
confirmed by DNA sequence analysis. HEp-2 cells were transfected with these constructs, 
either by electroporation or using the Fugene transfection reagent and the expression was 
monitored 24 or 48 hours later by western blotting (Figure 1). The results showed that, in 
contrast to EGFP-hDis3L1 (which was included as a positive control) no expression of 
the tagged hDis3L2 protein could be detected, irrespective of the tag or the transfection 
procedure. Note that the band stained with anti-VSV-tag antibodies in material from the VSV-
hDis3L2 transfected cells (Figure 1B) represents a background reactivity of the anti-VSV-tag 
antibodies. Other attempts to obtain hDis3L2 expression by transient transfection of COS-1 
cells or by boosting the expression by the addition of sodium butyrate to the medium also 
did not lead to detectable hDis3L2 expression (data now shown). As an alternative for the 
transfected cells, an in vitro transcription-translation system (rabbit reticulocyte lysate) was 
used to produce the VSV-hDis3L2 protein. Also in this expression system hDis3L2 was not 
detectably expressed, in contrast to hDis3L1, which resulted in a Mr 120,000 polypeptide in 
SDS-PAGE, in agreement with the calculated molecular mass (Figure 2).
These results suggested that either the production of the tagged hDis3L2 proteins was very 
low, for example due to inefficient transcription and/or translation, or that the translation 
products were rapidly degraded. A third explanation might be that the expressed protein is 
highly toxic for cultured cells as well as the in vitro transcription-translation system. To explore 
these possibilities in more detail, COS-1 and HEp-2 cells were transfected with constructs 
encoding either EGFP-hDis3L2, VSV-hDis3L2 or EGFP-hDis3L1 (as a positive control) and the 
expression of the tagged proteins was studied by fluorescence microscopy, using anti-VSV 
antibodies in case of the VSV-tagged protein. In agreement with previous findings (Staals et 
al, 2010; Tomecki et al, 2010), EGFP-hDis3L1 was expressed in many cells and accumulated in 
the cytoplasm, displaying a diffuse staining pattern (Figure 3A,B). In contrast, only very few of 
the cells transfected with the EGFP-hDis3L2 and VSV-hDis3L2 constructs showed a detectable 
level of fluorescence, indeed suggesting that elevating the expression of hDis3L2 has severe 
effects on cell physiology. The cells in which tagged hDis3L2 expression was observed often 
displayed altered morphologies, some reminiscent of apoptosis (data not shown) and others 
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Figure 1. Expression of EGFP- or VSV-tagged hDis3L1 and hDis3L2 in HEp-2 cells.
HEp-2 cells were transfected with expression constructs encoding EGFP, EGFP-hDis3L1, VSV-hDis3L1, VSV-hDis3L2 or 
EGFP-hDis3L2 using electroporation (A) or the Fugene 6 transfection reagent with different amounts of plasmid DNA, 
as indicated above the panels (B). Total cell extracts were prepared (24 or 48 hours after electroporation or 48 hours 
after Fugene transfection), separated by SDS–PAGE and analysed by western blotting using polyclonal anti-GFP and 
monoclonal anti-VSV-tag antibodies to visualize the expression of tagged hDis3L1 and hDis3L2. Monoclonal anti-
Υ-tubulin antibodies were used as loading control. The asterisk indicates the presence of an unknown protein that 
was recognized by the anti-VSV-tag antibodies. The position of a 100 kDa marker in the gels is indicated on the left.
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Figure 2. In vitro transcription and translation of VSV-hDis3L1 and VSV-hDis3L2.
VSV-hDis3L1 and VSV-hDis3L2 were expressed in vitro using a coupled transcription-translation system supplemented 
with 35S-methionine. Translation products were visualized by separation on SDS-PAGE followed by autoradiography.
characterized by oversized nuclei. In these cells EGFP-hDis3L2 appeared to accumulate 
either in cytoplasmic speckles or was more diffusely distributed in the cytoplasm (Figure 
3C,D). Cells expressing VSV-hDis3L2 with a relatively normal morphology contained the 
highest concentrations of VSV-hDis3L2 in small cytoplasmic speckles (Figure 3E,F). Despite 
the very small number of cells with detectable expression of the tagged protein and the 
disturbed cell morphologies, these results suggest that hDis3L2 resides in the cytoplasm, 
which is in agreement with observations from other laboratories (Astuti et al, 2012; Lubas et 
al, 2013; Malecki et al, 2013). Taken together, these results suggest that a small increase in 
the expression level of hDis3L2 may have severe consequences for cell viability. This might 
be due to the uncontrolled enzymatic activity of hDis3L2, but may also be caused by other 
phenomena. Interestingly, HEp-2 cells transfected with siRNAs to knock-down endogenous 
hDis3L2 protein levels displayed slightly elevated cell growth rates (data not shown).
Previously, it was shown that FLAG-tagged hDis3L2 was detectably expressed in stably 
transfected HEK293 cells (Astuti et al, 2012). Although rather speculative, the stable integration 
probably resulted in less dramatic increases in cellular Dis3L2 levels, thereby allowing 
detectable expression. Lysates from these cells were used to study the ribonuclease activity 
of the FLAG-tagged protein. More specifically, lysates from the HEK293 cells stably transfected 
with a construct encoding FLAG-tagged hDis3L2, or the corresponding FLAG-tag encoding 
vector, were used to immunoprecipitate the tagged protein using anti-FLAG-tag antibodies, 
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after which the precipitates were incubated with a radiolabeled RNA substrate in the presence 
of different concentrations of Mg2+. While no activity was observed for the material from cell 
lines expressing the FLAG-tag alone, the FLAG-hDis3L2 containing precipitate efficiently 
converted the substrate RNA to small products (Figure 4). No degradation intermediates were 
detected, which is consistent with processive exonucleolytic degradation of the substrate. 
The highest activity was observed with no or relatively low magnesium concentrations, 
although also in the presence of relatively high concentrations the substrate was degraded. 
These results suggest that hDis3L2 acts as a Mg2+-independent exoribonuclease.
Due to the similarity of hDis3L2 with hDis3 and hDis3L1, the exosome complex might be 
associated with hDis3L2. However, an analysis of exosome proteins copurifying with FLAG-
tagged hDis3L2 by western blotting using anti-hRrp40 antibodies did not lead to the detection 
of hRrp40 (data not shown).
Figure 3. Localization of EGFP- or VSV-tagged hDis3L1 and hDis3L2 in HEp-2 and COS-1 cells.
COS-1 (A, C and E) and HEp-2 (B, D and F) cells were transfected with expression constructs encoding EGFP-hDis3L1 
(A-B), EGFP-hDis3L2 (C-D) or VSV-hDis3L2 (E-F). Forty-eight hours after transfection the cells were fixed and EGFP-
fusion proteins were visualized directly by fluorescence microscopy. The VSV-tagged proteins were visualized by 
incubating the cells with anti-VSV-tag antibodies after fixation and permeabilization, followed by Alexa Fluor 
555-conjugated goat anti-mouse antibodies and fluorescence microscopy.
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Figure 4. RNA degradation by Dis3L2 in vitro.
Cell lysates from stably transfected HEK293 cells expressing either the FLAG-tag alone (FLAG) or FLAG-tagged 
hDis3L2 (FLAG-hDis3L2) were subjected to immunoprecipitation with anti-FLAG antibodies. Precipitated proteins 
were incubated with a 267 nucleotide radiolabelled RNA substrate and the reaction products were subsequently 
analysed by denaturing polyacrylamide gel electrophoresis followed by autoradiography. The incubations were 
performed in the presence of various concentrations of Mg2+ (indicated in mM above the lanes).
Discussion
The results presented here indicate that hDis3L2 is an exosome-independent, cytoplasmic 
ribonuclease. hDis3L2 displayed exoribonuclease activity in vitro which does not seem to 
require Mg2+ (Figure 4). It should be noted that traces of Mg2+ might have been introduced in 
the reaction mixture that was used to analyse the activity in the absence of magnesium, e.g. 
via the (purification of the) RNA substrate. For the exoribonuclease activity of the structurally 
related proteins hDis3 and hDis3L1, Mg2+ has been previously shown to be required, albeit 
at low concentrations (Staals et al, 2010; Tomecki et al, 2010). Akin to hDis3 and hDis3L1, 
the active site of hDis3L2 is expected to be situated in its RNB domain, as deletion mutants 
abrogating this domain diminished its activity (Astuti et al, 2012). Since the same stable cell 
lines were used in this study, these findings also make it less likely that other (co-purifying) 
proteins are responsible for the observed activity in our RNA degradation assay.
In contrast to hDis3 and hDis3L1, hDis3L2 does not seem to be associated with the exosome 
core. First, no co-immunoprecipitation of the exosome with (FLAG-tagged) hDis3L2 was 
observed, which is substantiated by recently published data from other laboratories (Lubas 
et al, 2013; Malecki et al, 2013). Second, hDis3L2 lacks a PIN domain, which mediates the 
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interaction of Dis3 with the exosome (Schaeffer et al, 2012; Schneider et al, 2009). Finally, 
previous analyses of purified exosome complexes failed to identify hDis3L2 as a copurifying 
protein, even when sensitive approaches such as SILAC were applied (Chen et al, 2001; Staals 
et al, 2010; Tomecki et al, 2010). These observations argue against an exosome-dependent 
role of hDis3L2 in RNA metabolism.
None of the attempts to express tagged hDis3L2 in transiently transfected mammalian cells 
(HEp-2 and COS-1) to levels that are detectable by western blotting using total cell lysates 
was successful. One explanation for these observations might be that the (over)expression 
of the recombinant protein has severe effects on cell viability. When individual cells were 
examined by fluorescence microscopy, only very few cells showed detectable expression of 
the fluorescently tagged hDis3L2 protein. It is not likely that this is due to low transfection 
efficiencies, because EGFP-hDis3L1 and VSV-hDis3L1, which were analyzed in parallel, were 
readily expressed. Since also the morphology of most of the cells with detectable hDis3L2 
expression was unusual, elevated expression levels of hDis3L2 indeed seem to be detrimental 
for cell survival. The expression data in the BIOGPS database (Wu et al, 2009) suggest that 
hDis3L2 is ubiquitously expressed in human tissues. Although this expression profile does 
not allow a proper comparison of the expression levels between different tissues, it is 
possible that the expression of Dis3L2 in vivo is tightly regulated. A possible explanation for 
our observed unusual cell morphologies can therefore be the disturbance of these tightly 
controlled hDis3L2 protein levels (e.g. by exogenous hDis3L2 expression).
As explained in the introduction, the importance of Dis3 for proper mitotic progression 
has been known since its discovery in yeast, where the protein was shown to have roles in 
chromatid disjoining and kinetochore formation (Murakami et al, 2007; Ohkura et al, 1988). 
The evidence in favor for a role of hDis3L2 in controlling the proper expression levels of 
several cell-cycle related mRNAs is currently building up. Firstly, mRNA levels of important 
proteins required for proper mitotic progression were found to be affected in cells where 
hDis3L2 protein levels were knocked down by RNAi (Astuti et al, 2012). Most notably, proteins 
involved in centrosome duplication (TTK), chromatid separation (securin) and several 
proteins controlling mitotic checkpoints (Aurora B, phosphorylated CDC25C, cyclin B1 and 
RAD21) were affected. Interestingly, the knockdown of hDis3L2 also resulted in aberrant cell 
morphologies, which could be a consequence of the aforementioned disturbed protein levels. 
Secondly, recent RNA-seq data have demonstrated that depletion of hDis3L2 resulted in the 
stabilization of many cell-cycle related mRNAs (Lubas et al, 2013). These findings suggest that 
the observed aberrant cell morphologies in hDis3L2 overexpressing cells (Figure 3) might be 
a result of a disturbance in the expression levels of cell-cycle and/or mitosis-related proteins, 
as both depletion and overexpression of proteins involved in these processes can affect cell 
morphology.
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These data indicate that some RNA substrates of hDis3L2 are mRNAs encoding proteins with 
important functions in the cell cycle, making hDis3L2 a potential tumor suppressor. In line 
with this is the observation that cells with depleted hDis3L2 protein levels have a growth 
advantage over wild-type cells (Astuti et al, 2012). Furthermore, the observation that germline 
mutations in the hDis3L2 gene were found to be the cause of the Perlman syndrome further 
supports the role of hDis3L2 as a tumor suppressor. A possible link between the mutations 
in hDis3L2 and the development of the Perlman syndrome has recently been found by the 
identification of one of its substrates: the pre-let-7 miRNA (Chang et al, 2013). Silencing of this 
particular miRNA is especially important in stem cells, keeping them in an undifferentiated 
and proliferative state, while it is relieved in somatic cells (Yu et al, 2007). Lastly, recent studies 
have revealed a genetic link between human height variation and sequence variations in 
chromosomal loci containing the hDis3L2 gene (Estrada et al, 2009; Gudbjartsson et al, 2008; 
Okada et al, 2010). Further studies will be required to investigate whether hDis3L2 is involved. 
Recently, a novel exoribonuclease homologous to hDis3L2 was identified in 
Schizosaccharomyces pombe (Malecki et al, 2013). S. pombe Dis3L2 was shown to be involved in 
an exosome-independent 3’-5’ mRNA decay pathway occurring at or near P-bodies. P-bodies 
are granule-like cytoplasmic foci where translationally-silenced mRNAs and many different 
enzymes for various mRNA decay pathways are concentrated (Kulkarni et al, 2010). One of 
these enzymes is hXrn1, an important exoribonuclease responsible for 5’-3’ mRNA decay 
(Sheth and Parker, 2003). Although 3’-5’ mRNA decay was initially assumed to contribute little 
to the mRNA decay associated with these foci, this possibility now needs to be reinvestigated 
with the discovery of Dis3L2, which provides a source of 3’-5’ ribonuclease activity. It appears 
that Xrn1 and Dis3L2 operate redundantly in mRNA decay substrates, as deletion of Dis3L2 
was found to be synthetically lethal with a Xrn1 deletion (Malecki et al, 2013). In addition, 
hDis3L2 was recently shown to physically interact with hXrn1 and depletion of either hDis3L2 
or hXrn1 stabilized an overlapping pool of RNAs (Lubas et al, 2013), indicating that at least 
some of their RNA substrates are indeed shared.
It will be interesting to investigate whether the observed cytoplasmic speckles in Dis3L2 
overexpressing HEp-2 cells (Figure 3) also represent P-bodies. Since no P-body marker (such as 
DCP2) was included in our analysis, we cannot differentiate between this and other plausible 
explanations for the observed speckled staining pattern, such as protein aggregates, or stress 
granules. Co-localization experiments with P-body markers, e.g. by fluorescence microscopy, 
are needed to shed more light on this issue. It will also be interesting to investigate whether 
hDis3L2 overexpression affects the abundance of these P-bodies, because depletion of 
hDis3L2 was shown to increase the number of P-bodies per cell (Lubas et al, 2013). 
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In summary, the significance of RNA degradation by Dis3L2 for cellular RNA metabolism 
has just begun to become apparent and future experiments will provide more insight in the 
biochemical function of this exciting novel exoribonuclease.
Materials and methods
cDNA cloning and generation of the hDis3L2 expression constructs
The complete coding sequence of the largest isoform of hDis3L2 (RefSeq accession number: 
NM_152383.4) was isolated from a custom HEp-2, oligo(dT)-primed cDNA library by PCR 
using the following oligonucleotides: 
5’ - ACGCGTGGATCCAATGAGCCATCCTGACTACAG - 3’ and 
5’ - CCCGAGGACTCAAGCACCAGCCCCGGGTGAGTCGAC- 3’. 
The resulting PCR product was subsequently cloned into the pCR4-TOPO vector according to 
the manufacturer’s guidelines (Invitrogen). The sequence of the selected clone was confirmed 
by DNA sequencing. N-terminal EGFP- and VSV-tagged hDis3L2 expression constructs were 
made by inserting the coding sequence into the pEGFP-C3 (Clontech) and pCI-neo-5’-VSV 
(Raijmakers et al, 2002) vectors, respectively, using the appropriate restriction sites that were 
added in the cDNA cloning primers.
Transient transfection of HEp-2 and COS-1 cells
Transfection of HEp-2 and COS-1 cells with the constructs encoding EGFP- and VSV-tagged 
hDis3L1 or hDis3L2 using the transfection reagent Fugene 6 (Roche) was performed in a 
6-well cell culture format according to the manufacturer’s recommendations using either 2, 
4 or 8 µg of plasmid DNA per 5 x 105 cells. The transfection of the cells by electroporation 
was performed essentially as described before (Staals et al, 2010), with the exception that for 
the COS-1 cells, ice-cold PBS (phosphate-buffered saline) was used to resuspend the cells, 
after which the cells were electroporated at 300V and 125µF. Twenty-four or forty-eight hours 
after transfection the cells were harvested by trypsinization, resuspended in lysis-buffer (25 
mM Tris-HCl, pH 7.5, 100 mM KCl, 1 mM EDTA, 0.5 mM PMSF, 0.05% NP-40, 1 mM DTT) and 
sonicated 3 times 30 seconds on ice using a Branson micro-tip.
Fluorescence microscopy 
To study the subcellular localization of the tagged hDis3L1 and hDisL2 proteins, HEp-2 and 
COS-1 cells were transfected as described above, seeded on glass coverslips and fixed after 
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forty-eight hours with 3.7% paraformaldehyde. EGFP fusion proteins were visualized directly, 
while the VSV-tagged proteins were detected indirectly by incubation with a monoclonal 
anti-VSV antibody after permeabilization of the cells, followed by Alexa Fluor 555-conjugated 
goat anti-mouse antibodies (Invitrogen). Incubations with antibodies were performed in PBS 
supplemented with 1% sheep serum. The localization of EGFP- and VSV-tagged proteins was 
visualized by fluorescence microscopy.
Immunoblotting
For the detection of proteins on western blots, polyclonal rabbit antibodies (anti-GFP, anti-
g-tubulin “GTU-88” (Abcam)) and monoclonal mouse antibodies (anti-VSV-tag) were diluted 
in blocking buffer (5% non-fat dry milk, PBS, 0.05% NP-40). Blots were incubated with these 
antibodies for 1 h at room temperature. Bound antibodies were detected by incubation with 
IRDye 800CW-conjungated polyclonal goat anti-mouse or goat anti-rabbit antibodies (Li-Cor) 
for 1 h in blocking buffer and visualization using an Odyssey Infrared Imaging System (Li-Cor).
In vitro transcription and translation of Dis3L1 and Dis3L2
In vitro transcription and translation of hDis3L1 and hDis3L2 were performed by using the 
VSV-tagged expression constructs (described above) and the TnT Coupled Reticulocyte 
Lysate System (Promega), supplemented with 35S-methionine using the manufacturer’s 
recommendations.
RNA degradation assays
Cell pellets derived from the stable HEK293 cell clones expressing the FLAG-tag alone or the 
FLAG-tagged wild-type hDis3L2 were resuspended in six volumes of lysis buffer containing 
a protease inhibitor cocktail (Roche) and were incubated for 30 min on ice, sonicated and 
centrifuged at 13,000g at 4 °C for 30 min. Monoclonal mouse antibody to the FLAG-tag pre-
coupled to protein A–agarose beads (Sigma) was added, and precipitates were washed twice 
with IPP500 (500 mM NaCl, 10 mM Tris-HCl, pH 8.0 and 0.05% NP-40) and twice with IPP150 
(150 mM NaCl, 10 mM Tris-HCl, pH 8.0 and 0.05% NP-40). Cell extracts were incubated with 
the antibody-coupled beads overnight at 4 °C. Beads were washed twice with IPP150 and 
twice in RNA degradation buffer (20 mM HEPES-KOH, pH 7.5, 50 mM KCl and 1 mM DTT), 
containing different concentrations of Mg2+ (as indicated in Figure 4). RNA degradation assays 
were performed using a radiolabeled 267-nucleotide RNA substrate (the human 5.8S rRNA 
sequence and the most 5’ 100 nucleotides of ITS2), which was obtained by in vitro transcription 
in the presence of α-32P-UTP (Perkin-Elmer). After gel purification of the RNA substrate, it was 
incubated for 2 h with the immunoprecipitated material at 37 °C in RNA degradation buffer 
containing MgCl2 concentrations as indicated. Reactions were stopped by the addition of 
2 volumes RNA loading buffer (9 M urea, 0.1% bromophenol blue and 0.1% xylene cyanol) 
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supplemented with 20% phenol. Samples were analyzed by denaturing polyacrylamide gel 
electrophoresis followed by autoradiography.
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Abstract
The exosome is a multi-subunit complex, which is involved in 3’-5’ processing or degradation 
of different classes of RNA. The human exosome contains nine components which are shared 
by the cytoplasmic and nuclear complex and are therefore termed ‘core’ components. In yeast 
Dis3/Rrp44, a member of the RNase R family of exoribonucleases, is stably associated with the 
exosome core. In this study, we addressed the ribonucleolytic activity of its human orthologue, 
hDis3 using in vitro activity assays. This revealed that hDis3 functions as a hydrolytic 3’-5’ 
exoribonuclease, capable of degrading both structured and unstructured RNA substrates. 
Previous studies indicated that hDis3 is not (stably) associated with the exosome core, arguing 
for an exosome-independent role for hDis3 in RNA metabolism. To obtain more insight into 
processes mediated by hDis3, we identified proteins interacting with hDis3 by LC-MS/MS 
analysis of proteins co-purifying with hDis3 from HEp-2 cell extracts. The results showed that 
hDis3 interacts with many proteins involved in pre-mRNA splicing and pre-RNA processing. The 
interaction with one of these, SF3a60, was confirmed by coimmunoprecipitation experiments. 
We performed a global analysis of the effects of hDis3 depletion on steady-state mRNA levels. 
Although a relatively small subgroup of mRNAs appeared to be similarly affected as observed 
after depletion of an exosome core component or an exosome-associated ribonuclease 
(PM/Scl-100), the results are consistent with an exosome-independent role of hDis3 in pre-
mRNA splicing.
Introduction
In the last decade major advances have been made with regard to the function, composition 
and structure of the RNA exosome, a multi-subunit complex containing 3’-5’ exoribonuclease 
activity. The exosome has been demonstrated to be required for a variety of processes 
including the 3’-end processing of nuclear RNAs such as the 5.8S ribosomal RNA and small 
nucle(ol)ar RNAs, as well as the degradation of aberrant rRNAs, tRNAs and pre-mRNAs in 
the nucleus, whereas in the cytoplasm the exosome was shown to be required for the rapid 
decay of unstable mRNAs containing AU-rich sequence elements, as well as regular mRNA 
turnover (Chlebowski et al, 2013; Lykke-Andersen et al, 2009; Sloan et al, 2012). Next to the 
degradation of these ‘canonical’ RNAs, transcripts arising from pervasive transcription have 
also been shown to be targets for the exosome (Davis and Ares, 2006; Neil et al, 2009; Preker 
et al, 2008). Finally, exosome complexes were demonstrated to participate in several aspects 
in RNAi, such as the processing of miRNAs (Flynt et al, 2010) and the degradation of mRNAs 
that have been targeted for destruction by RISC (Orban and Izaurralde, 2005).
The eukaryotic exosome consists of at least nine components which are shared by the nuclear 
and cytoplasmic complex and are therefore often termed ‘core’ components. Six subunits 
(Rrp41, Rrp42, Rrp43/OIP2, Rrp45/PM/Scl-75, Rrp46, Mtr3) share homology with the bacterial 
3’-5’ exoribonuclease RNase PH and were shown to form a hexameric ring structure. Three 
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additional subunits show similarity to S1 and KH RNA-binding proteins (Rrp40p, Rrp4p and 
Csl4p) and form a second ring bound to one side of the hexameric ring (Liu et al, 2006). In the 
yeast Saccharomyces cerevisiae, an additional protein, Dis3/Rrp44, has been demonstrated 
to bind to the other side of the hexameric ring structure, although its interaction with the 
exosome core is unstable at high salt conditions (Bonneau et al, 2009; Schneider et al, 2009; 
Staals et al, 2010; Tomecki et al, 2010; Wang et al, 2007). Interestingly, Dis3 has been reported 
to be the major active 3’-5’ exoribonuclease of the yeast exosome and to be essential for 
the recognition of specific RNA substrates (Dziembowski et al, 2007; Schneider et al, 2009). 
Moreover, it has been shown that Dis3 is essential for cell survival (Mitchell et al, 1997). Dis3 
shares sequence similarity to RNase R, a member of the RNase II family of exoribonucleases 
which can processively degrade a single-stranded RNA substrate in the 3’ to 5’ direction 
resulting in the release of nucleotide 5’ monophosphates (Amblar et al, 2006). In addition, 
the yeast Dis3 protein has been demonstrated to possess endoriboncuclease activity, which 
is dependent on the PIN domain located in the N-terminal region (Lebreton et al, 2008). This 
PIN domain is also responsible for the interaction with the exosome core (Dziembowski et al, 
2007; Schneider et al, 2009).
Another protein which was shown to be stably associated with the exosome core is Rrp6, 
a hydrolytic 3’-5’ exoribonuclease which belongs to the RNase D family. Rrp6 is associated 
with nuclear exosomes in yeast, whereas its human counterpart, PM/Scl-100, appears to be 
present in the cytoplasm as well (Brouwer et al, 2001; Lejeune et al, 2003; van Dijk et al, 2007). 
Besides the differences in localization of the yeast and human Rrp6/PM/Scl-100, the capacity 
to degrade structured RNA substrates appeared to be slightly different as well (Januszyk et 
al, 2011).
Like in yeast, the human nine subunit exosome core was found to be catalytically inactive 
(Liu et al, 2006). As such, the human exosome core was postulated to function as a scaffold 
for the interaction with ribonucleases akin to the situation in yeast. Interestingly, the human 
genome encodes three putative homologues of yeast Dis3, which are termed hDis3 (958 aa), 
Dis3-like exonuclease 1 (hDis3L1 or hDis3L, 1001 aa) and Dis3-like exonuclease 2 (hDis3L2, 
885 aa) (Astuti et al, 2012; Staals et al, 2010; Tomecki et al, 2010). Of these three proteins, 
hDis3 shows the highest level of sequence similarity with yeast Dis3 (Figure 1). Further 
analysis of the sequences by pattern and profile searches revealed a conserved PIN domain 
in the yeast and human Dis3 proteins, while several residues crucial for the endonucleolytic 
potential of this domain were absent in hDis3L1 and hDis3L2 (Staals et al, 2010; Tomecki et 
al, 2010). All Dis3 proteins contain a highly conserved RNB domain, which has been shown to 
be essential for their 3’-5’ exoribonuclease activity (Astuti et al, 2012; Dziembowski et al, 2007; 
Staals et al, 2010; Tomecki et al, 2010). A putative nuclear localization signal was identified in 
the C-terminal region of hDis3: PKKKKM (aa 949 to 954). 
The unstable interaction with the exosome core (Staals et al, 2010; Tomecki et al, 2010) 
argues for an exosome-independent role of hDis3 in RNA metabolism. To obtain more insight 
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in the role of hDis3 in cellular processes, we characterized its enzymatic activity, studied 
its interaction with other proteins and performed a global analysis of mRNAs affected by a 
reduction of hDis3 levels.
Results
Dis3 expression in primate cell lines
The human Dis3 polypeptide has a molecular mass of 109 kDa and a theoretical isoelectric 
point of 6.7. Nucleotide sequence database searches revealed a putative isoform of hDis3 
in which amino acids 78-129 are replaced by VSAWRPGTWASVASSLRLPGSL, most likely as a 
result of an alternative splicing event (GenBank acc. number: NM_001128226). This results 
in a hDis3 isoform with a molecular mass of 105 kDa. Interestingly, the alternative elements 
are located within the PIN domain and thus may affect the endonucleolytic activity of this 
domain and/or the binding to the exosome core.
A polyclonal antibody to hDis3 detected two polypeptides in HEp-2 cell lysates, migrating 
at approximately 110 kDa and 85 kDa in SDS-PAGE gels (Figure 2A, lane 1). siRNA-mediated 
knockdown of hDis3 resulted in a significant reduction of the 110 kDa signal (Figure 2A, lane 
3), indicating that the 110 kDa band represents hDis3 and that the 85 kDa band is probably 
due to cross-reactivity of the antiserum. As controls, siRNAs for EGFP and the exosome-
associated protein MPP6 were used, and these did not detectably affect hDis3 expression 
levels (Figure 2A, lanes 1 and 2). 
To further investigate the expression of hDis3, extracts of several different primate cell lines 
were analyzed by western blotting. The 110 kDa Dis3 protein appeared to be expressed at 
similar levels in all cells analyzed (Jurkat, a human T lymphocyte cell line; COS-1, a monkey 
kidney cell line; HEK293, a human embryonic kidney cell line; HEp-2, a human epithelial 
cell line; HL60, a human promyelocytic cell line; Figure 2B). Searching the BioGPS database 
(Wu et al, 2009) revealed that hDis3 expression was detected in all of the 79 different human 
tissues that were analysed at the mRNA level, indicating that hDis3 is indeed ubiquitously 
expressed. The RT-PCR primers used to generate this dataset cannot differentiate between the 
Figure 1. Yeast and human Dis3 and Dis3-like sequence alignment.
A multiple alignment of the amino acid sequences of yeast Dis3 (yDis3), human Dis3 (hDis3), human Dis3-like 1 
(hDis3L1) and human Dis3-like 2 (hDis3L2) was generated by the MUSCLE algorithm. The secondary structure of 
hDis3L1, as predicted by PsiPred, is depicted below the sequence alignment; β-strands are represented with 
green arrows and α-helices with red bars. Protein domains predicted by SMART are indicated by colored boxes 
surrounding the sequences. The putative NLS of hDis3, “PKKKKM”, is indicated as well. The graphical presentation 
of the alignments was generated with Jalview (Waterhouse et al, 2009) using the default color scheme used for 
alignments in Clustal X.
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Figure 2. The human Dis3 protein is an unmodified 110 kDa protein, which is ubiquitously expressed 
in various primate cell lines.
A) Total cell extracts of HEp-2 cells transiently transfected with siRNAs directed against EGFP (lane 1), MPP6 (lane 
2) or hDis3 (lane 3) were separated by SDS-PAGE and analyzed by western blotting, using anti-hDis3 antibodies. A 
monoclonal anti-γ-tubulin antibody was used as a control. The position of molecular weight markers (in kDa) are 
indicated on the left. (B) Total cell extracts of Jurkat, COS-1, HEK293, HEp-2 and HL60 cells were analyzed by western 
blot using the anti-hDis3 antibodies. (C) A total cell extract of HeLa cells was fractionated by isoelectric focusing 
using a non-linear gradient from pH 3.0 to pH 10.0, followed by SDS-PAGE and western blotting. Subsequently, the 
human Dis3 protein was identified by immunoblotting using anti-hDis3 antibodies. A sample of the HeLa cell extract 
(“Input”) was separated in parallel during SDS-PAGE as a reference.
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‘canonical’ hDis3 transcript and the splice variant described above. Searching for sequences 
specific for the shorter isoform in EST databases suggested that this isoform is expressed 
in testis, brain and lymph node tissues, suggesting that this isoform is not ubiquitously 
expressed. Two-dimensional IEF/SDS-PAGE analysis with a HeLa total cell extract, followed 
by immunoblotting resulted in the detection of only a single spot, suggesting that the 
majority of hDis3 molecules is not modified by post-translational modifications affecting the 
charge of the protein (Figure 2C). Also here, only 1 band was visible, most likely representing 
the longer isoform.
hDis3 is a hydrolytic 3’-5’ exoribonuclease 
To study the exonucleolytic activity of the hDis3 protein, lysates of HEp-2 cells transiently 
transfected with EGFP or EGFP-hDis3 were subjected to immunoprecipitation with anti-
GFP antibodies. Subsequently, the immunoprecipitated material was used in an in vitro 
exoribonuclease assay using either low (0.02 mM, Figure 3A) or high (5 mM, Figure 3B) MgCl2 
concentrations. The immunoaffinity-purified EGFP-hDis3 (Figure 3A, lanes 5-7) appeared to 
be highly efficient in degrading a structured RNA substrate, the 5.8S rRNA joined to the first 50 
nts of the ITS2 (internal transcribed spacer 2) of the rRNA precursor. The ribonuclease activity 
associated with EGFP-hDis3 was strongly reduced in the presence of relatively high MgCl2 
(5mM) concentrations (Figure 3B, lanes 5-7), which resembles the Mg2+-requirements found 
for hDis3L1 (Staals et al, 2010) and Dis3L2 (Chapter 6). 
Based upon the sequence similarity of hDis3 and RNase II it is expected that hDis3 is a hydrolytic 
enzyme. In order to discriminate between phosphorolytic and hydrolytic exoribonuclease 
activity, which results in the production of nucleotide diphosphates and monophosphates, 
respectively, the reaction products of the EGFP-hDis3 immunoprecipitates were analyzed 
by thin-layer chromatography (Figure 3C). The results showed that only UMP was produced 
(note that only radiolabeled UTP was used to generate the substrate RNA), indicating that 
hDis3 is indeed a hydrolytic 3’-5’ exoribonuclease.
To rule out the possibility that the observed 3’-5’ exoribonuclease activity associated with 
EGFP-hDis3 was due to a co-purified exoribonuclease, a substitution mutant of hDis3 was 
generated in which a conserved aspartic acid (position 487) was replaced by an alanine 
(D487A, see Figure 1). This residue was chosen because it is predicted to be part of the 
catalytic site of hDis3 and has been shown to be essential for the exoribonuclease activity 
(Dziembowski et al, 2007; Tomecki et al, 2010). EGFP-hDis3-D487A was immunoprecipitated 
with anti-GFP antibodies from transiently transfected HEp-2 cells and incubated with the 
substrate RNA in the presence of 0.02 mM MgCl2. The results in Figure 4A show that this 
mutation completely abolished the exoribonuclease activity of EGFP-hDis3. The lack of 
activity is not due to differences in expression levels, because both the wild-type and mutant 
hDis3 fusion proteins were expressed to comparable levels (Figure 4B). From these results we 
conclude that hDis3 indeed acts as a hydrolytic 3’-5’ exoribonuclease. 
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Figure 3. hDis3 is associated with hydrolytic exoribonuclease activity.
(A) Total cell extracts were prepared from transiently transfected HEp-2 cells expressing EGFP or EGFP-hDis3. 
Using anti-GFP antibodies, the precipitated complexes were analyzed for exoribonuclease activity by incubating 
a randomly 32P-labelled substrate RNA at different MgCl2 concentrations at 37°C. Samples were taken at 30, 60 and 
90 minutes and analyzed by denaturing gel electrophoresis. The untreated RNA-substrate (input) was uses as a 
control. (B) Thin layer chromatography analysis of the reaction products of EGFP and EGFP-hDis3 obtained after 
incubation for 90 minutes at low (0.02 mM) or high (5.0 mM) MgCl2. Unlabeled UMP, UDP and UTP were visualized by 
UV-shadowing which were used as markers and are indicated on the right.
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The RNA substrate used in the experiments described above was degraded very efficiently 
in a processive manner. This 5.8S rRNA containing molecule has a relatively high GC content 
(~63%). To investigate whether hDis3 displays substrate specificity, several other RNAs were 
used in the in vitro assay, including 5’-end labeled poly(A) and poly(U) homopolynucleotides 
and a randomly labeled U3 snoRNA. In all cases the wild type hDis3 degraded the RNA 
substrates in a processive manner, whereas the hDis3-D487A mutant did not detectably affect 
these RNAs (Figure 4C). In contrast to the uniform sizes of the degradation products obtained 
with the 5.8S rRNA, poly(A) and poly(U) substrates, the U3 snoRNA substrate was converted 
to differently-sized degradation products. The migration distance on the gel suggests that 
these products are very small in size, arguing against the possibility that this is a result of 
secondary structures in the U3 snoRNA substrate. These data indicate that hDis3 is capable 
to degrade various RNAs irrespective of the nucleotide sequence.
Knockdown of hDis3 results in reduced cell growth
Previously, it has been shown that human exosome core components such as hRrp41 
are essential for normal cell proliferation (van Dijk et al, 2007). Also in yeast it has been 
demonstrated that exosome core components, as well as Dis3, are essential for cell survival 
(Mitchell et al, 1997). This prompted us to investigate the effect of hDis3 depletion on cell 
growth. HEp-2 cells were transfected with siRNAs specific for hDis3, hRrp41, PM/Scl-100, and 
EGFP, and proliferation was determined by cell counting at several time points (24, 48 and 
72 hours) after transfection. Knockdown of hRrp41 strongly inhibited cell growth, whereas 
moderately reduced growth rates were observed upon knockdown of hDis3 and PM/Scl-100 
(Figure 5). The results suggest that although hDis3 and PM/Scl-100 are required for efficient 
cell growth, they are probably not essential for this process.
hDis3 associates with splicing factor SF3a60 in an RNA independent manner
The relatively weak association of hDis3 with the exosome core under physiological conditions 
suggested that it exerts at least some of its activities independently of the exosome. To 
obtain more insight into an exosome-independent role of hDis3 in human cells, VSV-tagged 
hDis3 was purified from transiently transfected HEp-2 cells using anti-VSV antibodies. After 
separation by SDS-PAGE and subsequent in-gel digestion, the (co-)precipitated proteins were 
analyzed by LC-MS/MS. As a control, material from extracts of HEp-2 cells transfected with 
the ‘empty’ VSV-tag encoding plasmid was analyzed in parallel. The identified proteins co-
purifying with VSV-hDis3 are listed in Table 1. Strikingly, many of these proteins are involved 
in one of the different stages of pre-RNA processing and/or pre-mRNA splicing in the nucleus.
To confirm the interaction of hDis3 with proteins involved in nuclear RNA metabolism, 
immunoprecipitations were performed using a total HEp-2 cell extract and antibodies 
directed against several proteins involved in pre-mRNA processing: hnRNP H (heterogeneous 
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Figure 4. hDis3 is a processive, 3’-5’ exoribonuclease, which no apparent substrate specificities.
(A) EGFP (control), EGFP-hDis3 and EGFP-hDis3-D487A were purified from transiently transfected HEp-2 cells with 
anti-GFP antibodies and analyzed in an in vitro exoribonuclease assay using 0.02mM MgCl2. Samples were taken 
at 30, 60 and 90 minutes and analyzed by denaturing gel electrophoresis. The untreated RNA-substrate (input) 
was loaded as a control. (B) SDS-PAGE analysis of expressed EGFP-hDis3-WT and EGFP-hDis3-D487A using anti-
hDis3 antibodies. In lanes 1-3 cell extracts were loaded before immunoprecipitation (IP) with anti-GFP-antibodies, 
whereas in lanes 4-6 cell extracts were loaded after IP with anti-GFP-antibodies. (C) EGFP-hDis3-WT and EGFP-hDis3-
D487A were purified from transiently transfected HEp-2 cells with anti-GFP antibodies and analyzed in an in vitro 
exoribonuclease assay using 0.02mM MgCl2 and radiolabeled poly(A), poly(U) and U3 snoRNA as RNA substrates. 
Samples were taken at 5, 10, 20 and 40 minutes and analyzed by denaturing gel electrophoresis. The untreated RNA-
substrate (input) was loaded as a control.
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Figure 5. Dis3 is not essential for cell proliferation.
The exoribonucleases hDis3, PM/Scl-100 and an exosome core subunit (hRrp41) were downregulated by siRNA 
transfection and the effects on proliferation of the HEp-2 cells was assessed by cell counting. Knockdown of EGFP 
was used as a control. Cells were harvested and counted 24, 48, and 72 h after siRNA treatment.
nuclear ribonucleoprotein H), PABP1 (polyadenylate-binding protein 1) and SF3a60 (splicing 
factor 3A subunit 3). In parallel, the exosome complex was immunoprecipitated by antibodies 
to hRrp40 and an immunoprecipitation with NRS (normal rabbit serum) served as a negative 
control. Co-precipitation of hDis3 was visualized by probing western blots with anti-hDis3 
antibodies. Like hRrp40, hnRNP H and PABP1 did not detectably interact with hDis3 (Figure 
6A). In contrast, hDis3 efficiently co-precipitated with SF3a60. To provide further evidence for 
the hDis3-SF3a60 interaction, the reverse experiment was performed with material from HEp-
2 cells transiently transfected with VSV-hDis3, VSV-hRrp46 or the ‘empty’ VSV-tag encoding 
plasmid. The cell extracts were subjected to immunoprecipitation with anti-VSV antibodies 
and the precipitated complexes were analyzed by western blotting using the anti-SF3a60 
antibody. Indeed SF3a60 co-precipitated with VSV-hDis3, whereas no SF3a60 was detected 
in material immunoprecipitated from the control cell extracts (Figure 6B). 
To investigate whether the interaction between hDis3 and SF3a60 is dependent on RNA, 
immunoprecipitations were performed with HEp-2 cell extracts pretreated with RNase A and 
RNase T1. Antibodies to SF3a60 co-precipitated hDis3 irrespective of pretreatment of the cell 
extracts with RNases (Figure 6C). These results indicate that hDis3 interacts with SF3a60 in an 
RNA-independent manner.
Global mRNA analysis upon hDis3 depletion
The results described above indicate that hDis3 displays exoribonuclease activity, which does 
not seem to be (stably) associated with the exosome. Instead, the activity of hDis3 seems to 
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Figure 6. Dis3 interacts with SF3a60 in an RNA-independent manner.
(A) Total HEp-2 cell extracts were used for immunoprecipitations using anti-SF3a60 (lane 2), anti-PABP-1 (lane 3), anti-
hnRNP H (lane 4) and anti-hRrp40 (lane 5). A normal rabbit serum (NRS) was used as a control (lane 6). Precipitated 
proteins were analyzed by western blotting using anti-hDis3 antibodies (upper part) or anti-hRrp4 antibodies 
(lower part). Input material (10%) of the extract was loaded in lane 1 as a control. (B) HEp-2 cells were transiently 
transfected with VSV-hDis3, VSV-hRrp46 and VSV (control) constructs and the expressed VSV-tagged proteins were 
purified with anti-VSV antibodies. The precipitated protein complexes were analyzed by western blotting using anti-
SF3a60 antibodies. A total HEp-2 cell extract (10%) was loaded in lane 1. The positions of molecular mass markers 
(kDa) are indicated on the left. (C) HEp-2 cell extracts, either treated with or without RNase A and RNase T1, were 
used for immunoprecipitations using anti-SF3a60 antibodies (lanes 5-6) or a normal rabbit serum (NRS) as a control 
(lanes 3-4). The precipitated proteins were analyzed by western blotting using anti-hDis3 antibodies. Input material 
(10%) of the treated or untreated extracts was loaded in lanes 1 and 2, respectively.
be associated with the splicing factor SF3a60, hinting at a possible role of hDis3 in pre-(m)
RNA processing and/or surveillance events. As such, this putative exosome-independent 
activity is likely to affect at least in part other substrates than those degraded/processed in an 
exosome-dependent fashion. To investigate this issue, changes in mRNA levels resulting from 
knocking down hDis3, hRrp41 (resulting in destabilization of the exosome core complex) and 
PM/Scl-100 were determined by microarray analyses. Forty hours after siRNA transfection 
reduced protein levels were demonstrated by western blotting (data not shown). After RNA 
isolation from extracts of these cells, oligo(dT)-primed cDNAs were analyzed by a microarray 
containing probes for 21,000 human protein-coding genes. The number of upregulated and 
downregulated mRNAs (p<0.05) was similar for each of the depletions, although depletion 
of PM/Scl-100 resulted in a slightly lower number of affected transcripts (Figure 7A). After 
clustering of the significantly affected transcripts, a heat map was generated (Figure 7B). 
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This revealed that a number of mRNAs were similarly affected upon depletion of all three 
proteins, but that the overlap for hRrp41 and PM/Scl-100 was much larger than that for either 
of these proteins with hDis3. 
Previous results (association with SF3a60 and the nuclear localization of hDis3) indicated 
that the activity of hDis3 might be associated to the pre-RNA processing events occurring in 
the nucleus. If hDis3 through its association with the splicing machinery is involved in pre-
mRNA splicing, the depletion of hDis3 might cause a decrease in mature mRNAs. In view of 
the experimental approach to deplete hDis3, mRNAs with a high turnover rate are expected 
to be more strongly affected than relatively stable mRNAs. To investigate this, we categorized 
the expected half-lives of ~5200 mRNAs (Yang et al, 2003), and determined the ratio of up- and 
downregulated mRNAs identified by the microarray analysis for these categories (Figure 7C). 
This analysis revealed that mRNAs with a high turnover rate were stabilized upon depletion 
of hRrp41 or PM/Scl-100 when compared to relatively stable mRNAs. Depletion of hDis3, 
however, did not seem to affect the stability of mRNAs with a high turnover rate, because the 
ratio of up- and downregulated mRNAs was similar for all three categories.
Taken together, the mRNA population affected by hDis3 depletion shows only a limited overlap 
with the mRNAs up- or downregulated by hRrp41 and PM/Scl-100 depletion, consistent with 
an exosome-independent function of hDis3 in mRNA metabolism. In addition, no relation 
between the turnover rate of mRNAs and hDis3 functioning was observed, in contrast to the 
exosome and the associated PM/Scl-100 exonuclease, which appear to be more strongly 
involved in the degradation of relatively instable mRNAs.
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Figure 7. Global changes of mRNA levels due to hRrp41, PM/Scl-100 or hDis3 downregulation.
(A) Absolute number of significantly affected mRNA transcripts, resulting from the knockdown of hRrp41, PM/Scl-100 
or hDis3. The blue bars represent the number of transcripts that were significantly (p<0.05) upregulated, while the 
yellow bars represent the significantly downregulated transcripts. (B) Heatmap of mRNAs that were significantly 
(p<0.05) affected by hRrp41, PM/Scl-100 or hDis3 depletion. Clustering of the data was performed using the self-
organizing maps algorithm. Blue bars represent upregulated transcripts and yellow bars represent downregulated 
transcripts. (C) The mRNA decay rates (transcripts per hour) were categorized to include slow (0-0.2), moderate (0.2-
0.5) and fast (0.5-10) decaying mRNAs. The ratio of the number of upregulated to downregulated mRNAs (belonging 
to a particular mRNA decay category) was calculated for each of the depleted proteins. The number of transcripts 
that were used to calculate these ratios are indicated above the bars.
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Discussion
The presence of three distinct Dis3(-like) genes in humans indicates that the ribonuclease 
activity of the exosome is more complex than in yeast, in which Dis3 has been identified as a 
major exosome-associated ribonuclease. In this study we explored the functional activities 
of hDis3, which in agreement with previous studies displays only relatively weak interactions 
with the exosome core (Staals et al, 2010; Tomecki et al, 2010). In contrast to the yeast Dis3 
protein, hDis3 does not appear to be essential for cell proliferation. The RNA-independent 
association of hDis3 with the pre-mRNA splicing factor SF3a60 points to a role for this human 
Dis3 variant in pre-mRNA processing.
The exoribonuclease activity of hDis3
The EGFP-hDis3 fusion protein efficiently degraded several different RNA substrates with no 
apparent sequence-specificity (Figure 4). The exoribonuclease activity of hDis3 appeared 
to be processive and not substantially hampered by secondary structures in the RNA 
substrate, since no intermediate RNA degradation products were observed, similar to what 
has been reported for yeast Dis3 (Dziembowski et al, 2007). For the yeast Dis3 protein it 
was demonstrated that the energy required to unwind such structures is provided by the 
hydrolysis of the substrate strand, which might also be the case for hDis3 (Lee et al, 2012).
The ribonuclease activity associated with the immunoaffinity-purified hDis3 preparations, 
which are devoid of detectable exosome proteins, strongly suggests that hDis3 is an active 
3’-5’ exoribonuclease acting independently of the exosome. A recent study showed that 
the activity of yeast Dis3 is modulated by its association with the exosome core complex 
(Wasmuth and Lima, 2012). Since the human Dis3 protein does not appear to be stably 
associated to the human exosome, it likely that the activity of hDis3 is regulated by other 
yet unknown mechanisms. In addition to enzymatic activity regulatory mechanisms, the 
proper subcellular localization will affect the population of substrates that can be converted 
by hDis3. However, little is known on the intracellular transport of the hDis3 protein. The 
clustering of basic residues in the C-terminal region (Figure 1) suggests that this region may 
contain a nuclear localization signal. Indeed, removal of this part of hDis3 showed that this 
region is important for its nuclear accumulation and fusion of this part to a reporter protein 
resulted in nuclear accumulation of the reporter (data not shown). In addition, we found 
that ectopically expressed VSV-hDis3 interacted with the importin beta-1 subunit (Table 1). 
Consistent with these data, in both yeast and Drosophila melanogaster, an interaction of Dis3 
with a member of the importin protein family has also been reported (Graham et al, 2009; 
Mamolen et al, 2010; Synowsky et al, 2009). Taken together, these results strongly suggest 
that hDis3 is actively transported to the nucleus.
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Association of Dis3 with SF3a60
Since our results indicate that the human Dis3 protein can function in an exosome-
independent manner, we set out to find other proteins associated with hDis3 to gain more 
insight into its biological role. The results showed that hDis3 is associated with SF3a60 (also 
referred to as SF3a3) and potentially other proteins involved in pre-RNA processing. SF3a60 
is a constituent of the SF3A splicing factor, which is required for pre-spliceosome formation 
and assembly of the 17S U2 snRNP (Nesic and Kramer, 2001; Tanackovic and Kramer, 2005). 
The SF3A splicing factor contributes to U2-type branch site recognition and is essential for 
pre-mRNA splicing in humans (Tanackovic and Kramer, 2005). Consistent with the subcellular 
localization of hDis3, SF3A is localized in the nucleoplasm and excluded from the nucleoli 
(Huang et al, 2011).
Considering the enzymatic activity of hDis3, it is tempting to speculate that hDis3 is involved 
in RNA processing and/or nuclear RNA surveillance pathways associated with the major 
spliceosome. The disturbance of the correct assembly of the spliceosome or the stalling of 
splicing might trigger an mRNA surveillance mechanism involving hDis3 and SF3a60 leading 
to degradation of the pre-mRNA. On the other hand, the activity of hDis3 might also be directly 
involved in RNA processing, where SF3a60 could recruit hDis3 to the 3’ end of (debranched) 
introns, followed by 3’-5’ degradation.
If hDis3 indeed has a role in pre-mRNA processing in the nucleus, hDis3 down-regulation 
may retard the maturation of these RNAs and the subsequent export to the cytoplasm. It is 
therefore anticipated that such perturbation would decrease rather than increase the level 
of mature mRNAs in the cytoplasm. This could (partly) explain the lower ratio of up- versus 
downregulated mRNAs in our microarray analyses when hDis3 levels were reduced than that 
observed after the depletion of exosome(-associated) proteins.
In support of our hypothesis that hDis3 is actively involved in pre-mRNA processing and/or 
surveillance pathways are two studies that recently addressed the possible RNA substrates of 
Dis3 in yeast, either by sequence analysis of UV-crosslinked RNAs, or by transcriptome-wide 
tiling microarrays (Gudipati et al, 2012; Schneider et al, 2012). In both studies, Dis3 was found 
to be associated with the intronic regions of the nuclear pre-mRNAs. These studies showed 
that more than half of the pre-(m)RNAs are degraded in a Dis3-dependent manner before 
splicing could finish. This surprising observation indicates that the level of mature RNA is 
the result of competition between processing and degradation and that pre-RNAs that fail to 
mature timely are quickly degraded by Dis3.
The interaction of hDis3 with components of the splicing machinery formed on pre-mRNA 
has been observed before (Rappsilber et al, 2002), although the role of hDis3 was not 
addressed. Its interaction with SF3a60 might therefore provide more clues to pinpoint its 
exact role. For instance, it has been shown that SF3a60 is involved in efficient linking of active 
transcription to proteins and/or complexes involved in post-initiation processes such as pre-
mRNA splicing (Sims et al, 2007). The presence of hDis3 in these protein assemblies might 
therefore be an important source of endo- and/or exoribonuclease activity that might be 
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required for these processes. Interestingly, it has recently been postulated that the activity of 
the nuclear exosome is recruited to a subcomplex of the major spliceosome: the U4/U6.U5 
tri-snRNP (Nag and Steitz, 2012). It was proposed that this activity might also be important 
for pre-mRNA processing and/or degradation of aberrant transcripts. Therefore, studying 
the identity and regulation of the ribonuclease activities associated with nuclear pre-mRNA 
processing in more detail is interesting, yet challenging.
Finally, it is noteworthy to mention that the interaction between hDis3 and SF3a60 does not 
automatically point towards a role for hDis3 in splicing events, as splicing complexes have 
been implicated in other processes as well, as exemplified by the splicing factor Spf30. This 
protein also associates with spliceosomes (including the U2 snRNP) and was shown to play 
a role in heterochromatin assembly and the silencing of these and centromeric regions of 
the chromosome in fission yeast (Bernard et al, 2010). The authors proposed a model where 
Spf30 is recruited towards these silenced regions in a Dis3-dependent manner. Together with 
the exosome, these proteins were found to be required for the silencing of these regions, 
as (polyadenylated) centromeric transcripts accumulated when Dis3, the exosome or Spf30 
was mutated. The putative role of hDis3 in the surveillance of pre-mRNA molecules, its exact 
role in the splicing process and/or other processes requiring SF3a60 now awaits further 
investigations.
In conclusion, the results of this study demonstrate that the human Dis3 protein displays 
somewhat different features when compared to its closest homologue in yeast. In contrast 
to the essential role of Dis3 in cell survival in yeast, human cells survive hDis3 depletion, 
as witnessed by the moderate growth defects that were observed. However, the possibility 
that this relatively mild phenotype is a result of an incomplete knockdown should not be 
disregarded. The finding that hDis3 is confined to the nucleoplasm together with the recent 
discovery of two additional homologues that are expressed in higher eukaryotes, hDis3L1 
and hDis3L2 (Staals et al, 2010; Tomecki et al, 2010), suggest a functional diversification 
of the different hDis3(-like) proteins. hDis3L1 has been reported to associate stably with 
the cytoplasmic exosome core and plays a role in the degradation of rRNAs and other 
cytoplasmic RNAs. hDis3L2 is not associated with the exosome core and appears to be 
involved in controlling the levels of specific RNAs that are important for mitotic progression 
(Astuti et al, 2012) and proliferation (Chang et al, 2013). In addition, hDis3L2 was found to be 
located at or near P-bodies, where it was shown to be involved in polyuridylation-stimulated 
RNA decay (Lubas et al, 2013; Malecki et al, 2013). The functions of hDis3 still remain to be 
elucidated, although the results presented here point towards a role in pre-mRNA processing 
and/or surveillance.
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Methods
Bioinformatics
Prediction of functional domains was done using the Pfam protein family database (Punta et 
al, 2012). Sequence database searching was performed by BLAST using GenBank databases 
containing either ESTs or genomic sequence information. The graphical presentation of the 
multiple sequence alignments was generated with Jalview (Waterhouse et al, 2009) using the 
default color scheme used for alignments in Clustal X.
hDis3 expression constructs
The cDNA encoding hDis3 (GenBank accession number: NP 055768) was kindly provided by 
Dr. T. Nishimoto and the hDis3 coding sequence was subsequently cloned into the pCI-neo-
5′-VSV and pEGFP-C3 vectors. The mutant hDis3 protein in which the aspartic acid at position 
487 was changed into an alanine was created by using the Quick Change Site-directed 
mutagenesis kit (Stratagene), to generate the EGFP-hDis3-D487A construct.
Transient transfection and preparation of cell extracts 
HEp-2 cells were grown to 70% confluency in DMEM containing 10% fetal calf serum (FCS) 
(DMEM+). For immunoprecipitation, approximately 10 x 106 cells were transfected with 
30 µg of plasmid DNA in 850 µl of DMEM+ by electroporation at 260 V and 950 µF using a 
Gene-Pulsar II (Bio-Rad). After transfection, cells were seeded in 75-cm2 culture flasks and 
cultured overnight in DMEM+. The trypsinized cells were washed with PBS, after which total 
cell extracts were prepared by resuspending the cells in lysis buffer (25 mM Tris-HCl, pH 7.5, 
150 mM KCl, 1 mM EDTA, 0.5 mM PMSF, 1 mM DTT and 0.05% NP-40) and sonicated using a 
Branson microtip, followed by centrifugation for 5 min at 16,000 x g.
Immunoprecipitation
Polyclonal antibodies from rabbits (anti-SF3a60, anti-hRrp40, anti-GFP, anti-PABP-1 and 
anti-hnRNP H) and human autoimmune patients (α-PM/Scl-positive and α-PM/Scl-negative) 
were coupled to protein-A agarose beads (Kem-en-Tec) in IPP500 (500 mM NaCl, 10 mM Tris-
HCl, pH 8.0, 0.05% NP-40) by incubation for 1 h at room temperature. Similar conditions 
were used to couple monoclonal mouse anti-VSV-tag antibodies to protein G-agarose beads. 
Beads were washed twice with IPP500, and twice with IPP150 (composition similar to IPP500, 
but containing 150 mM instead of 500 mM NaCl). For each immunoprecipitation equal 
amounts of cell extract were incubated with the antibody-coupled beads for 2 h at 4o C in 
the absence or presence of RNase A (10 g/ml) and RNase T1 (100 U/ml). Subsequently, beads 
were washed four times with IPP150, and co-immunoprecipitated proteins were analyzed by 
western blot analysis or used in an exoribonuclease activity assay.
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Western blot analysis
For western blot analysis, proteins were separated by SDS-PAGE, and transferred to 
nitrocellulose membranes. In order to visualize the proteins, blots were incubated with 
the mouse monoclonal antibodies anti-hRrp4 (Modiquest) and anti-γ-tubulin, or with the 
mouse polyclonal antibody anti-hDis3 (Abnova), or with the rabbit polyclonal antibodies 
anti-hRrp40 and anti-SF3a60 in blocking buffer (5% skimmed milk, PBS, 0.05% NP-40). The 
anti-hDis3 antibody recognizes the C-terminal part (amino acids 851 to 956) of hDis3. As 
secondary antibody, horseradish peroxidase-conjugated goat anti-mouse IgG or goat anti-
rabbit IgG (Dako Immunoglobulins) was used, 2500-fold diluted in blocking buffer. Bound 
antibodies were visualized by chemiluminescence.
2D isoelectric focusing / SDS-PAGE
A total cell extract of HeLa cells (approximately 100 μg) was separated in one dimension by 
isoelectric focusing using IPG strips with a non-linear pH gradient from 3 to 10 (Amersham 
Biosciences), followed by separation in the second dimension by SDS-PAGE. Separated 
proteins were transferred to nitrocellulose membranes by western blotting.
Exoribonuclease activity assay
Immunoprecipitated material (bound to the protein A or protein G agarose beads) were 
washed once with buffer A (10 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2 , 1 mM Na2HPO4, 
0.5 mM MnCl2, 0.5 mM DTT) or buffer B (same composition as buffer A only containing 0.2 mM 
MgCl2). 
32P-labeled RNA substrate (approx. 100 ng) was added to the immunoprecipitated 
material, and the suspension was incubated at 37 °C. Formamide loading buffer was added 
to 10 µl samples taken at different time points, heated for 2 minutes at 70 °C and placed 
on ice. Reaction products were analyzed by denaturing polyacrylamide gel electrophoresis 
(15% acrylamide, 7M urea in 0.5x TBE) followed by autoradiography. Two RNA substrates 
were generated by in vitro transcription in the presence of 32P-labeled UTP. The human 5.8S 
rRNA containing in addition 50 nts of the ITS2 at the 3’-end was generated by linearizing the 
corresponding plasmid construct with BamHI followed by in vitro transcription using T7 
RNA polymerase. The U3 snoRNA was transcribed in vitro using T7 RNA polymerase and a 
KpnI-linearized pUC19-U3CD plasmid as template, as described previously (Granneman et 
al, 2002). Poly(A) and poly(U) RNA substrates were 5’-end labeled using T4 polynucleotide 
kinase and [γ-32P]ATP (Schilders et al, 2007). Labeled RNAs were separated by denaturing 
polyacrylamide gel electrophoresis, after which the corresponding band was excised and 
eluted from the gel.
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RNA interference and cell growth assay
An siRNA duplex (containing 3’ dTdT overhangs) was generated based upon the coding 
region of the human Dis3 sequence described above: 5’- GCCUACAGGUAGAGUUGUAdTdT-3’. 
The siRNAs for human MPP6, PM/Scl-100, and hRrp41 were identical to those described 
previously (Lejeune et al, 2003; Schilders et al, 2005; van Dijk et al, 2007). For the siRNA 
treatment, approximately 3 x 105 HEp-2 cells were transfected with 100 pmol of siRNA using 
Oligofectamine transfection reagent (Invitrogen) as described by the manufacturer with 
the exception that during transfection 10% FCS was present in the medium. As a control, 
cells were transfected with a siRNA directed against EGFP. For the analysis of effects on cell 
growth, cells were harvested and counted with a Coulter AC-T series analyzer.
Microarray analysis
HEp-2 cells seeded in 6-well plates were transfected with siRNAs targeting hRrp41, PM/Scl-100 
or hDis3, essentially as described above. MilliQ water instead of siRNA solution was used in a 
control transfection. After 40 hours incubation the cells were harvested by trypsinization and 
centrifugation and the cells were resuspended in Trizol (Invitrogen) for isolation of total RNA, 
according to the manufacturer’s recommendations. Subsequently, the total RNA was further 
purified by the RNeasy kit (Qiagen). Roughly 10 ug of total RNA was used for cDNA synthesis 
and hybridization on a custom microarray chip (UMCU human oligo v2.0), containing 21,000 
different human mRNA probes (van de Peppel et al, 2003). Each knockdown was performed 
independently in duplicate and two microarrays were used per knockdown for the dye-
swap correction (Cy3/Cy5). Significantly changed transcripts (p<0.05) were expressed as 
fold-changes relative to the control (EGFP) siRNA transfection. Data was further processed 
in Excel. Clustering of the significantly affected transcripts was performed with Cluster 
(Eisen et al, 1998), using the self-organizing maps algorithm. Heat maps of the resulting 
clustered data were made in Treeview (Saldanha, 2004). mRNA decay rates were extracted 
from Supplementary Table 9 from the Yang et al. study (Yang et al, 2003) and mapped to its 
corresponding Uniprot accession number for comparison with the microarray data.
LC-MS/MS
The gel containing the immunoaffinity-purified VSV-hDis3 was cut into 19 slices, proteins 
were reduced with 1,4-dithiothreitol (6.5 mM) and alkylated with iodoacetamide reagent 
(54 mM). After thorough washing, the gel slices were rehydrated in trypsin solution (10 ng/
μl) on ice. After addition of 30 μl of NH4HCO3 (50 mM, pH 8.5), samples were digested for 16 
h at 37°C. The supernatant of the digest was collected and the gel slices were washed for 
15 min in 5% formic acid at room temperature, after which the supernatant was combined 
with the earlier fraction and stored at −20°C. All LC-MS/MS analyses were performed on 
an LTQ-Orbitrap mass spectrometer (Thermo, San Jose, CA) connected to an Agilent 1200 
series nano-LC system. Peptides were fractionated on C18 with a multi-step gradient of 0.6% 
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HAc (solution A) and 0.6% HAc/80% acetonitrile (solution B). The mass spectrometer was 
operated in the data-dependent mode to automatically switch between MS and MS/MS. 
Raw MS data were converted to peak lists using Bioworks Browser software, version 3.1.1. 
All spectra were searched with Mascot against all human proteins in the Swissprot (v56.2) 
database with a precursor mass tolerance of 15 ppm and a product mass tolerance of 0.9 
Da with trypsin as an enzyme, allowing two miscleavages. Carbamidomethyl of cysteine 
was specified as a fixed modification. Deamidation of asparagine and glutamine, oxidation 
of methionine, acetylation of the n-terminus and phosphorylation of serine, threonine and 
tyrosine were specified in Mascot as variable modifications. Identifications were processed 
using Scaffold (Proteome Software) version 4.0.4. Peptide identifications were accepted if 
they could be established at greater than 95.0% probability by the Peptide Prophet algorithm 
and at a minimum Mascot score of 25. Protein identifications were accepted if they could be 
established at greater than 99.0% probability, as assigned by the Protein Prophet algorithm.
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Introduction
Almost two decades after its initial discovery in yeast, it is now well established that the 
exosome fulfills a fundamental role in many aspects of cellular RNA metabolism. Perhaps 
owing to its crucial role in the maturation and degradation of rRNA species (which are 
estimated to constitute as much as 75% of the total RNA population present in a living 
cell), the exosome is an evolutionary indispensable source of ribonuclease activity, which is 
reflected by the lethality that is associated with exosome-related knockouts (Allmang et al, 
1999a; Allmang et al, 1999b). Additionally, the omnipresence of exosome complexes and its 
structural analogues in all three domains of life (covered in Chapter 1), emphasizes this view 
even further. Despite the evolutionary pressure to retain the catalytic activity associated with 
the exosome complex, two decades of exosome-research have taught us that the way how 
this activity is achieved can be markedly different among species. 
The core of the exosome is a collection of proteins with potential 3’-5’ exoribonuclease 
and RNA-binding activities that are clustered within one moderately-sized protein complex 
of ~286 kDa (Liu et al, 2006). This complex can be subdivided in two moieties. Firstly, there 
is the ring-like structure, which is composed of six proteins that share homology with the 
bacterial 3’-5’ phosphorolytic exoribonuclease RNase PH. Secondly, three proteins harboring 
KH and/or S1 RNA-binding domains are located on one side of the ring structure. These RNA-
binding proteins are thought to form the entrance to a central channel in the exosome core, 
which spans the proteins that make up the ring-like structure. The width of this channel has 
been estimated to be just large enough to accommodate a single-stranded RNA molecule. 
Collectively, these proteins are dubbed the “exosome core” complex, as this particular 
structural setup has been conserved from eubacteria (when considering exosome-like 
complexes, such as PNPase) to archaea and eukaryotes. However, this is where the analogy 
between the complexes from different prokaryotic and eukaryotic lineages stops, as recent 
insights have shown that the modus operandi of the activity of the exosome complex in 
higher eukaryotes is differently organized.
The activity of the archaeal exosome complex resembles that of the eubacterial PNPase: 
the RNA substrate is guided towards and into the central channel where the active site is 
located. In the archaeal exosome complex, this active site is formed by the two RNase-PH-like 
proteins Rrp41 and Rrp42, which are located within the ring-structure (Lorentzen et al, 2005). 
Studies addressing the structure and activity of the yeast and human complexes, however, 
resulted in the remarkable conclusion that the eukaryotic exosome core is catalytically inert 
(Liu et al, 2006), suggesting that eukaryotic exosome complexes have lost the phosphorolytic 
activity associated with the (Rrp41-Rrp42)3 hexamer. Indeed, sequence analysis of archaeal 
and eukaryotic Rrp41 revealed that key residues involved in phosphate binding (Chapter 1, 
Figure 3) were not conserved in eukaryotes. An exception is the Rrp41 protein from plants, 
consistent with the phosphorolytic activity that was found to be associated with the plant 
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exosome core (Chekanova et al, 2000). The activity that was previously found to be associated 
with the yeast and human exosome complexes must therefore be provided by auxiliary 
proteins. Indeed, two different ribonucleases were identified and found to associate with the 
exosome core complex, thereby endowing it with ribonuclease activity: Rrp6 (PM/Scl-100 in 
humans) and Dis3 (Allmang et al, 1999b; Dziembowski et al, 2007). Similar to the subcellular 
distribution of the exosome core complex, yeast Dis3 was found in both the nuclear and the 
cytoplasmic compartments, making it a major source of ribonuclease activity for the yeast 
exosome (Dziembowski et al, 2007; Liu et al, 2006; Schaeffer et al, 2009). This role could not 
be attributed to Rrp6, since the protein only appeared to be present in the nucleus (Allmang 
et al, 1999b), suggesting that it exclusively operates in concert with the nuclear exosome. 
Since homologues of both proteins (PM/Scl-100 and hDis3) were also present in humans, it 
was predicted that the activity of the human exosome complex was provided by these two 
proteins in a similar fashion. The subcellular distribution of PM/Scl-100 overlaps with that of 
yeast Rrp6 in that it seems to be abundant to the nucleus (with the highest concentrations 
found in the nucleoli). On the other hand, and in contrast to yeast Rrp6, low amounts of 
PM/Scl-100 have also been reported to be situated in the cytoplasm of human (Lejeune et al, 
2003; Schilders et al, 2007; van Dijk et al, 2007), fly (Graham et al, 2009a) and protozoan (Haile 
et al, 2007) cells. This fraction might represent a free pool of PM/Scl-100 and/or PM/Scl-100 
associated with the cytoplasmic exosome. More importantly, the subcellular distribution of 
hDis3 was markedly different from that of yeast Dis3, with high levels only in the nucleoplasm 
and exclusion from the nucleoli and cytoplasm (Chapter 7). Moreover, previous attempts to 
co-purify the human exosome with hDis3 repeatedly failed (Allmang et al, 1999a; Chen et al, 
2001; Raijmakers et al, 2002). In other words, while nuclear exosome activity could potentially 
originate from either PM/Scl-100 or hDis3, the source of activity for the cytoplasmic exosome 
was still enigmatic.
Ribonuclease activity of the human exosome
This thesis focused on how the ribonuclease activities associated with the human exosome 
complex, which led to the identification and characterization of two additional members of 
the Dis3 family, which are not present in the yeast Saccharomyces cerevisiae and which are 
termed hDis3L1 and hDis3L2. In Chapter 3, we described the initial characterization of the 
hDis3L1 protein, which revealed that hDis3L1 is a hydrolytic 3’-5’ exoribonuclease, the activity 
of which was found to be associated with the exosome core. Moreover, hDis3L1 appeared to 
reside exclusively within the cytoplasm, which explains at least in part the exoribonuclease 
activity associated with the cytoplasmic exosome complex. Finally, we showed that also 
hDis3 can interact with the exosome core structure, although this particular interaction 
appeared to be less stable compared to the interactions of hDis3L1 and PM/Scl-100 with 
the exosome core. In Chapter 4, we addressed (one of) the cellular function(s) of hDis3L1 
by siRNA-mediated silencing. This approach revealed not only that hDis3L1 participates 
in cytoplasmic degradation of rRNA and mRNA species, but also uncovered a novel RNA 
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degradation route that involves the transient polyadenylation of rRNA and mRNA fragments 
that are destined for degradation. Since previous results indicated that three different 
exoribonucleases (PM/Scl-100, hDis3 and hDis3L1) could associate with the exosome, we 
set out to investigate the conditions and their influence on ribonuclease activity of these 
enzymes when bound to the exosome complex. The results from Chapter 5 showed that 
the regulation of activity of the exosome could be mediated by the Mg2+-concentration and 
ionic strength and that exosome-associated levels of hDis3L1 and PM/Scl-100 may influence 
one another. The results of this thesis provide a better understanding on how the activity 
of the human exosome is organized (Figure 1), especially when the cytoplasmic exosome is 
considered. The identification and characterization of multiple Dis3(-like) proteins not only 
revealed that the activity of the human exosome is differently organized when compared to 
its yeast counterpart, but also have major implications for cytoplasmic RNA processing and 
degradation processes that have previously been ascribed to the exosome core. This will be 
discussed in more detail below.
Exosomes and Dis3(-like) proteins in cytoplasmic RNA degradation
Over the years, many functions have been ascribed to the cytoplasmic exosome, most of 
which are focused on the turnover and surveillance of mRNA species. Especially for mRNAs 
with high turnover rates, the levels of mRNAs are strongly dependent on mRNA decay 
(Garneau et al, 2007). Generally speaking, mRNAs can be either degraded in a 5’-3’ fashion 
Figure 1. Subcellular distribution of the exosome-associated ribonucleases.
Schematic representation of the subcellular distribution of the human exosome in association with PM/Scl-100, 
hDis3 and hDis3L1. Non-exosome-associated pools of hDis3, hDis3L1 and PM/Scl-100 may exist in the nucleoplasm 
and cytoplasm, respectively (indicated with question marks).
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by Xrn1, or enter the 3’-5’ degradation route that involves the exosome and/or Ski complexes 
(Anderson and Parker, 1998; van Dijk et al, 2007; van Hoof et al, 2000). Also in cases where 3’-5 
degradation is stimulated by the cis-acting AU-rich elements in mammalian unstable mRNA 
transcripts, the cytoplasmic exosome plays a central role (Chen et al, 2001). The surveillance 
of mRNAs represents a process in which aberrant forms of messengers are recognized 
and promptly degraded. As already mentioned in Chapter 1, many different surveillance 
mechanisms involving the exosome are in place to detect different abnormalities within the 
mRNA body: NMD (nonsense mediated decay), NSD (nonstop mediated decay) and NGD (no-
go decay) (Doma and Parker, 2006; Mitchell and Tollervey, 2003; van Hoof et al, 2002). 
In view of the lack of catalytic activity of the human exosome core, the discovery of hDis3L1 
as a novel ribonuclease associated with the cytoplasmic exosome opens new doors to 
investigate whether hDis3L1 is involved in any of these processes. The results presented in 
Chapters 3 and 4 show that hDis3L1 is involved in a novel cytoplasmic decay route for rRNA 
and mRNA species. The depletion of hDis3L1 resulted in the accumulation of polyadenylated 
degradation intermediates, indicating that these molecules are genuine hDis3L1 substrates. 
Surprisingly, the exosome core seemed to be dispensable for this process, since no noticeable 
accumulation of these cytoplasmic degradation intermediates was observed when the 
exosome core components hRrp40 or PM/Scl-75 were depleted. This result might indicate 
that hDis3L1 can function in an exosome-independent manner, although the possibility that 
(incomplete) depletion of hRrp40 and PM/Scl-75 did not result in complete destruction of the 
exosome core cannot be excluded completely. Nevertheless, codepletion of other exosome 
core subunits has been observed previously for PM/Scl-75 (van Dijk et al, 2007). Alternatively, 
the depletion of individual exosome core components does not always have the same 
outcome on RNA degradation, as it has been shown for ARE-mediated mRNA decay, in 
which PM/Scl-75 was found to have a more prominent role when compared to other core 
components (Stoecklin et al, 2006). 
It will be interesting to know whether the Ski complex acts in collaboration with hDis3L1 to 
degrade cytoplasmic RNA substrates. In yeast the interaction of the Ski complex with the 
exosome core is bridged by the Ski7 protein (Araki et al, 2001; van Hoof et al, 2000), but no 
clear human homologues for this protein have been described so far. The C-terminal part of 
the Ski7 protein resembles the translation factors EF1-alpha and Hbs1 (Benard et al, 1999), 
and an ortholog of the latter is encoded in the human genome: HBS1-like protein (HBS1L). 
Interestingly, our proteomic analysis of purified exosome complexes (Chapter 3) identified 
a peptide sequence corresponding to this particular protein (data not shown). Although a 
single peptide might reflect a background signal, one has to keep in mind that the purified 
exosome used for the proteomic analysis was extensively washed with 1 M NaCl to reduce 
the co-purification of weakly interacting proteins as much as possible. Moreover, HBS1L has 
been found to co-purify with hDis3L1 in another study (Tomecki et al, 2010). Since the protein 
responsible for bridging the human exosome and Ski complexes is currently still unknown, 
HBS1L is certainly an attractive candidate for further investigations.
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If hDis3L1 indeed is involved in the activities that have been ascribed to the cytoplasmic 
exosome, one important difference with the situation in yeast is that hDis3L1 lacks 
endoribonuclease activity. It is possible that this particular activity is of lower importance 
for at least some of these processes. Indeed, it has been reported that the endoribonuclease 
activity of yeast Dis3 is not required for some mRNA surveillance mechanisms (Schaeffer 
and van Hoof, 2011). Moreover, only the exoribonuclease mutant of yeast Dis3 was found 
to be synthetic lethal with a exoribonuclease mutant of Xrn1, while the endoribonuclease 
Dis3 mutant was not (Schneider et al, 2009). These results suggest that in cytoplasmic mRNA 
turnover and surveillance the endoribonuclease activity of Dis3(-homologues) is of minor 
importance and could explain why this particular activity was not conserved in hDis3L1. 
Future studies will hopefully address if and to what extent the exoribonuclease activity of 
hDis3L1 affects the different mRNA turnover and surveillance mechanisms. 
Previously, it has been reported that a minor fraction of PM/Scl-100 is localized in the 
cytoplasm of human cells (Lejeune et al, 2003; van Dijk et al, 2007). Although this fraction 
might be associated with the exosome, preliminary co-immunoprecipitation data suggests 
otherwise (Chlebowski et al, 2013). We therefore favor the possibility that cytoplasmic PM/Scl-
100 functions in an exosome-independent fashion, in agreement with previous suggestions 
(Graham et al, 2009b). In the latter study the Drosophila Rrp6 protein was proposed to have 
exosome-independent roles during the cell cycle and mitotic progression. Whether the 
cytoplasmic pool of non-exosome-associated PM/Scl-100 performs similar tasks in humans 
is currently not known.
Although not associated with the exosome core, Dis3L2 was recently shown to be the major 
ribonuclease responsible for an additional cytoplasmic 3’-5’ mRNA degradation route 
in Schizosaccharomyces pombe, (Malecki et al, 2013). In this study, deletion of Dis3L2 was 
found to be synthetically lethal with a Xrn1 deletion, indicating that Dis3L2 fulfills important 
roles in (m)RNA metabolism. Furthermore, the Lsm1-Dis3L2 double knockout resulted in the 
accumulation of polyuridylated mRNAs, which were shown to be the preferred substrate for 
the S. pombe Dis3L2. It is likely that a similar mRNA degradation route is present in plants as 
well, and requires the SOV protein, which probably represents an ortholog of Dis3L2 (Zhang 
et al, 2010). The preferred targeting of RNA substrates containing an uridylated 3’ end is also 
conserved in mice, as murine Dis3L2 was recently shown to degrade a member of the let-7 
family of miRNAs in an uridylation-dependent manner (Chang et al, 2013). In fact, the division 
of Dis3 homologues into three different categories (Dis3, Dis3L1 and Dis3L2) seems to be 
widespread in eukaryotes, with S. cerevisiae being one of the few exceptions (Malecki et al, 
2013). 
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Post-transcriptional modification of exosome core and associated proteins
The association of various exoribonucleases with the exosome core will not be the 
only mechanism by which the activity of the complex can be modulated. In addition, 
posttranslational modifications (PTMs) may be involved, because these are known to 
contribute to the regulation of enzymatic activities in general (Walsh et al, 2005). We 
therefore also searched within our human exosome proteomic dataset (Chapter 3) for 
PTMs of exosome core components and of exosome-associated proteins (hDis3L1, 
PM/Scl-100, MPP-6 and C1D). This did not reveal PTMs, which, at least in part, may be due to 
the relatively low sequence coverage for most of these proteins. As an alternative approach, 
we analyzed individual exosome core and exosome-associated proteins for the presence 
of PTMs by 2-dimensional isoelectric focusing - SDS-polyacrylamide gel electrophoresis 
(Figure 2). Multiple spots were observed for hRrp4, hRrp40, PM/Scl-75 and PM/Scl-100, 
suggesting that these proteins are indeed modified. Coincidentally, the proteins found to 
be modified in this analysis were also previously found to be targeted by autoantibodies in 
polymyositis/ scleroderma-overlap patients (Table 3, Chapter 1). PTMs have been postulated 
to play a role in the generation of neo-epitopes that may initiate an autoimmune response. 
As such, these PTMs might also be of clinical value. The identification and implication of 
these (and potential other) modifications will certainly be a challenging task for future studies 
addressing the catalytic and autoantigenic properties of the exosome.
Polyadenylation and polyuridylation-stimulated RNA degradation
Polyadenylation of RNAs is a widespread cellular mechanism that can have many different 
outcomes depending on which RNA is polyadenylated, the position of the RNA molecule at 
which the poly(A)-tail is added and in which species and/or cellular compartment this event 
takes place. Perhaps the most well-known example of eukaryotic polyadenylation is the 
posttranscriptional addition of poly(A)-tails to the 3’ end of mRNAs as part of their maturation 
process, promoting transcript stability, nuclear export and translation efficiency (Guhaniyogi 
and Brewer, 2001), which is therefore also referred to as ‘stable polyadenylation’. In contrast, 
the addition of poly(A)-tails to the 3’ end of prokaryotic mRNAs is known to promote their 
degradation and indeed the resulting polyadenylated mRNAs are often very short-lived, 
giving rise to the term ‘transient polyadenylation’.
Over the years, it has become clear that also eukaryotes employ transient polyadenylation for 
the rapid degradation of RNAs. As mentioned in Chapter 1, the nuclear TRAMP complex has 
been shown to add poly(A)-tails to RNAs during RNA quality control and 3’-end processing 
events, often in concert with Rrp6 and Dis3 (Wyers et al., 2005;LaCava et al., 2005;Vanacova 
et al., 2005;Kadaba et al., 2006). The rapid degradation of transiently polyadenylated RNA is 
probably one of the reasons why these molecules have escaped detection for many years. 
Now, by silencing the ribonuclease(s) responsible for their degradation, these transcripts 
accumulated, which facilitated their detection. This not only revealed new RNA degradation 
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Figure 2. Two-dimensional isoelectric focusing – SDS-PAGE analyses of exosome core and exosome-
associated proteins.
HeLa cell extracts (70 mg total protein) were separated by isoelectric focusing on 7 cm, non-linear IPG Immobiline 
Drystrips with a pH-range of 3 to 10, after which proteins were size-fractionated by SDS-PAGE. After western blotting 
of the 2D gels, proteins on the blots were stained with antibodies recognizing (A) the exosome core proteins hRrp4, 
hRrp40, hRrp41, hOIP2 and PM/Scl-75, or (B) the exosome-associated proteins hDis3 and PM/Scl-100. Positions of 
the respective proteins on the blots are indicated with arrowheads. The positions of molecular weight markers are 
indicated on the left of each panel. The “1D control” lane contains 20 μg total protein of the same HeLa cell extract, 
which was size-fractioned by SDS-PAGE without prior isoelectric focusing.
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and processing pathways, such as that involving the nuclear TRAMP complex, but also 
identified new classes of RNAs, such as CUTs (cryptic unstable transcripts) in yeast, and 
PROMPTs (promotor upstream transcripts) in humans (Neil et al, 2009; Preker et al, 2008).
Likewise, by the silencing of hDis3L1, we identified a novel RNA degradation pathway in 
the cytoplasm that involves the transient poly(A)-rich tailing of degradation intermediates 
(Chapter 3 and 4). This mechanism might not be unique to humans, as a similar mechanism 
was recently shown to be present in algae as well, although the subcellular distribution 
of the polyadenylated 18S rRNA species studied in algae was not determined (Zhuang et 
al, 2013). Rather than exclusively consisting of adenosines, these tails were found to be 
heteropolymeric in nature, as the other three nucleotides were also detected within the tail 
sequence, albeit at a much lower frequency. One of the future challenges in this field will 
be to find the polymerase responsible for synthesis of these tails. In S. pombe, the addition 
of poly(U)-tails to mRNAs was shown to be dependent on the Cid1 protein, which has an 
orthologue in humans (Rissland and Norbury, 2009). Interestingly, these orthologues may 
also be responsible for the polyuridylation-stimulated histone mRNA degradation, a process 
that also involves the 3’-5’ exoribonuclease activity of the exosome (Mullen and Marzluff, 
2008).
As mentioned above, another example of 3’-end RNA tailing was recently demonstrated in 
two independent studies, where Dis3L2 functions to degrade polyuridylated cytoplasmic 
mRNA and miRNA species (Chang et al, 2013; Malecki et al, 2013), the tails of which were 
added by 2 members of the 3’ terminal uridylyl transferase family (TUTases). It is, however, 
not known if these noncanoncial transferases are also involved in the uridylation of other 
RNA species. 
In summary, 3’-end polyadenylation and polyuridylation serve as important cues in the 
degradation of many different classes of RNA, which is schematically illustrated in Figure 
3. It is also important to note that these discoveries can have profound implications for 
conventional RT-PCR procedures utilizing oligo(dT) in reverse priming reactions to enrich for 
mRNAs species (Nam et al, 2002).
Exosomes and Dis3(-like) proteins in human disease
As discussed in Chapter 2, the identification of the human exosome was accelerated due 
to the discovery that the serum of patients with the polymyositis/scleroderma-overlap 
syndrome contained autoantibodies targeting several exosome(-associated) proteins. 
In fact, two exosome(-associated) proteins still owe their name to this phenomenon: 
PM/Scl-75 and PM/Scl-100. It is still an open question why exactly these proteins were found 
to be targeted by the immune system and how this relates to the phenotype of these patients. 
The same can be said about the exosome core component hRrp46, which was found to be 
immunogenic in patients with chronic myelogenous leukemia (Yang et al, 2002). 
Several recent studies indicated that also mutations in exosome core (and associated) 
proteins can have a pathogenic role in human disease. Firstly, whole-genome sequencing 
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Figure 3. Polyadenylation- and polyuridylation-stimulated RNA degradation by exoribonucleases.
(A) In yeast, nuclear non-coding RNAs (ncRNAs) are polyadenylated by the TRAMP complex, followed by processing or 
degradation by the exosome associated with Rrp6 and Dis3. (B) Human cytoplasmic rRNA (and mRNA) degradation 
intermediates are tailed by an unknown polymerase, followed by hDis3L1-mediated degradation in association with 
the exosome. (C) Human pre-miRNAs are polyuridylated by TUTases, after which degradation is initiated by hDis3L2. 
In S. pombe, a similar mechanism is in place for the degradation of mRNA species.
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of multiple myeloma patients revealed that 11% contained mutations in the hDIS3 gene 
(Chapman et al, 2011). Interestingly, all of these mutations were found to cluster exclusively 
in the region encoding the RNB domain of hDis3 and about 50% of these or equivalent 
mutations were previously shown to severely diminish the exoribonuclease activity of the 
enzyme (Barbas et al, 2009; Schneider et al, 2007). Notably, no mutations in hDis3L1 were 
identified in this study. It will therefore be interesting to determine the substrate repertoire of 
hDis3 in order to identify genes that might be involved in tumor formation in these patients. 
Recently, this issue has been addressed by transcriptome-wide studies in yeast, but due to 
the dissimilarities between the yeast and human Dis3 proteins and the higher complexity 
of the human genome, these results cannot be extrapolated to humans in a simple way 
(Gudipati et al, 2012; Schneider et al, 2012). 
Next to hDis3, mutant versions of its paralogue hDis3L2 have also been linked to tumor 
formation (Astuti et al, 2012). Patients that were diagnosed with the Perlman syndrome were 
found to contain germline mutations resulting in truncated versions of this protein. In parallel 
to the mutations found in the study of Chapman and colleagues (Chapman et al, 2011), all 
of these truncations affected the RNB domain, resulting in an inactive form of the protein. 
Although the full substrate repertoire of hDis3L2 is currently unknown, recent studies have 
identified at least a subset. In humans, hDis3L2 depletion was found to increase the half-life 
of several important mRNAs, many of which were involved in controlling the cell cycle (Lubas 
et al, 2013). The activity of hDis3L2 is probably not restricted to mRNAs, as evidenced by 
its role in the degradation of the pre-let-7 miRNA (Chang et al, 2013). It was shown that the 
Lin28A protein recruits the enzymes responsible for the uridylation of the pre-let-7 miRNA, 
thereby tagging it for degradation by hDis3L2. Note that this finding is consistent with the 
observed accumulation of uridylated RNAs in Dis3L2 depleted cells in S. pombe (Malecki et 
al, 2013). The Lin28A-mediated silencing of let-7 is known to be active in stem cells, keeping 
them in an undifferentiated and proliferative state, while it is relieved in somatic cells (Yu et al, 
2007). Whether or not the Lin28A-mediated regulation of let-7 is relevant for the development 
of the Perlman syndrome awaits further characterization.
Exome sequencing of patients showing clinical symptoms reminiscent of pontocerebellar 
hypoplasia (PCH) revealed mutations in the human exosome core component hRrp40 (Wan 
et al, 2012). PCH is a collective term for several rare neurodegenerative disorders, which 
results in the impaired development of different brain tissues. The disease is inherited in an 
autosomal recessive fashion and the responsible gene had not been identified. All but one of 
the identified mutations in the hRrp40 gene were shown to be located in the hRrp40-coding 
sequence, often resulting in substitutions of conserved amino acids of the N-terminal domain 
and the KH and S1 RNA-binding domains. hRrp40 is one of the ‘cap’ proteins that are stacked 
on the ring-structure, which have been proposed to mediate the recruitment of substrate 
RNA and to guide this towards the central channel (Oddone et al, 2007). hRrp40 also seems to 
be of structural importance, as it stabilizes the integrity of the ring-structure (Liu et al, 2006). 
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Curiously, two of the identified mutations in hRrp40 occur at highly conserved residues that 
were proposed to be of importance for the latter function.
Concluding remarks and future perspectives
The exosome is a remarkably versatile protein complex, involved in many different aspects 
of RNA metabolism. In fact, it is believed that almost every type of RNA will encounter the 
exosome somewhere within its lifecycle. Not surprisingly, the list of substrate RNAs of the 
exosome is astonishing, and will undisputedly grow as additional functions of the exosome 
will be explored. The identification of hDis3 and hDis3L1 as important ribonucleases for the 
activity of the exosome will certainly facilitate this process even further (e.g. by observing 
the stabilization of substrate RNAs after depletion of hDis3 and/or hDis3L1). In addition, 
there are several interesting reports about unexpected functions of the exosome, such as 
its involvement in controlling the eukaryotic circadian clock (Guo et al, 2009) and its role 
in promoting antibody diversity by regulating the activation-induced cytidine deaminase in 
immunoglobulin heavy-chain class switch recombination and somatic hypermutation (Basu 
et al, 2011). Finally, exosome core components can have individual non-exosome associated 
roles, as for example has been reported for hRrp46, which appeared to be involved in the 
clearance of apoptotic DNA (Yang et al, 2010).
The involvement in so many different (and sometimes essential) cellular processes, together 
with its relationship with several human diseases, indicates that the exosome is not only an 
important topic for fundamental research, but is also of major importance from a clinical 
perspective. Deciphering how the versatile activities of the exosome are modulated is 
therefore a key topic for the upcoming years.
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Summary
RNA metabolism is the collective term for all the different processes involving changes of RNA 
molecules during their lifecycle. Following transcription, many RNAs undergo maturation 
steps, during which the RNAs are processed and modified. In eukaryotes, several quality 
control pathways exist to coordinate these processes and to monitor the integrity of (mature) 
RNAs. The (partial) degradation of RNA is an indispensable step in many of these processes. 
A central role in these processes is played by the exosome, a multisubunit protein complex 
with ribonuclease (RNA degradation) activity. Since the term exosome is now also widely 
used for cell-derived vesicles that are present in biological fluids and cell culture media, the 
intracellular RNA degrading complex is frequently indicated with ‘RNA exosome’.
A key advancement in our understanding of the eukaryotic exosome was the observation that 
the complex was devoid of intrinsic ribonuclease activity. Instead, the catalytic activity of the 
exosome is introduced by a set of ribonucleases, which can associate with the complex. For 
the well-characterized exosome in yeast, two of these ribonucleases were readily identified: 
yRrp6 and yDis3. Shortly thereafter, their human counterparts were identified as well: PM/
Scl-100 and hDis3, respectively. Opposed to PM/Scl-100, the association of hDis3 with the 
human exosome remained elusive for many years. Furthermore, both these proteins are 
predominantly localized in the nucleus, while exosome complexes can be found in both the 
cytoplasm and the nucleus. These observations suggested that the activity of the human 
exosome is differently organized.
The objective of this study was to establish how the activity of the human exosome is 
accomplished and to determine which proteins and factors contribute to its activity. On 
one hand, the results of this study will be of importance from a fundamental, scientific point 
of view. For example, the experimental manipulation of newly identified ribonucleases 
associated with the exosome may facilitate the detection of novel substrates (or their 
degradation intermediates), potentially revealing new RNA degradation and/or processing 
pathways in human cells. On the other hand, the results of this study can be of medical 
importance, because several diseases are associated with dysfunctioning of (ribo)nucleases, 
or with the targeting of (ribo)nucleases by the immune system. 
In Chapter 1 we describe the discovery of the exosome from a historical perspective and 
provide a functional and structural comparison of exosome and exosome-like complexes in 
the three different domains of life. The current knowledge of important exosome-interacting 
proteins together with their contribution to several exosome-related functions is discussed 
as well.
The association of exosome complexes with several medical conditions is covered in 
Chapter 2. The occurrence of autoantibodies targeting exosome components and exosome-
associated proteins in autoimmune disease patients will be discussed, which concurrently 
facilitated the identification of the exosome complex in humans. In addition, the current 
knowledge on aberrant expression of exosome and exosome-associated proteins in cancer 
patients is described.
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The abovementioned nuclear localization of the ribonucleases PM/Scl-100 and hDis3 raised 
the question whether other ribonucleases are involved in the catalytic activities associated 
with the cytoplasmic human exosome complex. This question is addressed in Chapter 3. By 
analyzing immunoaffinity-purified exosome complexes by mass spectrometry, we identified 
a novel exosome-associated ribonuclease called hDis3-like exonuclease 1 (hDis3L1). We 
showed that hDis3L1 localized exclusively to the cytoplasm and that it is stably associated 
with the exosome complex. In addition, we demonstrate that the association of hDis3 with 
the exosome is relatively weak. Characterization of the enzymatic activity of hDis3L1 showed 
that the protein has exoribonuclease activity and contributes to the activity of the exosome. 
In contrast to hDis3, hDis3L1 lacks endoribonuclease activity, consistent with the lack of 
conservation of catalytically important residues in the N-terminal PIN domain.
In Chapter 4 we address one of the biological roles of hDis3L1. Analyses of RNA degradation 
intermediates in the cytoplasm of human cells revealed hetero- and homopolymeric 
adenylated tails at internal positions of substrate RNAs. These polyadenylated degradation 
intermediates accumulated when protein levels of hDis3L1 were knocked down, which 
suggests that hDis3L1 is involved in polyadenylation-stimulated degradation of RNA in 
the cytoplasm. While polyadenylation-stimulated RNA degradation was known to occur in 
prokaryotes, organelles and nuclei of eukaryotic cells, the results of this study indicate that 
RNA degradation occurs by a similar mechanism in the cytoplasm as well.
In the study described in Chapter 5, we investigated the contributions of PM/Scl-100, hDis3 
and the newly discovered hDis3L1 to the activity of the exosome complex as a whole. The 
results showed that the activities of hDis3 and hDis3L1 are most prominent at relatively low 
Mg2+ concentrations, in contrast to the activity of PM/Scl-100, which is dependent on much 
higher Mg2+ concentrations. Furthermore, the data suggested that the activity of PM/Scl-100 
is modulated by other (yet unkown) exosome-association proteins. SiRNA-mediated knock-
down studies with these three ribonucleases showed that their expression levels influence 
each other and that the association of hDis3L1 and PM/Scl-100 with the exosome might be 
mutually exclusive. These observations have important implications for the regulation of 
exosome complexes in vivo.
Analysis of the genomes of human and other higher eukaryotes revealed that they encode 
yet another protein with homology to the Dis3-like ribonucleases, which is called Dis3-like 
exonuclease 2, or hDis3L2 in humans. In Chapter 6 we show that hDis3L2 is not detectaby 
associatied with the exosome, as revealed by co-immunopurification experiments. 
Overexpression of hDis3L2 in HEp-2 cells had a severe impact on cell morphology and 
viability, suggesting that cellular hDis3L2 levels are tightly regulated. In vitro activity assays 
showed that hDis3L2, like the other Dis3-like proteins, contains ribonuclease activity. Based 
on the results from the experiments described in this chapter and literature data we conclude 
with a discussion about the possible functional roles of hDis3L2.
The weak association of hDis3 with the exosome argues that hDis3 might have (additional) 
exosome-independent roles as well. In the experiments described in Chapter 7, we explored 
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the role of hDis3 outside the context of the exosome. We show that hDis3 associates with 
proteins involved in pre-mRNA splicing and processing. Furthermore, microarray analyses 
revealed that hDis3 affects the levels of a different set of mRNAs compared to the exosome, 
substantiating the different substrate repertoire of hDis3.
Finally, in Chapter 8, we summarize and integrate the most important results of this 
study and discuss what impact they have on our understanding of the human exosome. 
We conclude that the activity of the exosome is largely determined by the localization 
of the exosome-associating ribonucleases. This implies that hDis3 and PM/Scl-100 are 
predominantly responsible for the activities of the exosome in the nucleus. With the 
identification of hDis3L1, we have found an important mediator of the ribonuclease activity 
associated with the cytoplasmic exosome. The characterization of hDis3L1 also revealed a 
novel, hDis3L1-dependent RNA degradation pathway in the cytoplasm. It is possible that 
other cytoplasmic activities attributed to the exosome are mediated by this ribonuclease 
as well. Furthermore, we showed that the regulation of the activity of the exosome can be 
modulated by the microenvironment and possibly other, yet unknown exosome-associated 
proteins. The presence of the three different Dis3 homologues in other eukaryotes suggests 
that these conclusions might be applicable to exosomes in other eukaryotic species as well.
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Samenvatting
RNA metabolisme is een collectieve term die alle verschillende processen omvat met 
betrekking tot veranderingen aan RNA moleculen tijdens hun levenscyclus. Na transcriptie 
ondergaan veel RNA’s maturatie stappen, die het RNA bewerken en veranderen. In eukaryoten 
bestaan er een aantal kwaliteitscontroles die deze processen coördineren en de integriteit 
van het (mature) RNA monitoren. Bij veel van deze processen is het (deels) afbreken van 
RNA een onmisbare stap. Het exosoom, een eiwitcomplex met ribonuclease (RNA-afbraak) 
activiteit, speelt hierin een belangrijke rol. Omdat de term exosoom nu ook veel gebruikt 
wordt voor de van cellen afgesplitste blaasjes, die aanwezig zijn in biologische vloeistoffen 
en in media van celculturen, wordt dit intracellulaire, RNA-afbrekende eiwitcomplex vaak 
aangeduid als het ‘RNA exosoom’.
Een belangrijke vooruitgang in het begrijpen van het eukaryote exosoom was de observatie 
dat het complex zelf geen intrinsieke ribonuclease-activiteit heeft. De katalytische activiteit 
van het exosoom wordt in plaats daarvan verzorgd door een set van ribonucleases die 
associëren met het complex. Twee van deze ribonucleases werden al snel geïdentificeerd in 
het goed gekarakteriseerde exosoomcomplex van gist: yRrp6 en yDis3. Kort hierna werden 
de tegenhangers hiervan ook in menselijke cellen geïdentificeerd: PM/Scl-100 en hDis3. In 
tegenstelling tot PM/Scl-100 bleef de associatie van het hDis3 eiwit gedurende vele jaren 
maar moeilijk aantoonbaar. Daarnaast bevinden deze twee eiwitten zich voornamelijk in de 
kern, terwijl exosoomcomplexen in zowel de kern als het cytoplasma te vinden zijn. Deze 
observaties suggereerden dat de activiteit van het humane exosoom anders georganiseerd 
is.
Het doel van deze studie was om vast te stellen hoe de activiteit van het humane exosoom 
tot stand gebracht wordt en om te bepalen welke eiwitten en factoren bijdragen aan de 
activiteit van het exosoom. Enerzijds zijn de resultaten van deze studie belangrijk vanuit een 
fundamenteel wetenschappelijk oogpunt. Zo is het mogelijk om door het experimenteel 
manipuleren van nieuw geïdentificeerde, exosoom-geassocieerde ribonucleases nieuwe 
RNA-substraten (of de afbraakproducten daarvan) en mogelijk nieuwe afbraak- en/of 
bewerkingsroutes in humane cellen bloot te leggen. Anderzijds kunnen de resultaten van 
deze studie van medisch belang zijn, omdat enkele ziekten geassocieerd zijn met een 
ontregeling van (ribo)nucleases, of met een immuunrespons tegen deze (ribo)nucleases.
In Hoofdstuk 1 beschrijven we de ontdekking van het exooom vanuit een historisch 
perspectief en geven we een functionele en structurele vergelijking van het exosoom 
en ‘exosoom-achtige’ complexen in de drie levensdomeinen. Onze huidige kennis van 
belangrijke exosoom-interacterende eiwitten samen met hun bijdragen aan enkele exosoom-
gerelateerde functies worden ook bediscussieerd. 
De relatie van exosoomcomplexen met betrekking tot een aantal medische aandoeningen 
wordt behandeld in Hoofdstuk 2. De aanwezigheid van autoantilichamen gericht tegen 
exosoomcomponenten en exosoom-geassocieerde eiwitten in auto-immuunpatiënten zal 
worden behandeld. Deze ontdekking heeft tegelijkertijd de identificatie van het humane 
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exosoom gefaciliteerd. Daarnaast wordt de huidige kennis met betrekking tot de afwijkende 
expressie van exosoom en exosoom-geassocieerde eiwitten in kankerpatiënten besproken.
De bovengenoemde lokalisatie van de ribonucleases PM/Scl-100 en hDis3 in de celkern wierp 
de vraag op of andere ribonucleases mogelijk betrokken zijn bij de katalytische activiteit die 
geassocieerd is met het cytoplasmatische humane exosoomcomplex. Deze vraag wordt 
behandeld in Hoofdstuk 3. Door het analyseren van immuno-affiniteits opgezuiverde 
exosoomcomplexen met behulp van massaspectrometrie hebben we een nieuwe exosoom-
geassocieerde ribonuclease gevonden, genaamd hDis3-like exoribonuclease 1 (hDis3L1). We 
hebben laten zien dat hDis3L1 zich exclusief in het cytoplasma bevindt en dat het stabiel 
met het exosoomcomplex geassocieerd is. Daarnaast laten we zien dat hDis3 relatief zwak 
aan het exosoom bindt. Uit enzymatische activiteitsanalyses van hDis3L1 bleek dat dit eiwit 
over exoribonuclease-activiteit beschikt en bijdraagt aan de activiteit van het exosoom. In 
tegenstelling tot hDis3 heeft hDis3L1 geen endonuclease activiteit, wat in overeenstemming 
is met het gebrek aan belangrijke, evolutionair-geconserveerde katalytische residuen in het 
N-terminale PIN domein van dit eiwit.
In Hoofdstuk 4 richten we ons op een van de biologische rollen van hDis3L1. Analyses 
van RNA-afbraakintermediairen in het cytoplasma van humane cellen lieten zien dat er 
heterogene en homogene gepolyadenyleerde staarten op interne posities in het RNA zaten. 
Deze gepolyadenyleerde afbraakintermediairen hoopten zich op wanneer het eiwitniveau 
van hDis3L1 omlaag werd gebracht, hetgeen suggereerde dat hDis3L1 betrokken is bij de 
door polyadenylatie-gestimuleerde afbraak van RNA in het cytoplasma. Alhoewel het bekend 
is dat polyadenylatie-gestimuleerde RNA-afbraak optreedt in prokaryoten, organellen en 
kernen van eukaryote cellen, lieten de resultaten van deze studie zien dat RNA-afbraak ook 
in het cytoplasma via een vergelijkbaar mechanisme verloopt.
In de in Hoofdstuk 5 beschreven studie hebben we de bijdragen aan de activiteit van 
het exosoom van PM/Scl-100, hDis3 en het nieuw ontdekte hDis3L1 eiwit onderzocht. De 
resultaten lieten zien dat de activiteit van hDis3 en hDis3L1 met name bevorderd wordt door 
lage Mg2+-concentraties, in tegenstelling tot de activiteit van PM/Scl-100, die afhankelijk is 
van relatief hoge Mg2+-concentraties. Daarnaast lieten de resultaten zien dat de activiteit van 
PM/Scl-100 gereguleerd kan worden door andere (nog onbekende) exosoom-geassocieerde 
eiwitten. Ten slotte hebben we middels siRNA-experimenten met de drie ribonucleases laten 
zien dat de expressieniveau’s elkaar kunnen beïnvloeden en dat de binding van hDis3L1 of 
PM/Scl-100 aan het exosoom de binding van de ander wellicht uitsluit. Deze waarnemingen 
hebben belangrijke consequenties voor de regulatie van exosoomcomplexen in vivo.
Uit analyse van het humane genoom en andere genomen van hogere eukaryoten bleek 
dat deze nog voor een ander eiwit coderen dat structureel verwant is aan de Dis3-like 
ribonucleases, dat Dis3-like exonuclease 2, of hDis3L2 (in menselijke cellen) wordt genoemd. 
In Hoofdstuk 6 laten we door middel van co-immuunprecipitatie experimenten zien dat 
hDis3L2 niet detecteerbaar associeert met het exosoom. Overexpressie van hDis3L2 in HEp-
2-cellen had ernstige effecten op de morfologie en viabiliteit van de cellen, wat suggereert dat 
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cellulaire hDis3L2 niveaus strikt gereguleerd zijn. In vitro activiteitsexperimenten lieten zien 
dat hDis3L2, net als de andere Dis3-like eiwitten, ribonuclease-activiteit heeft. Door middel 
van de huidige literatuur en de resultaten uit dit hoofdstuk eindigen we met een discussie 
over de mogelijke biochemische en celbiologische functies van hDis3L2.
De zwakke binding van hDis3 aan het exosoom wijst erop dat hDis3 mogelijk ook (additionele) 
exosoom-onafhankelijke rollen heeft. Met behulp van de experimenten in Hoofdstuk 7 
hebben we daarom de rol van hDis3 buiten de context van het exosoom onderzocht. We 
hebben laten zien dat hDis3 associeert met eiwitten die betrokken zijn met pre-mRNA splicing 
en ‘processing’. Daarnaast hebben microarray-analyses uitgewezen dat hDis3 de niveaus van 
een andere set van mRNAs beïnvloedt in vergelijking met die van het exosoom. Dit versterkt 
onze hypothese dat hDis3 een ander substraatrepertoire heeft.
Ten slotte worden in Hoofdstuk 8 de meest belangrijke resultaten van deze studies 
samengevat en geïntegreerd en wordt de invloed hiervan op onze kennis van het humane 
exosoom bediscussieerd. De activiteit van het exosoom wordt voor een belangrijk deel 
bepaald door de lokalisatie van de met het exosoom geassocieerde ribonucleases. Dit 
betekent dat hDis3 en PM/Scl-100 voornamelijk verantwoordelijk zullen zijn voor de 
activiteiten van het exosoom in de celkern. Met de identificatie van hDis3L1 hebben we 
een belangrijk ribonuclease voor exosoomcomplexen in het cytoplasma gevonden. Deze 
ontdekking heeft daarnaast ook een nieuwe, door hDis3L1-gemedieerde, afbraakroute 
voor RNAs in het cytoplasma blootgelegd. Het is mogelijk dat een deel van de andere 
aan het cytoplasmatische exosoom toegeschreven activiteiten ook afhankelijk zijn van 
deze ribonuclease. Verder hebben we laten zien dat de activiteiten van het exosoom 
gereguleerd kunnen worden door het micromilieu en mogelijkerwijs door andere, nog 
onbekende exosoom-bindende eiwitten. De aanwezigheid van de drie verschillende Dis3-
homologen in andere eukaryote cellen suggereert dat deze conclusies mogelijk ook voor 
exosoomcomplexen in andere eukaryote organismen van toepassing zijn.
202
Curriculum vitae
Raymond H.J. Staals werd geboren op 16 oktober 1979 te Grubbenvorst. In 1998 behaalde hij 
zijn VWO-diploma aan het Blariacumcollege te Venlo, waarna hij begon aan de studie Biologie 
aan de Universiteit van Utrecht. Tijdens deze studie heeft hij twee wetenschappelijke stages 
gelopen. Zijn eerste stage was op de afdeling Ecofysiologie van Planten van de Universiteit 
van Utrecht, onder begeleiding van dr. A.J.M. Peeters. Zijn tweede stage was op de afdeling 
Medische Oncologie in het Josephine Nefkens Instituut, Erasmus Medisch Centrum te 
Rotterdam, onder begeleiding van dr. E.A.C. Wiemer. Het doctoraalexamen Biologie heeft hij 
gehaald in augustus 2006. Tussen 2005 en 2006 heeft hij gewerkt op het Blariacumcollege 
te Venlo als leraar biologie (bovenbouw van het HAVO en VWO). Van 2006 tot 2011 heeft 
hij gewerkt als promovendus op de afdeling Biomoleculaire Chemie van de Radboud 
Universiteit Nijmegen, onder begeleiding van prof. dr. G.J.M. Pruijn. Gedurende deze periode 
werd het onderzoek verricht dat is beschreven in dit proefschrift. Van 2011 tot 2014 heeft 
hij gewerkt als Research Fellow in het Laboratorium voor Microbiologie op de Universiteit 
van Wageningen, onder begeleiding van prof. dr. J. van der Oost. Begin 2014 heeft hij de 
Health Science Career Development Postdoctoral Fellowship van de Universiteit van Otago 
gehonoreerd gekregen. Sinds maart 2014 is hij werkzaam als Assistant Research Fellow in het 
Fineran laboratorium (Department of Microbiology and Immunology) op de Universiteit van 
Otago in Nieuw-Zeeland.
203
List of publications
Staals RH*, Zhu Y*, Taylor DW*, Kornfeld JE, Sharma K, Barendregt A, Koehorst JJ, Vlot M, Neupane 
N, Varossieau K, Sakamoto K, Suzuki T, Dohmae N, Yokoyama S, Schaap PJ, Urlaub H, Heck AJR, 
Nogales E, Doudna JA, Shinkai A, van der Oost J (2014) RNA-targeting by the Type III-A CRISPR-Cas 
Csm complex of Thermus thermophilus. Mol Cell 20 (in press)
Richter C*, Dy RL*, McKenzie RE*, Watson BN, Taylor C, Chang JT, McNeil MB, Staals RH, Fineran PC 
(2014) Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, 
bi-directionally from the primed protospacer. Nucleic Acids Res 42: 8516-8526
Niemela EH*, Oghabian A*, Staals RH, Greco D, Pruijn GJ, Frilander MJ (2014) Global analysis of the 
nuclear processing of transcripts with unspliced U12-type introns by the exosome. Nucleic Acids 
Res 42: 7358-7369
Fineran PC, Gerritzen MJ, Suarez-Diez M, Kunne T, Boekhorst J, van Hijum SA, Staals RH, Brouns SJ 
(2014) Degenerate target sites mediate rapid primed CRISPR adaptation. Proc Natl Acad Sci U S A 
111: E1629-1638
Louwen R, Staals RH, Endtz HP, van Baarlen P, van der Oost J (2014) The role of CRISPR-Cas systems in 
virulence of pathogenic bacteria. Microbiol Mol Biol Rev 78: 74-88
Staals RH*, Agari Y*, Maki-Yonekura S*, Zhu Y, Taylor DW, van Duijn E, Barendregt A, Vlot M, Koehorst 
JJ, Sakamoto K, Masuda A, Dohmae N, Schaap PJ, Doudna JA, Heck AJ, Yonekura K, van der Oost 
J, Shinkai A (2013) Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of 
Thermus thermophilus. Mol Cell 52: 135-145
Westra ER*, Staals RH*, Gort G, Hogh S, Neumann S, de la Cruz F, Fineran PC, Brouns SJ (2013) CRISPR-
Cas systems preferentially target the leading regions of MOBF conjugative plasmids. RNA Biol 10: 
749-761
Staals RH, Brouns SJ (2013) Distribution and Mechanism of the Type I CRISPR-Cas Systems. In CRISPR-
Cas Systems, pp 145-169. Springer
Westra ER, Swarts DC, Staals RH, Jore MM, Brouns SJ, van der Oost J (2012) The CRISPRs, they are 
a-changin’: how prokaryotes generate adaptive immunity. Annu Rev Genet 46: 311-339
Westra ER, van Erp PB, Kunne T, Wong SP, Staals RH, Seegers CL, Bollen S, Jore MM, Semenova E, 
Severinov K, de Vos WM, Dame RT, de Vries R, Brouns SJ, van der Oost J (2012) CRISPR immunity 
relies on the consecutive binding and degradation of negatively supercoiled invader DNA by 
Cascade and Cas3. Mol Cell 46: 595-605
Astuti D*, Morris MR*, Cooper WN, Staals RH, Wake NC, Fews GA, Gill H, Gentle D, Shuib S, Ricketts CJ, 
Cole T, van Essen AJ, van Lingen RA, Neri G, Opitz JM, Rump P, Stolte-Dijkstra I, Muller F, Pruijn GJ, 
Latif F, Maher ER (2012) Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth 
and Wilms tumor susceptibility. Nat Genet 44: 277-284
Staals RH, Bronkhorst AW, Schilders G, Slomovic S, Schuster G, Heck AJ, Raijmakers R, Pruijn GJ (2010) 
Dis3-like 1: a novel exoribonuclease associated with the human exosome. EMBO J 29: 2358-2367
Slomovic S*, Fremder E*, Staals RH, Pruijn GJ, Schuster G (2010) Addition of poly(A) and poly(A)-rich 
tails during RNA degradation in the cytoplasm of human cells. Proc Natl Acad Sci U S A 107: 7407-
7412
Staals RH, Pruijn GJ (2010) The human exosome and disease. Adv Exp Med Biol 702: 132-142
Vreeburg RA, Benschop JJ, Peeters AJ, Colmer TD, Ammerlaan AH, Staal M, Elzenga TM, Staals RH, 
Darley CP, McQueen-Mason SJ, Voesenek LA (2005) Ethylene regulates fast apoplastic acidification 
and expansin A transcription during submergence-induced petiole elongation in Rumex palustris. 
Plant J 43: 597-610
*These authors contributed equally to this work
204
Dankwoord
Dit is vaak het meest gelezen onderdeel van een proefschrift en daardoor misschien wel het 
belangrijkste, zeker wanneer je beseft dat zonder de hulp van de onderstaande personen dit 
boekje nooit het levenslicht zou hebben gezien.
Ik wil graag beginnen met mijn promotor Ger Pruijn. Ger, dank je wel dat je ondanks de 
lange tijd die het geduurd heeft, altijd voor me klaar stond. Ik heb enorm veel van je geleerd, 
zeker wat betreft het schrijven van wetenschappelijk-correcte manuscripten en het kritisch 
bestuderen van mijn onderzoeksresultaten. Ik heb je vaak in mijn gedachten vergeleken 
met bèta-actine. Ik zal dit uitleggen. Niet alleen is bèta-actine essentieel voor de structurele 
integriteit, het wordt ook vaak gebruikt om zaken te normaliseren. Dat laatste had ik af en 
toe nodig als ik bij je langskwam met, in mijn ogen, tegenvallende resultaten, waar je vaak 
weer een positieve draai aan wist te geven. Andersom kon je me voorzien van kritiek op de 
momenten dat ik dacht dat ik iets onomstotelijk had aangetoond.
Els, wat was het altijd fijn om te weten dat ik voor werkelijk alles bij je terecht kon. Misschien 
in eerste instantie voor een goed gesprek, maar ook als er iets geregeld moest worden. Ik kon 
er gewoon blind op vertrouwen dat dingen altijd correct door jou werden afgehandeld: dank 
je wel voor alle hulp en steun!
Lettie, Walther en Wilbert, bedankt dat ik gebruik heb mogen maken van jullie ruime 
ervaring in de wetenschap, ik heb er veel baat bij gehad en denk nog vaak terug aan onze 
gesprekken. Ik sta nog steeds beschikbaar, mochten jullie hulp nodig hebben bij eventuele 
computerproblemen.
I would like to thank Professor Schuster and Professor Maher and members of their labs 
for the excellent collaborations we had. This has been a fantastic experience for me to 
see what you can achieve when working together on a project. De samenwerking met het 
lab van Professor Heck is een bijzondere. Met de identificatie van Dis3-like 1, is jullie werk 
doorslaggevend geweest voor het vinden van de ‘rode draad’ in mijn promotie traject. Ik ben 
er trots op dat we nu nog steeds samenwerken in het CRISPR veld en hoop dat we dit in de 
toekomst blijven doen; bedankt voor alles!
Ik had het geluk dat ik bij aanvang van mijn promotietraject op een rijdende ‘exosoom 
trein’ kon springen. Deze trein werd gerund door Erwin, Geurt en Wilma, maar we hadden 
ook een extra bemanningslid aan boord genaamd Reinout, die ondanks dat hij officieel op 
een andere trein werkzaam was, ons vaak voorzag van zijn enorme exosoom kennis. Ik wil 
jullie alle vier bedanken voor jullie hulp en advies voor het opzetten en uitvoeren van goed 
doordachte exosoom experimenten, maar ook voor het creëren van een leuke sfeer op het 
lab en daarbuiten.
205
Wat betreft de sfeer op het lab, wil ik graag een persoon in bijzonder noemen: Remon, aka ‘de 
sloper uit Oss’. Het is bijna onwerkelijk dat we, ondanks alle ongein op het lab en daarbuiten, 
in staat zijn geweest om het boekje af te maken. Ik heb mede door jou een ontzettend leuke 
tijd op BMC gehad, waarvoor dank! Mariska, super leuk dat je er vaak bij was als we weer eens 
wat buiten BMC gingen doen. Ik kom snel eens even kijken naar jullie mooie nieuwe woning!
Verder wil ik ook graag al mijn andere collega’s van 2.55 bedanken dat ze het zo lang met mij 
hebben weten vol te houden op het lab: (“guy”) Sandy, (“soulless”) Joyce, (“ja”) Chantal, (“large 
mouth”) Tamara, Carla O., Helma, Judith, en Annemarie. Sandy, RNA buddeh, gelukkig ben 
je een Facebook-fanaat en kan ik af en toe meelezen hoe leuk je het daar in de States hebt: 
you go guy! Joyce, je hebt behoorlijk wat zielige (ha!) grapjes moeten incasseren,maar je was 
gelukkig zelf ook niet op je mondje gevallen. Chantal, bedankt voor je vele goede (*kuch*) 
tips wat betreft de muziekkeuze op het lab en sorry dat we je van ‘zeauveel’ dingen hebben 
beschuldigd. Ook jouw promotie zal nu niet meer lang op zich laten wachten. Tamara, ik 
weet dat je prima Nederlands kunt lezen, dus bij dezen: bedankt voor de super leuke tijd 
in en buiten het lab! Heb me altijd rot kunnen lachen om de vele bizarre gesprekken die 
we hebben gehad en wil je nogmaals bedanken voor de leuke vakantie in Kroatië; hopelijk 
kom je me nog eens bezoeken in Nieuw-Zeeland. Carla O., gelukkig beschik je zelf over een 
gezonde portie humor en kon je de Remon en Raymond terror vaak met een rake opmerking 
de kop in drukken. Bedankt voor de excellente organisatie en hulp in het lab! Helma, ik vond 
het leuk om je als U-genoot te hebben en te mogen profiteren van je (RNA) kennis. Judith en 
Annemarie, bedankt dat jullie zo’n leuke buren voor me waren. Judith, bedankt voor je hulp 
aan hoofdstuk 5: dit waren geen gemakkelijke experimenten, maar je hebt het toch maar 
weer voor elkaar gekregen, super!
Natuurlijk wil ik het 2.35 lab ook niet vergeten. Marina, thanks for the interesting conversation 
we had about science and non-science related topics. Elina, many thanks for organizing all 
the great (dinner) parties and for sending me your thesis all the way to New Zealand. I’m 
was very pleased to be able to provide (a minor) contribution to one of your chapters and 
wish you all the best in Finland! Sanne en Carla, ik ken weinig mensen die elke dag met zo’n 
vrolijk humeur op het lab staan; daar kan deze ‘grumpy cat’ nog een hoop van leren! Sander 
en Lonneke, bedankt voor de leuke sfeer op het lab en het ‘über’-gezellig maken van de 
congressen die we samen hebben bezocht. Siebe (en/of Teo?), heb enorm kunnen genieten 
van je droge humor en je no-nonsense mentaliteit, bedankt voor al je hulp en advies voor 
mijn experimenten.
Een groot deel van het werk dat beschreven staat in dit proefschrift is mede tot stand 
gekomen door de inzet van een aantal excellente studenten die ik heb mogen begeleiden 
tijdens mijn promotietijd: Marie-Christine, Walter, Christian, Manuela, Victoria en Peter. Wat 
heb ik toch ontzettend geboft met jullie! Naast het feit dat ik het super leuk heb gevonden 
om met jullie samen te werken, hebben jullie allemaal een zeer belangrijke bijdrage geleverd 
aan de verschillende onderwerpen. Bedankt voor al jullie inzet en de ontzettend leuke tijd!
206
Natuurlijk is het ook belangrijk om ook wat ontspanning te vinden na het werk of in het 
weekend. Marieke en Dave, bedankt dat jullie deur altijd open stond voor een gezellig avondje 
of weekend! Janneke, bedankt voor de leuke tijd in Grave, en al is het anders gelopen dan we 
hadden gedacht, uiteindelijk is het allemaal goed gekomen en heeft het ons (ook letterlijk) 
verder gebracht.
Maurice en Karlijn, ik vind het nog steeds erg bijzonder dat jullie mij peetoom van Emma 
hebben gemaakt: ik ben hier ontzettend blij mee! Ik zou willen dat ik wat vaker langs kon 
komen, maar de afstand van bijna 20.000 kilometer maakt dat op dit moment een beetje 
lastig. Ik hoop dit in de komende jaren goed te maken. Hetzelfde geldt voor Lucien. Als bijna-
afgestudeerde ga je binnenkort immers ook het ‘dokters pad’ op en ben daarom benieuwd 
hoe je dat zult ervaren. Als ik zie wat je allemaal voor talenten in huis hebt, weet ik zeker dat 
je ook dit tot een goed einde zal gaan brengen. Bedankt voor je bijdrage aan de cover: die is 
prachtig geworden! Vond het fijn dat jullie alle drie (Emma interesseert het geloof ik nog niet 
zo) altijd geïnteresseerd waren, ondanks dat het vaak moeilijk te begrijpen was waar ik nou 
precies mee bezig was!
Last but not least: mum en ded. Ik vind het erg moeilijk om de juiste woorden te vinden om 
goed duidelijk te kunnen maken hoeveel jullie voor me betekenen. Jullie stonden, en staan 
nog steeds, altijd voor mij klaar wat er ook gebeurde. Zo hebben jullie me altijd gestimuleerd 
om gewoon te gaan voor de dingen die ik graag wilde doen, zelfs toen dit betekende dat ik 
aan de andere kant van de wereld zou gaan wonen. Zonder jullie hulp en steun had ik het dan 
ook nooit zo ver kunnen schoppen en daar ben ik jullie oneindig dankbaar voor!!
